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I. INTRODUCTION 
The prelmplantatlon stages of mammalian development involve the in 
vivo fertilization of an ovum to form a zygote which then undergoes a 
series of cleavage divisions to give rise to a blastocyst embryo in 
about four days. The hollow, spherical blastocyst embryo is equivalent 
in size to the original zygote (about 0.1 mm in diameter), but is com­
posed of 30-40 cells. Three-fourths of these cells comprise the surface 
monolayer of trophectoderm, while the remaining one-fourth of cells com­
prise the inner cell mass (ICM). The trophectoderm surrounds the blasto-
coel and the inner cell mass which is located at one pole of the blasto-
coel. The trophectoderm is surrounded by the mucoproteinous zona 
pellucida. Prior to implantation, between four to five days after 
fertilization, the blastocyst embryo hatches from the zona pellucida and 
invades the uterine endometrium. 
In man and laboratory rodents, implantation initiates the development 
of the hemochorial placenta. The trophectoderm of the embryo becomes 
very invasive, exhibiting phagocytic-like properties. The mural tropho-
blast cells, adjacent to the blastocoelic cavity cease dividing, but 
continue to replicate their DNA to form primary giant cells. The polar 
trophoblast cells, overlying the inner cell mass, continue to divide and 
form a conical mass of cells, the ectoplacental cone. The peripheral 
cells of this cone transform into secondary giant cells that are indis­
tinguishable from those of the mural trophoblast. Nongiant cells of the 
2 
ectoplacental cone produce villi which penetrate the endometrial cell 
layer and invade maternal capillaries. The inner cell mass divides to 
form the egg cylinder which differentiates to form the chorion, allan-
tois, yolk sac, amnion, and the embyro (Gardner and Johnson, 1975). A 
parabiotic relationship is thus established between the embryo and the 
mother. The embryo is nourished through the fetal stages of development 
until birth terminates the relationship. 
The preimplantat ion stages of mammalian development involve a 
series of observable morphological changes, as described above. An under­
standing of the molecular events during this time of development has 
been more difficult to obtain due to limitations on availability of 
materials. Therefore, most ideas concerning early mammalian embryogenesis 
have been obtained from experiments on amphibians and echinoderm embryos— 
both of which are large in size and can be obtained In large quantities. 
Generally speaking, many conclusions about early embryogenesis in amphib­
ians and echlnoderms do not apply to mammals. Externally developing 
eggs, from amphibians and echlnoderms, inherit from the maternal organism 
the machinery for protein synthesis that is necessary for development 
through the cleavage stages. The embryo may synthesize mSNA during 
cleavage, but it Is not essential since embryos appear to be insensitive 
to actlnomycin D treatment. Synthesis of tRNA and rRNA begins at the 
late blastula and gastrula stages of development (Gross, 1968). 
With the development of microanalytlc techniques, mlcromanlpulatlve 
procedures, and chemically defined culture media, the feasibility of 
examining mammalIan embryos has been Improved (Sherman, 1979). Most 
3 
work on early mammalian embryogenesls has been done with the mouse 
because of Its short gestation period (about 20 days), the availability 
of genetic markers, and the ability to successfully culture mouse embryos 
from the two-cell stage to the blastocyst stage In simple, chemically 
defined Whltten and Blggers (1968) medium. 
Molecular events (I.e., protein synthesis, RNA synthesis, and DNA 
synthesis) have been Investigated In mouse embryos In order to determine 
when the embryonic genome Is first expressed during the prelmplantatlon 
stages of development and how the expression Is regulated. The expres­
sion of the embryonic genome into cellular phenotypes, requires the 
synthesis of messenger RNA (mRNA) molecules and their subsequent trans­
lation into protein. Protein synthesis was initially studied by examin­
ing enzyme activity during the early stages of development. The first 
report of enzyme activity in prelmplantatlon mouse embryos was made by 
Brinster (1965). He found that lactate dehydrogenase decreased in activity 
from the two-cell through the blastocyst stages of development. The 
activity of several other enzymes during prelmplantatlon development have 
been reported and are briefly reviewed. The activities of gluco8e-6-
phosphate dehydrogenase (Brinster, 1966; Epstein et al., 1969), guanine 
deaminase (Epstein et al., 1971) and glucose phosphate isomerase 
(Chapman et al., 1971) decrease from the fertilized egg to the blastocyst 
stage of development, while the activities of hypoxanthine-guanine 
phosphoribosyl transferase, adenine phosphoribosyl transferase, and 
hexoklnase increase during these same stages of development (Brinster, 
1968; Epstein, 1970). 
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le should be mentioned that enzyme activity studies do not 
necessarily confirm embryonic gene expression. Increases and decreases 
in enzyme activities could be attributed to the unmasking of certain 
maternal mRHA's and the degradation of other maternal mRHA's. Chapman 
et al. (1971) were the first to clearly demonstrate that early mammalian 
embryos translated embyronic mBNA's as opposed to maternal mRNA's. The 
investigators detected the presence of the paternal isozymic form of 
glucose phosphate isomerase in late mouse blastocyst embryos. Brinster 
(1973) later demonstrated that expression of the paternal glucose phos­
phate isomerase occurred by the 6-cell stage. These findings with mouse 
embryos are in contrast to findings in other species in which paternal 
alleles are not active until the hatching stage in Drosophjla (Wright 
and Shaw, 1970), the tailbud stage in frogs (Wright and Subtelny, 1971) 
and the primitive streak stage in Japanese quail (Ohno et al., 1968). 
Another independent set of data which supports the necessity of 
the embryonic gene expression during early mouse development involves 
the T-locus (reviewed by Bennett, 1975; McLaren, 1976; Klein and Hammer-
berg, 1977). The T-locus is located on chromosome 17 and has been iden­
tified by sets of dominant and recessive mutations which affect embryonic 
12 development in the mouse embryo. One mutation, the t_ , when present 
in the homozygous condition, allows the embryo to develop to the morula 
(16-cell) stage, but no further—the embryo dies. Several biochemical 
12 hypotheses have been proposed to explain the lethality of the _t homo­
zygous recessive condition. Defects in ribosomal RNA production, lipid 
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production and aerobic metabolism have been shown, so It Is clear that 
the embryonic genome is not functioning properly. 
Generally speaking, there appears to be no net increase in the 
protein content of the preimplantation mouse embryo. Epstein and Smith 
(1973) examined the problem of amino acid uptake and endogenous pools 
in relation to protein synthesis. They concluded that there was a sig­
nificant increase in the rate of protein synthesis in mouse embryos be­
tween the 8-cell and blastocyst stages of development, but the protein 
synthetic rate remained fairly constant when examined on a per cell 
basis. This study suggested that protein synthesis during preimplanta­
tion development was a dynamic process and supported the appearance of 
different enzymes during development. 
Electrophoretic profiles on 2-D gels have demonstrated that a 
variety of proteins are produced throughout the preimplantation stages 
of development in the mouse. A large population of proteins is consti­
tutive (present throughout the entire period), while other proteins 
appear to be stage specific. Proteins have been detected in the fer­
tilized egg through the second cleavage division, then disappear. Pro­
teins that were absent during early cleavage were detected from the 
8-cell stage through the blastocyst stage of development (Van Blerkom 
et al., 1976; Levinson et al., 1978). The 2-D gel method is very sen­
sitive. It is capable of detecting protein synthesized at rates as low 
as 0.05% of the total synthesis (Solter and Knowles, 1979). The 2-D 
gel method does have limitations. Levinson et al. (1978) were unable 
to detect any differences in protein patterns of embryos from several 
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different Inbred strains of mice, although the strains differed In 
several Isozymes synthesized during the period examined. Also, post-
translatlonal modifications of proteins at certain stages of development 
may alter their electrophoretlc profile and, consequently, give the Im­
pression that they are stage specific. 
Stage-specific glycoproteins have been examined by In vitro 
incubation of preimplantation mouse embryos with D-[^H]-or D-[^^C]-
glucosamlne (Pinsker and Mlntz, 1973). The embryos were treated with 
pronase to remove the zona pelluclda, then disrupted with detergent, 
and fractionated by gel filtration. It was found that mouse embryos of 
the 4- to 8-cell stage and morula to blastocyst stage of development 
were able to convert glucosamine to galactosamlne, N-acetyl glucosamine, 
and glucose with blastocyst embryos showing the most label incorporation. 
It was postulated that these glycoproteins may be Involved in providing 
the receptors for the embryo to Implant into the uterine wall (Pinsker 
and Mlntz, 1973; Surani, 1979). A more complete discussion of cell sur­
face glycoproteins on preImplantation mouse embryos Is given later. 
The demonstration of quantitative and qualitative changes in protein 
synthesis does not in Itself furnish conclusive evidence for activity 
of the embryonic genome. Through the use of Isozymlc markers, as men­
tioned earlier, and the use of inhibitors of RNA synthesis, the expres­
sion of the embryonic genome can be studied. In the mouse, there is a 
negligible Increase in the net RNA content from fertilization to the 
early blastocyst stage of development (Olds et al., 1973). The follow­
ing classes of RNA have been identified in the preimplantation mouse 
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embryo: 4s RNA and 5s RNA by the 2- or 4-cell stage and rlbosomal RNA 
by the 4-cell stage (Clegg and Piko, 1975). 
Monesl et al. (1970) Incubated prelmplantatlon mouse embryos in the 
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presence of 1 #g/ml actinomycin D. The rate of H-leucine incorporation 
decreased to about 50% of control values over a period of 12 hours,then 
remained relatively constant. These results suggested that the embryonic 
genome was impaired in its de novo production of a class of mRNA's, 
which are turned over fairly rapidly, then replaced. The nonspecific 
effects of actinomycin D on tRNA's and rRNA's complicate the validity 
of this conclusion. Later studies with actinomycin D and the more 
specific, RIJA polymerase inhibitor, a-amanatin, have been used to show 
that compaction of blastomeres is relatively resistant to inhibitor at 
the 8-cell stage, but identical or lower doses of inhibitor interfere 
with cavitation when added to morula stage embryos (Golbus et al., 1973; 
Warner and Versteegh, 1974; Levey et al., 1977). These results suggest 
that endogenous mRNA's support the initial stages of preimplantation 
development, but the morula stage requires the synthesis of new mRNA. 
This could also mean that post-transcriptional control is important in 
the earliest stages of development, whereas, transcription control is 
Important in the morula and later stages of development. Studies invol­
ving enzyme activities, paternal isozyme expression and inhibitors of 
RI'IA synthesis leave little doubt that the embryonic genome is expressed 
during preimplantation development in the mouse. 
Several studies have been performed to characterize DNA synthesis 
in preimplantation mouse embryos according to duration of cell cycles. 
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quantity of MJA present, and DNA polymerase activity. The first cell 
division In the mouse zygote occurs 24 hours after fertilization. The 
time required for subsequent cell cycles diminishes as cleavage progresses 
(McLaren, 1972). MJA synthesis begins four to six hours after fertiliza­
tion (Luthardt and Donahue, 1973). The initial S phase following ferti­
lization lasts for about four hours. In the second and subsequent cell 
cycles, DNA replication requires six to seven hours (Luthardt and 
Donahue, 1975; Mukherjee, 1976; Sawlckl et al., 1978). The shortening 
of the cell cycle time is probably due to a decrease in the duration of 
the phase. It has been reported that the 2-cell mouse embryo has a 
12-15 hour Gg phases while the G^ phase in the 4- to 8-cell transition 
period is only 0.5 hour (Sawlckl et al., 1978). 
The cell cycle is believed to vary within the cells of the same 
embryo, starting at the morula (16-cell) stage of development. The Inner 
cells of morula and blastocyst embryos have been shown to have higher 
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H-thymldine labeling Indices than the outer cells (Barlow et al., 1972). 
This suggests that a shorter cell cycle is present in the inner cells 
as opposed to the outer cells of the embryos at these stages of develop­
ment. 
Olds et al. (1973) determined the quantity of DNA present In each 
stage of preimplantatlon mouse development by perchloric acid precipi­
tation and fluorometry. They found the mean values of DNA to be 23.8, 
29.3, 41.1, 155, and 439 pg for the oocyte, 1-cell, 2-cell, 8-cell, and 
blastocyst (about 32 cells) stages of embryonic development, respectively. 
On a per cell basis, DNA content decreases from the oocyte (24 pg/cell) 
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through the blastocyst stage (13 pg/cell) of development. The "extra" 
DNA in early stages was attributed to polar body DNA, with three polar 
bodies persisting to the 2-cell stage and one polar body persisting to 
the 16-cell stage. The point that needs to be emphasized, is though 
the embryo has retained the same size throughout the preimplantation 
stages of development, total DNA content has increased almost 20 times. 
The onset of DNA synthesis infers the existence of the necessary 
enzymatic machinery for DNA replication. Kiessling and Weitlauf (1979, 
1981) have detected DNA polymerase activity in preimplantation mouse 
embryos. Their detected enzyme exhibited properties similar to DNA 
polymerase-V and the activity increased markedly when the embryos dif­
ferentiated into inner cell mass and trophectoderm. Mammalian cells con­
tain three types of template directed DNA polymerizing enzymes designated 
DNA polymerases -a, and -Y(Weissbach et al., 1975). DNA polymerase-
œ is believed to be involved in replication, while DNA polymerase-# is 
believed to be involved in DNA repair. DNA polymerase-Y has had no 
function ascribed to it at this time, though it has been hypothesized 
to have a very specialized role (Huberman, 1981). Therefore, Kiessling 
and Weitlauf*s report of DNA polymerase-Y-like activity during embryonic 
development when differentiation into two cell types occurs is of special 
interest for defining a role for DNA polymerase-Y and for further in­
vestigation into the details of the mechanisms which control DNA synthesis 
in preimplantation mouse embryos. 
A discussion of DNA synthesis in preminplantaion mouse embryos cannot 
be concluded without mentioning the role of mitochondrial DNA. The 
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mouse oocyte contains round mitochondria with concentrically arranged 
cristae. During early embryogenesis, there is a gradual elongation of 
the mitochondria to an adult-like form. Fiko and Chase (1973) examined 
the mitochondrial activity in mouse embryos of the 2- to 4-cell stage 
through the blastocyst stage of development. They used a DNA inhibitor, 
ethidium bromide, and a protein inhibitor specific to the mitochondria, 
chloramphenicol. They found that mitochondrial ribosomal and transfer 
RNA syntheses occurred from the 8- to 16-cell stage through the blasto­
cyst stage of development. A mitochondrial protein synthesizing system 
also operated during these stages of development. However, they con­
cluded that embryo development and cellular differentiation up to the 
blastocyst stage were not dependent on mitochondrial genetic activity. 
Cascio and Wassarman (1981) used an inhibitor of cytoplasmic protein 
synthesis, emetine, and confirmed Pikb and Chase's earlier work with 
regard to 8-cell mouse embryos. In addition, Cascio and Wassarman (1981) 
found that proteins of mitochondrial origin comprise only one to two 
percent of the total protein produced during this stage. 
In summary, the preimplantation mouse embryo genome is biochemically 
active with regard to protein synthesis, RNA synthesis and DNA synthesis. 
The rest of this introduction will deal with one particular class of pro­
teins found on early mouse embryos: cell surface proteins. 
A large part of this dissertation involves the examination of cell 
surface proteins on 8-cell and blastocyst mouse embryos. Special effort 
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was placed on the detection of Histocompatibility-2 (H-2) antigens on 
these embryonic stages of development. Therefore, a brief account of 
the history, structure and function of these proteins will be given. 
In 1937, Peter Gorer described a set of molecules that he had 
observed in the mouse (Gorer, 1937). Tliese molecules could be recognized 
by: (1) making antiserum against them and then studying them serolog­
ically and (2) transplanting cells or tissues carrying one type of mole­
cule Into a mouse containing corresponding molecules which were different; 
the introduced cells were destroyed (rejected) by the recipients. The 
molecules were designated hlstocompatlbillty-2 (H-2) antigens by Gorer, 
Lyman and Snell (1948). Later research proved that the H-2 antigens 
were coded for by a series of linked genes which were then denoted as 
the 11-2 complex. Other species exhibit similar complexes: e.g., HLA 
in the human, Rt-1 in the rat, in the chicken, and SLA in the pig. 
The major histocompatibility complex (MHC) serves as the generic name 
for these complexes and also reflects the fact that there are many 
"minor" histocompatibility systems which appear to play a lesser role 
in the rejection phenomenon (Klein, 1975). 
The H-2 complex is located in the middle portion of chromosome 17 
(see Figure la). Chromosome 17 also bears three other groups of loci: 
(1) loci controlling embryonic differentiation (%, Kb, Fu, and qk); 
(2) loci controlling hair growth (tf and thf); and (3) loci coding for 
isozymes (Fgk-2. Ce-2, Ap-1, Glo-1. and Map-2) (Klein, 1975, 1979). 
Pu tf 
Tla 
Glo-1 H-2K H-2D 
Pgk-2 
.Ce-2 
Figure la. Abbreviated genetic map of chromosome 17 (Klein, 1975, 1979). The loci from left to 
right are centromere (•), brachyury (%), quaking (gfc), fused (Eji) » tufted (tf), 
knobby (Kb)« glyoxylase-1 (Glo-1), histocompatibility-2K (H-2K). histocompatibility-
2D (H-2D), thymus-leukemia antigen (Tla), phospoglycerate kinase-2 (Pgk-2), kidney 
catalase (Ce-2), acid phosphatase-liver (Apl), a-mannoside processing-2 (Map-2), 
thin fur (thf). Brackets indicate the order of loci is not known 
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The H-2 complex is diagrammed in Figure lb. The position of each 
H-2 locus was determined by typing recombinants derived from heterozygous 
parents in which two chromosome 17s have undergone crossing-over in a 
particular position within the H-2 complex. 
The H-2 loci can be grouped into at least three classes based on 
phenotypic expression. Class I loci (H-2K and H-2D) code for membrane-
bound glycoproteins (the H-2 antigens) with a molecular weight of 45,000. 
The Class I molecules (H-2K and H-2D) consists of a single polypeptide 
chain of about 350 amino acids with two associated carbohydrate side 
chains. In the membrane, the Class I molecule is noncovalently associated 
with /^-microglobulin which is a shorter polypeptide chain (about 100 
amino acids) and 12,000 MW. /^-Microglobulin is not encoded by the H-2 
complex, but has recently been mapped to the H-3 region of chromosome 2 
(Michaelson, 1981). Class I molecules are detectable on all lymphoid 
cells and most other cells of the organism. Class I molecules can be 
detected serologically by producing antibodies against them or by gener­
ating lymphocytes that are cytotoxic for H-2K and H-2D bearing target 
cells. 
Class I molecules are characterized by private and public 
specificities. These specificities are serologically detectable and are 
used to describe the haplotype of a mouse strain. The set of serolog­
ically detected proteins produced by the H-2 complex of an inbred strain 
of mice comprises the haplotype for that strain of mice and is desig­
nated by a small Roman letter (e.g., a, b, d, or k). The private 
Region TL 
Locus 
H-2K Ir—1 Ss 
•= 1 
H-2G H-2D 
1 =
Tla 
-I = 1 
Products Cell Cell Serum Erythrocyte Cell Cell 
Membrane Membrane Proteins Membrane Membrane Membrane 
Molecules Molecules Molecules Molecules itolecules 
Functions Marker for Immune 
cytotoxicity response 
against control 
nonself cell-
components cell 
inter­
actions 
Complement Conylement Marker for 
components component cytotoxicity 
against 
nonself 
components 
Unknown 
Figure lb. Enlarged H-2 complex (Shreffler, 1979; Klein et al., 1981) 
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specificity is exhibited by only the JK or only the ^  protein product 
of a particular Inbred strain of mice, whereas, the public specificities 
are detectable in either the ^  or JD protein product of one Inbred strain 
of mice or may be detectable in the K. or_D. protein product of a differ­
ent inbred strain of mice. 
Class II molecules (la antigens) are membrane-bound glycoproteins 
consisting of two noncovalently associated polypeptide chains,a (35,000 
MW) and # (28,000 MW), and an unknown number of carbohydrate chains. 
A minimum of four polypeptide chains Aq, Ag, A^(E^), and are encoded 
by the I region. The chains are synthesized separately in the cytoplasm, 
but combine to form heterodimers before they integrate into the plasma 
membrane. The Aq combines with Ag to form an A molecule and the A^ com­
bines with Eq to form an E molecule (Klein et al., 1981). 
Class II molecules are expressed on lymph node and splenic 
lymphocytes, but are very weakly expressed on thymocytes. The Class 
II molecules are detectable on macrophages, fetal liver cells, epidermal 
cells, bone marrow cells, and spermatozoa, but are absent from erythro­
cytes, brain tissue, kidney cells, and liver cells. The Class II mole­
cules were originally detected serologically with antibodies and were 
later shown to be responsible for the activation of lymphocytes in a 
mixed lymphocyte reaction (reviewed by Cullen et al., 1976 and David, 
1976). 
Class III molecules are the serum protein Ss (serum serological) 
and Sip (sex-limited protein). Both proteins have a molecular weight 
of 200,000 and consist of three covalently linked polypeptide chains. 
16 
a (87,000 MW), /3 (78,000 ÎW) and y (33,000 MW). These molecules com­
prise the C4 component of the classical complement pathway (Klein, 1979). 
Class I and Class II glycoproteins are Involved In lomune 
responsiveness. Immune suppression, T-B cell Interaction, and the restric­
tion of T-cell specificity. The role of the H-2 products appears to be 
to provide a context for antigen recognition. This recognition capa­
bility may enable the organism to distinguish self from nonself. The 
simultaneous recognition of antigen and H-2 molecule restricts the 
specificity of the T lymphocyte. The Class I and Class II molecules are 
all heterodlmers and consist of one highly variable polypeptide chain 
(K, D, A^, and E^) and one relatively constant polypeptide chain (^g-
mlcroglobulln, A(%, and E(%) (Klein et al., 1981). The polymorphism of 
the resulting heterodlmers would provide the potential for an array of 
H-2 antigens which could specifically interact with cells within the 
same individual and against nonself cells or organisms. 
Mammalian viviparity has produced a situation which has puzzled 
transplantation biologists for at least the last three decades. The 
embryo, an allograft exhibiting a genetically different set of antigens 
than the mother, escapes the immune surveillance system of the mother 
and will implant in the endometrium and will be successfully nourished 
to term by the mother. 
Medawar (1953) proposed that there were three possible reasons why 
the fetus did not provoke an immunological response from the mother: 
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(1) there was an anatomical separation of the fetus from the mother; 
(2) the mother was immunologically inert during pregnancy; and (3) the 
fetus was antigenically immature. It is well-established that immuno­
globulins are transferred from the mother to the fetus during pregnancy 
(Brambell, 1970). Therefore, there is no anatomical barrier to an 
immunological response in the post-implanted embryo. 
The immunological inertness of the mother has been shown to be 
unlikely. Bernard et al. (1977) demonstrated with sheep Fab anti-mouse 
Immunoglobulins, labeled with peroxidase, that maternal immunoglobulins 
were present in the blastocoel and on the trophectodermal cells of day 5 
implanted mouse blastocysts. Maternal immunoglobulins were also found 
in the visceral yolk sac and embryonic gut of nine-day embryos. In a 
later study, Bernard et al. (1981) characterized the isotype and concen­
tration of immunoglobulin in the mouse uterus from two to six days post-
conception. They found that IgA plasma cells gradually concentrated 
around uterine glands and in the uterine lumen. IgG concentration in­
creased in the uterine stroma, while the decidua contained no detectable 
immunoglobulins. 
The cell-mediated response of the pregnant female has been reported 
to be depressed during pregnancy, but there also have been reports which 
clearly establish that the mother's cellular immune system can be sensi­
tized against paternal and embryonic antigens (reviewed by Bernard, 1977). 
Maternal hormonal changes may be responsible for suppressing some 
cellular responses during pregnancy. Estradiol has been shown to pro­
long first and second set skin grafts in mice and to involute the thymus 
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In adule mice. Estradiol, progesterone and diethylstilbestrol at 10-50 
lig/ml reduce lymphocyte proliferative response to mitogenic plant lectins 
PHA and con A (Rocklin et al., 1979). Most hormonal suppressions of 
2 immune systems 1^ vitro involve hormone concentrations that are 10 to 
3 10 times higher than normal physiological concentrations. 
Another suppressor of cellular responses during pregnancy is 
alpha-fetoprotein which is produced by the fetus and is present in the 
amniotic fluid and fetal serum of many species. The role of alpha-
fetoprotein is uncertain, but it appears to activate suppressor cells 
(Goldl et al., 1979). 
The fetus is believed to express antigens which are detectable by 
the mother, as can be demonstrated by the occurrence of hemolytic 
disease of the newborn (erythroblastosis fetalis), and by the variety of 
antibody specificities detectable in multiparous female serum. It has 
been postulated that multiparous serum contains blocking or enhancing 
antibodies which may act (1) by masking the foreign antigens on the 
embryonic cell surface, or (2) by leading to the shedding of antigens by 
the cell, thus preventing recognition by effector cells, or (3) by form­
ing antigen-antibody complexes which are then unable to be processed by 
maternal lymphocytes. The exact role that maternal immunoglobulins play 
is difficult to ascertain since some evidence for each of the three post­
ulates have been observed in animal systems (reviewed by Bernard, 1977 
and Rocklin et al., 1979). However, there is general agreement that the 
postImplantation embryo expresses antigens detectable by the maternal 
immune system (Klrkwood and Billington, 1981). 
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The role of the prelmplantatlon embryo In escaping maternal Immune 
surveillance Is not understood. There Is no physical barrier between 
the mother and the prelmplantatlon embryo except for the zona pelluclda, 
which is permeable to immunoglobulins (Sellens and Jenkinson, 1975). 
It is possible that the prelmplantatlon embryo is not present long enough 
to be recognized by the maternal Immune system and responded against. 
This seems unlikely, especially with reference to Bernard et al. (1981), 
who found that Immunoglobulin concentrations Increased in the uterus 
during the prelmplantatlon stages of pregnancy. The exact target of 
these Immunoglobulins is difficult to pinpoint. The Immunoglobulins 
may be against proteins of the zona pelluclda, which is shed prior to 
implantation. Nevertheless, the presence of increased immunoglobulin 
concentrations in the uterus may suggest that the prelmplantatlon embryo 
expresses antigenic determinants. The identification and characteriza­
tion of these determinants have been the subject of a great deal of 
investigation (reviewed by Johnson and Calarco, 1980; Jenkinson and 
Blllington, 1977). 
Studies involving prelmplantatlon stages of mouse development have 
shown that prelmplantatlon mouse embryos express teratoma-assoclated 
antigens (Artzt et al., 1973; Gooding et al., 1976); stage-specific 
antigens (Levinson et al., 1978; Solter and Knowles, 1978); the F9 anti­
gen (Artzt et al., 1973); sperm antigens (Menge and Fleming, 1978); 
PCC4 antigens (Gachelln et al., 1977); and H-Y antigens (Krco and Gold­
berg, 1976). 
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Of special Interest In the phenomenon of maternal tolerance of 
the prelmplantatlon embryo Is whether of not H-2 antigens are expressed 
on the embryo. Disparity between H-2 antigens Is responsible for tissue 
graft rejection. Therefore, their absence may explain the Inability of 
the mother to reject the genetically different embryo. H-2 antigens 
have been identified on post-implantation mouse embryos, seven to nine 
days old (Edidln, 1972a; Pathey and Edidln, 1973). The presence of H-2 
antigens on prelmplantatlon mouse embryos has proven to be more contro­
versial due to questions Involving the specificty of antlsera and the 
sensitivity of detection methods. 
H-2 antigens are detectable on sperm and unfertilized mouse ova 
(Johnson and Edidln, 1972; Edidln, 1972b). Several reports have failed 
to demonstrate H-2 antigens on embryos between the 1-cell and blastocyst 
stages (day 1 through day 5) of development (Palm et al., 1971; Edidln, 
1972a; Muggleton-Harris and Johnson, 1976; Sellens, 1977). Transplanta­
tion experiments in which blastocyst embryos were treated with anti-H-2' 
serum or in which the recipient, allogeneic females were prelmmunlzed with 
H-2 antigens prior to the transfer of the blastocyst embryos, have shown 
that the blastocyst embryos fall to develop (Klrby et àl., 1966; Klrby, 
1968; James, 1969). Searle et al. (1976) demonstrated the presence of 
H-2 antigens on the trophectoderm of blastocyst embryos by using a sensi­
tive electron mlcroscope-immunoperoxldase technique and specific anti-H-2 
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sera produced in congenic strains of mice. Webb et al. (1977) used I-
lactoperoxldase and anti-H-2 sera to attempt to label and Isolate H-2 
antigens from the 2-cell to the blastocyst stage of preimplaataion mnuae 
21 
development. Their method was able to detect H-2 antigens only on the 
inner cell mass of the late blastocyst embryo. They were unable to 
detect H-2 antigens on earlier stages of development or on the trophecto-
derm of the blastocyst where Searle et al. (1976) had detected H-2 
antigens. This discrepancy could be explained by the relative Insensl-
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tivity of the I-lactoperoxldase procedure. Krco and Goldberg (1977) 
have reported the presence of H-2 antigens on 8-cell entryos, though no 
confirmation of this report has appeared In the literature. They treated 
inbred and congenic 8-cell mouse embryos with pronase to remove the zona 
pellucida, then with antl-H-2 sera obtained from the National Institutes 
of Health (Bethesda, Maryland), followed by an incubation with guinea 
pig complement. Embryos were examined with a light microscope and scored 
positively for H-2 if at least one of the 8-cells was lysed. It can 
be concluded that H-2 antigens are probably expressed on the blastocyst 
embryo and maybe on the 8-cell embryo. Data presented in this disserta­
tion will support such a conclusion. 
As mentioned previously, la antigens are found on only select 
tissues throughout the body, as compared to wide distribution of H-2K 
and H-2D antigens. Examination of la antigens on mouse embryos with 
anti-la sera in conjunction with inmunopreclpitatlon and Immunofluores­
cence has shown that embryonic cells do not exhibit la antigens until 
11 days postconception (Delovltch et al., 1978). Jenklnson and Searle 
(1979) used a sensitive electron microscopic immunoperoxidase technique 
and specific antl-Ia sera on 3.5 day blastocyst embryos and the 7.5 day 
post-implantation conceptus. They were unable to detect la antigens on 
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either stage of development. Therefore, it appears as though la anti­
gens are not expressed as preimplantation embryos nor early post-
implantation embryos. 
In order to successfully detect H-2 antigens on mouse embryos, a 
sensitive assay system needed to be developed. Searle et al. (1976) 
used an Immunoperoxidase electron microscopic system and Webb et al. 
125 (1977) used an immunoprecipltation system with an I-label. Both 
research groups demonstrated the presence of H-2 on mouse blastocyst 
embryos. A third type of assay system was employed to generate the data 
for this dissertation—the complement-dependent cytotoxicity assay. 
Complement-dependent cytotoxicity assays are commonly used to demonstrate 
antibodies to cell surface antigens. The complement-dependent cytotox­
icity assay has been successfully applied to lymphoid cells where 
cytotoxicity is commonly measured by (1) release of ^^Cr (Sanderson, 
1964; Wlgzell, 1965) or (2) the uptake of trypan blue dye (Gorer and 
0'Gorman, 1956). In the ^^Cr release cytotoxicity assay, target lympho­
cytes are labeled with ^^Cr-chromate during a short Incubation period. 
Chromate enters the cells by an energy-independent process. The intra­
cellular chromate reduces to chromic ion which hydrates to form a 
hexaquo ion. This maintains a concentration gradient for chromate and 
allows for very high levels of uptake. The cells are then washed and 
incubated with antiserum and complement. A cytotoxic index is deter­
mined by the activity released by the test sample divided by the total 
activity released by control (normal serum-tested) cells. 
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In the cytotoxicity assay involving the uptake of trypan blue dye, 
the cytotoxic effects of antibody and complement are measured by the 
failure of dead cells to exclude the vital dye. Quantitation of cells 
Is determined by microscopic examination of test samples. 
These cytotoxicity assays have both advantages and disadvantages 
which should be considered. Cytotoxicity assays Involving the release 
of ^^Cr have the advantage of being objective, but have the disadvantage 
of requiring prelabellng and washing of cells. And, of course, ^^Cr is 
a 7-emitter, so that prolonged use could be a health hazard. Dye uptake 
cytotoxicity assays have the advantages of being inexpensive, fast and 
require few manipulations. Disadvantages are the possibility of operator 
subjectivity, a limit to the number of samples that can be analyzed by 
a single operator and the impossibility of evaluating samples when a 
large percentage of dead cells from the preparation procedure may be 
present. 
Objectivity and reproducibility have been obtained with cytotoxicity 
assays which take advantage of the fact that live cells will Incorporate 
small molecular weight radioactive precursors into high molecular weight 
products, whereas dead cells will not. Klein and Perlmann (1963) first 
3 
reported a cytotoxicity assay system in which H-thymldlne was incor­
porated into the DNA of ascites tumor cells which had been treated with 
3 
antiserum (or normal serum) and complement prior to H-thymldlne treat­
ment. Later, Knudsen et al. (1974) automated the assay, using a MASH 
(multiple automated sample harvester). The only limitation of the DNA 
synthesis cytotoxicity assay procedure is that the tested cells must be 
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undergoing mitosis, which requires a mltogenlc stimulation of lymphoid 
cells or the testing of tumor cells In their log phase of growth. It 
will be shown In this dissertation that a complement-dependent cytotox­
icity assay, employing ^H-thymidine, is feasible for use on preimplanta-
tlon mouse embryos since they are a rapidly dividing tissue and need not 
3 
be exogenously induced to divide. The use of H-thymidine uptake and 
cell harvesting provides an objective and automated procedure for the 
collection of data. Visual observation of trypan blue dye uptake by 
embryos treated with antiserum and complement was not feasible due to 
the three-dimensional morphology of the spherical embryos. Lysed cells 
could not be easily and objectively deciphered from live, nonlysed cells. 
Likewise, ^^Cr release was not possible to use since only one-two cpm 
per cell are taken up. 
The major purpose of the work described in this dissertation was 
to develop a reproducible and reliable assay procedure to examine H-2 
antigens on preimplantatlon mouse blastocyst and 8-cell embryos. First, 
the ability of rapidly dividing embryonic cells to incorporate 
3 
thymidine was examined and parameters for optimal H-thymidine incorpor-
3 
ation were developed. The effect of various compounds on H-thymidine 
incorporation by embyros was then examined. The ability of embryos to 
3 
incorporate H-thymidine was then used as a viability measurement after 
embryos were treated with anti-H-2 sera and complement in a cytotoxicity 
assay. Embryos were then screened for potential H-2 antigens using a 
variety of antlsera. 
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II. EXPERIMENTAL PROCEDURES 
A. Experimental Animals 
1. Mice 
CFl mice were obtained from Charles River Breeding Laboratories, 
Wilmington, Massachusetts. The Inbred and congenlc mouse strains listed 
In Table 1 were obtained from the Jackson Laboratory, Bar Harbor, Maine. 
The mice were housed in a day (14h)-night (lOh) cycled room with food 
and water ad libitum. The room was light from 7 a.m. to 9 p.m. daylight 
savings time, or 6 a.m. to 8 p.m. standard tine. Therefore, the clock 
was never changed throughout the year. Female mice were kept in poly­
carbonate cages in groups of eight. Male mice were kept in metal cages 
with one male per cage. 
2. Superovulation of mice 
Female mice, two-six months old, were superovulated with 5 lU PMS 
(pregnant mare serum, Organon, Plnebrook, New Jersey) at 4 p.m. (day­
light savings time) or 3 p.m. (standard time) followed 48 hours later 
with 10 lU hCG (human chorionic gonadotropin, ICN Nutritional Biochemlcals, 
Cleveland, Ohio). Each female was placed with a single male immediately 
after hCG injection and checked for the presence of a vaginal plug the 
following morning. 
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Table 1. H-2 haplotypes of mouse strains used In this study 
Strain KABJEC^GD 
C57BL/10Sn (BIO) bbbbbbbbb 
BIO.A kkkkkdddd 
610.BR kkkkkkkkk 
B10.D2 ddddddddd 
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B. Buffers, Solutions, and 
Culture Media 
The various buffers, solutions and culture media used can be found 
in Table 2. 
C. Preparation of Embryos 
1. Collection of embryos 
Embryos were collected as described by Rafferty (1970). Plug positive 
females were killed by cervical dislocation at 64 to 71 hours post-hCG 
injection to obtain âight-cell embryos, or 88 to 96 hours post-hCG injec­
tion to obtain blastocysts. A mid-line abdominal incision was made to 
expose the peritoneal cavity. The intestines were moved to the side to 
expose the bicomate uterus. For eight-cell embryos, the oviduct along 
with one-fourth of the upper uterine horn was excised and placed in a 
culture concavity slide (Carolina Biological Supply, Burlington, North 
Carolina) containing about 0.2 ml of Whitten and Biggers medium. The 
second oviduct was collected in the same slide. For blastocysts, the 
oviduct and entire uterine horn, excised at the vaginal junction, was 
placed in a culture concavity slide containing about 0.2 ml of Whitten 
and Biggers medium. The second uterine horn was collected into the same 
slide. 
A disposable 1 ml TB syringe (Becton-Dickinson, Rutherford, New 
Jersey) was filled with Whitten and Biggers media. For eight-cell embryos, 
a nondisposable blunted 30 gauge needle (Popper and Sons, New Hyde Park, 
New York) was attached to the syringe. The needle was then inserted into 
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the ostium of the oviduct as viewed through a Bausch & Lomb dissecting 
microscope (Fischer, Fair Lawn, New Jersey) and 0.2 ml of medium was 
flushed through the oviduct. For blastocysts, a disposable 30 gauge 
needle was attached to the syringe. The needle was then Inserted into 
the uterine lumen through the apical end of the uterine horn, near the 
oviduct and 0.5 ml of medium was flushed through the horn. Flushings 
from one mouse were collected in one concave slide, which was then 
placed In 5% GO^ in air (Matheson, analyzed, Jolliet, Illinois) and 
allowed to settle before embryos were collected, sorted, counted, and 
pooled. The pooled embryos were washed with three changes of Whltten 
and Blggers medium, then used. 
2. Pronasing of embryos 
Embryos were treated with pronase to remove their zona pelluclda, 
as described by Blggers et al. (1971). A 1 to 2 ml aliquot of pronase 
was thawed, then passed through a 0.45 /xm mllllpore filter before dilut­
ing 1:2 with Whltten and Blggers medium without BSA. The 0.4 to 0.5 
ml of diluted pronase was placed in a concave culture slide, then gassed 
with 5% CO2 In air before adding any embryos. A micropipette was par­
tially filled with Whltten and Blggers medium without BSA before picking 
up the embryos to be pronased. Twenty to fifteen embryos were treated 
at a time. Pronasing took 3 to 10 minutes. Pronase solution contain­
ing embryos was kept in 5% CO^ in air until the zona pellucidae were 
swollen and began to disappear. The embryos were then retrieved from 
the pronase solution by using a micropipette which was partially filled 
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with Whltten and Biggers medium containing BSA. The embryos were 
washed by passage through three changes of Whltten and Biggers medium, 
then were Incubated at 37°C-7Z CO^ for one to two hours before being 
assayed. 
3. Immunosurgery 
Immunosurgery was performed on CFl blastocysts according to the 
method of Solter and Knowles (1975). Blastocysts, collected from super-
ovulated mice, were pronased, washed, and Incubated at 37*C-7% COg for 
three hours. 
Rabbit antl-C57BL/10Sn serum was diluted 1:8 with Whltten and 
Biggers medium and 50 /Al was placed on a concave tissue culture slide. 
Five to ten embryos were then transferred to the antiserum and the slide 
was incubated. A normal rabbit serum slide was also prepared and 5 to 
10 embryos were added to the 50 ^  drop and incubated. After 30 minutes, 
the embryos were retrieved with a mlcroplpette from the slides and 
washed in three changes of Whltten and Biggers medium. The antlsera-
treated embryos were pipetted and expelled several times to remove the 
swollen trophoblastic cell layer. The inner cell masses were then trans­
ferred to 50/il of Whltten and Biggers medium in the well of a mlcro-
titer plate. The normal serum treated blastocysts served as positive 
3 
controls for H-thymldine incorporation. After a 10-15 minute period 
at 37*C-7% COg, 50/iil of ^H-thymidine (8/iCl/ml)) were added to all 
wells and the microtlter plate was reincubated for 24 hours, then the 
embryonic DNA was collected with a cell harvester. The filters were 
processed and were counted in a liquid scintillation counter. 
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Table 2. Buffers, solutions and culture media 
1. 
A. Embryo Culture Medium and Solutions 
Whltten and Biggers Culture Medium (as modified by our laboratory) 
Component Mol. Wt 
NaCl* 58. 4 
KCl 74. 6 
KH2PO4 136. 1 
MgS04-7H20 246. 5 
NaHCOg 84. 0 
Glucose 180, .2 
Ca lactate-|H20 
Na pyruvate 
308. 3 
110. ,0 
61% DL-Na lactate 112. 1 
Penicillin G, 
K salt (100 lU/ml) 
Streptomycin SO4 
1% phenol red^ 
Crystalline Bovine 
Serum Albumin* 
Distilled water^ 
g/1 mM 
5.140 88.01 
0.356 4.77 
0.162 1.19 
0.294 1.19 
2.106 25.07 
1.000 5.55 
0.527 1.71 
0.036 0.33 
2.245 20.03 
(in 3.68ml 
syrup/1) 
0.075 
0.050 
1.000 ml 
3.000 g 
to 1 liter 
Mllllosmols 
176.02 
9.54 
2.38 
2.38 
50.14 
5.55 
5.13 
0.66 
40.06 
Total 291.9 
®The original formula of Whltten and Blggers (1968) consisted of 
NaCl—4.000 g/1, Na lactate—2.416 g/1 and crystalline bovine serum 
albumin—4.00 gA. 
^A 1% stock solution of phenol red was prepared, refrigerated and 
used as needed. 
^Double strength medium was prepared by adding distilled water to 
500 ml. 
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Table 2. (Continued) 
2 .  Pronase Solution 
Pronase (56 unlts/mg) 100 mg 
(Calblochem., LaJolla, California) 
Polyvinylpyrrolidone 20 mg 
(GAP, New York, New York) 
Whltten and Riggers medium without BSA 20 ml 
B. Solutions for Peoxyribonuclease Activity 
1. MgSOA Solution (0.05 M) 
MgSO^'THgO 3.08 g 
Distilled H^O to 250 ml 
2. Acetate Buffer (1.0 M) pH 5.0 
17 N acetic acid 42 ml 
0.29 M Na acetate 23.78 g 
Distilled HgO to 1000 ml 
3. Stock Solution of Sodium Thymonucleate (2mg/ml) 
DNA calf thymus Type V 50 mg 
(Sigma, St. Louis, Missouri) 
Distilled HgO to 25 ml 
4. Enzyme Solution 
DNase I 1 mg 
(WorthIngton, Freehold, New Jersey) 
Distilled HgO to 100 ml 
5. Substrate Solutions 
Sodium thymonucleate stock solution 2 ml 
0.05 M MgS04»7H20 10 ml 
1.0 M acetate buffer 10 ml 
Distilled H^O 78 ml 
Table 2. (Continued) 
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C. Solutions Tested on Embryos 
1. Salts 
a. Phosphate Buffered Saline (PBS) pH 7.0 
0.003 M NaH2P04*H20 0.45 g 
0.007 M Na2HP04«12H20 2.40 g 
0.13 M NaCl 7.40 g 
Distilled H20 to 1000 ml 
b. Saline pH 7.0 
0.15 M NaCl 8.50 g 
Distilled HgO to 1000 ml 
2. Known Inhibitors of DNA Synthesis 
a. g-Amanatin Stock Solution (400 ug/ml) 
1 vial a-amanatin 2 mg 
(Calbiochem., LaJolla, California) 
Distilled H^O 2.5 ml 
b. Aphidicolin Stock Solution (2.5 mg/ml) 
Aphidicolin 50 mg 
(Impérial Chem., Cheshire, England) 
DMSO 15 ml 
Distilled H^O 5 ml 
c. Mitomycin C Stock Solution (500 wg/ml) 
1 vial Mitomycin C 2 mg 
(Sigma, St. Louis, Missouri) 
Whitten and Biggers medium 4 ml 
3. Known Inhibitors of Protein Synthesis 
a. Cycloheximide Stock Solution (2mM) 
Cycloheximide 0.563 g 
(Sigma, St. Louis, Missouri) 
Distilled H^O to 1000 ml 
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Table 2. (Continued) 
b. Puromycln Stock Solution (0.1 mM) 
Purotnycln 0.0545 g 
(Sigma, St. Louis, Missouri) 
Distilled HgO to 1000 ml 
4. Other Compounds 
a. Human chorionic gonadotrophln (hCG) (MW 36.700) 
(1.) hCG (lot CR-123; R. E. Canfleld, Columbia 
University, New York, New York) 
In distilled water 5 mg/ml 
(2.) ff-subunlt (G.S. Cox, lowa State University, 
Ames, lowa) 
In distilled water 4.6 mg/ml 
b. Theophylline Stock Solution (2 mM) 
Theophylline 0.036 g 
(Sigma, St. Louis, Missouri) 
Distilled HgO to 100 ml 
D. Lymphocyte Separation Medium 
1. 9% Flcoll (w/v) 
Flcoll 9 g 
(Pharmacia, Flscataway, New Jersey) 
Distilled water 100 ml 
2. 34% Hypaque (w/v) 
Hypaque 34 g 
(Wlnthrop Laboratory, New York, New York) 
Distilled water 100 ml 
3. Ficoll-Hypaque Medium (specific gravity 1.080) 
9% Flcoll 
34% Hypaque 
62.7 ml 
37.3 ml 
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Table 2. (Continued) 
E. Solutions for Spermatocyte Cytototoxlclty Assay 
1. 10% Buffered Formalin (Drake et al., 1972) 
Na2HP04 0.65 g 
NaH2P04.H20 0.40 g 
Formaldehyde (37%) 10 ml 
0.2% trypan blue (GIBOO) 90 ml 
Stirred for two hours 
2. CaCl^ (0.1 M) 
CaCl, 0.3675 g 
Distilled HgO to 25 ml 
3. 0.1% Deoxyrlbonuclease Solution 
Deoxyrlbonuclease 1.0 g 
(Worthlngton, Freehold, New Jersey) 
Distilled H-0 to 100 ml 
PBS 1000 ml 
4. Earle's Balanced Salt Solution (lacking calcium and 
magnesium) (GIBCO Catalogue 1978/1979) 
0.005 M KCl 
0.12 M NaCl 
0.03 M NaHCO. 
0.001 MNaH2P04*H20 
0.006 M Glucose 
Phenol red 
Distilled HgO to 
5. 0.4% Eos In In Buffer (Mayer et al., 1951) 
NaH2P04*H20 
Distilled H_0 to 
Na-HPO 
Distilled HgO to 
0.12 NaH-PO.'H-O 
0.13 Na.RPO; 
Eosln ? 
(Fisher, Fair Lawn, New Jersey) 
pH 7.0 
0.40 g 
6.80 g 
2.20 g 
0.14 g 
1.00 g 
0.01 g 
1000 ml 
pH 7.4 
1.72 g 
100 ml 
1.78 g 
100 ml 
20 ml 
80 ml 
0.4 g 
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Table 2. (Continued) 
6. Ethylenedlamlnotetraacetate (EPIA) (0.1 M) 
EDTA 2.922 g 
Distilled HgO to 100 ml 
7. NaCl (0.73 M) 
NaCl 4.25 g 
Distilled HgO to 100 ml 
8. PBS with 0.5% Fructose. 5% Fetal Calf Serum pH 7.0 
Fructose 0.005 g 
Fetal calf serum 5.26 ml 
PBS 100 ml 
F. Solutions for the Haemagglutlnatlon Test 
Dextran Buffer Stock Solution 
6% dextrose solution 
D-glucose 6 g 
Distilled water to 100 ml 
10% dextran solution 
dextran (MW 173,000) 10 g 
6% dextrose to 100 ml 
Autoclave, cool and freeze at -20*C 
2. 0.5% Dextran Buffer 
Dextran stock solution 5 ml 
Fetal calf serum (GIBCO) 2 ml 
NaN] 0.1 g 
PBS to 100 ml 
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Table 2. (Continued) 
G. MLR, CML. TCGF, and MELIA Media and Solutions 
1. Buffered Ammonium Chloride Solution (Garvey, et al., 1977) 
a. Tris Buffer (0.05 M) pH 7.4 
Trizma base 0.97 g 
Triznva HCI 6.61 g 
b. NH^Cl (0.14 M) 
NH4CI 7.42 g 
Distilled HgO to 1000 ml 
2. Concanavalin A Stock Solution (1 mg/ml) 
Concanavalin A 0.025 g 
(Miles-Yeda, Israel) 
Distilled HgO to 25 ml 
3. Hank's Balanced Salt Solution (HBSS) pH 7.4 
(GIBCO Catalogue 1978/1979) 
0.0025 M CaCL-'SH 0 0.28 g 
0.0054 M KCl 0.40 g 
0.0004 M KHgPO 0.06 g 
0.0005 M MgCl.'ôHgO 0.10 g 
0.0006 M MgSO^. 7HyO 0.10 g 
0.1369 M NaCl 8.00 g 
0.0042 M NaHCO 0.35 g 
0.0055 M Glucoâe 1.00 g 
Phenol red 0.01 g 
Distilled H^O to 1000 ml 
4. Mitomycin C Stock Solution (500 ^ g/ml) 
1 vial mitomycin C 2 mg 
(Sigma, St. Louis, Missouri) 
PBS ( filtered with 0.45 filter) 4 ml 
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Table 2. (Continued) 
5. 1% Phytoheamagglutlnin-P (PHA-P) Stock Solution (w/v) 
1 vial PHA-P 0.05 g 
(Difco, Detroit, Michigan) 
Distilled H^O 5 ml 
6. Protein Standards 
a. Crystalline Bovine Serum Albumin (1 mg/ml) 
BSA 0.024 g 
(Sigma, St. Louis, Missouri) 
Distilled H^O to 25 ml 
b. Human Chorionic Gonadotrophin (0.2 mg/ml) 
hCG 0.005 g 
(Calbiochem, LaJolla, California) 
Distilled H^O to 25 ml 
c. Ribonuclease A (1.1 mg/ml) 
Ribonuclease A 0.028 g 
(Worthington, Freehold, New Jersey) 
Distilled H^O to 25 ml 
7. Saturated Ammonium Sulfate ((NH,)-SO, Table, 
P. L. Biochem, Milwaukee, Wisconsin) 25*C, pH 8.0 
(NH4)2S0, 
Distilled H^O 
767 g 
to 1000 ml 
8. Sephadex G-lOO for 2 x 80 cm column 
Sephadex G-lOO 18.9 g 
(Pharmacia, Piscataway, New Jersey) 
0.9% NaCl (pH 7.4) 400 ml 
9. Supplemental RPMI 1640 (Rosenberg et al., 1978a) 
0.4 mM glutamine 
1.0 ^  sodium pyruvate 
5 X 10"' M 2-mercaptoethanol 
100 units/ml pencillin 
100 ^ g/ml streptomycin 
10% heat-inactivated GG-free newborn calf serum 
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Table 2. (Continued) 
I. Lowry Solutions (based on Lowry et al.. 1951) 
1. Reagent A 
2.68% KNa tartrate 4H-0 2.68 g 
Distilled HgO to 100 ml 
2. Reagent B 
IX CuSO^ 5H0 1.0 g 
Distilled H^O to 100 ml 
3. Reagent C 
0.1 N NaOH 4 g 
Distilled H^O to 1000 ml 
2% Na2C0- 2 g 
0.1 N NaOH 100 ml 
4. Mix 1 part A + 1 part B + 100 parts C (stable for 5 hours) 
5. Folin Reagent 
2 N Phenol 
(Fisher, Fair Lawn, New Jersey) 
Dilute to 1 N with distilled H^O 
6. Bovine Serum Albumin (BSA) Stock Solution (200 Mg/wl) 
BSA 0.005 g 
(Sigma, St. Louis, Missouri) 
Distilled H^O to 25 ml 
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Table 2. (Continued) 
J. Ehrllch-Lettre Cells Media and Solutions 
1. Acetic Alcohol 
Acetic acid 1 part 
Absolute ethanol 2 parts 
2. Colcemld Stock Solution (10 ug/ml) 
1 vial (GIBCO, Grand Island,New York) 0.1 mg 
Distilled HgO 
3. Culture Medium 
10 ml 
90% NCTC 135 
(GIBCO, Grand Island, New York) 
10% GG-free newborn calf serum 
(GIBCO, Grand Island, New York) 
1% AntIbiotic-AntImycotic solution 
(GIBCO, Grand Island, New York) 
0.5% Garamycln (10 mg/ml gentamycln) 
(Scherlng, Kenllworth, New Jersey) 
4. Freezing Medium 
90% culture medium 
10% dimethyl sulfoxide (DMSO) 
5. 0.9% Sodium Citrate 
Sodium citrate 0.9 g 
Distilled HgO to 100 ml 
6. 2% Trypsin Stock Solution 
Trypsin (100,000 units/mg) 0.5 g 
(GIBCO, Grand Island, New York) 
PBS (0.01 M phosphate) to 25 ml 
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D. Incorporation of H-thymldlne by Embryos 
1. DNA synthesis assay 
DNA synthesis In the embryos was assessed by the incorporation of 
3 3 
H-thymidine ([methyl- H]-thymldlne, 20 Ci/mmole, aqueous solution. 
New England Nuclear, Boston, Massachusetts). The ^-thymidine was 
diluted with an equal volume of double-strength Whitten and Biggers 
medium. Further dilutions were made with single-strength Whitten and 
Biggers medium. All assays were performed in 96-well flat-bottom tissue 
culture plates (Linbro; well capacity: 0.35 ml). For most assays, 
3 
a solution of 8 pCl/ml of H-thymldine was used. This was prepared by 
3 
adding 200 fil of H-thymidine in water to 25 ml of single-strength 
Whitten and Biggers medium. (See especially "Embryo Cytotoxicity Assay" 
later in dissertation.) 
At the beginning of each assay, 50 ^ 1 of Whitten and Biggers medium 
were placed into each well of the mlcrotlter plate and gassed for 
10-15 minutes with 5% CO^ in air. The appropriate number of entryos 
was added to the wells, using a finely drawn pasteur pipette. Either 
3 50 fil of the desired strength of H-thymldine were added immediately, 
3 
or the plate was prelncubated for a given time before the H-thymidine 
3 
was added. After the addition of H-thymidine, the plates were incu­
bated for the length of time dictated by the Individual experiments. 
All Incubations were at 37'C in a humid atmosphere of 7% OO^ in air. 
Each experiment was terminated by placing the tissue culture plate 
on ice. The contents of the wells were then harvested with distilled 
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water and 50-60 cm Hg vacuum (vacuum pump from Mllllpore, Bedford, 
Massachusetts) uslnR a Titertek cell harvester (Flow Laboratories, 
MacLean, Virginia) as previously described by Thurman et al. (1973). 
Briefly, the filter papers were prewet with water for five seconds 
by pressing the "rinse" button with the suction head in an empty row 
on the microtiter plate. Then the sample row was harvested with water 
by pressing the "rinse" button, for 30-60 seconds. The filters were 
then dried for 10-15 seconds by pressing the "air" button. The water 
line to the cell harvester must not have any air bubbles to ensure proper 
water flow. The GF/C filter paper mats were then dried at 65*C for at 
least 20 minutes. The filter paper discs were punched from the mat and 
each disc was placed in a glass scintillation vial (Fisher, Fair Lawn, 
New Jersey) containing 10 ml of toluene fluor. The fluor contained 
18.6 gm PPG, 2,5-diphenyloxazole (Fischer, Fair Lawn, New Jersey) and 
0.94 gm POPOP, p-bis-[2-(5-phenyloxazolyl)]-benzene (Amersham/Searle, 
Des Plaines, Illinois) per 3.8 liters of toluene (Fischer, Fair Lawn, 
New Jersey). The vials were then counted in a liquid scintillation 
counter (Beckman, Fullerton, California). 
2. Experimental protocols 
To prove that ^-thymidine was being incorporated into the 
embryonic DNA; two types of experiments were designed. In the first 
type, mitomycin C, a known inhibitor of IMA synthesis, was tested on 
3 
embryos prior to incubation with H-thymidine. In the second type of 
3 
experiment, embryos were first incubated with H-thymidine, then were 
treated with DNase I (Worthington, Freehold, New Jersey). 
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a. Mitomycin C treatment of embryos Two milligrams of mitomycin 
C (Sigma, St. Louis, Missouri)Were dissolved in 2 ml of Uhitten and 
Diggers medium to give a 1000 pg/ml stock solution which was then di­
luted with Whltten and Riggers medium to give mitomycin C concentrations 
of 500, 400, 300, 200, 100, 50, and 25 ^ /ml. CFl blastocysts were 
either treated with pronase to remove the zona pelluclda or were left 
untreated. All embryos were then incubated for one-two hours at 37*C 
and 7% CO^ in air. The embryos were placed into 0.5 ml of the desig­
nated concentrations of mitomycin C or Whltten and Blggers medium only 
for 0,5, 1, 1.5, or 2 hours at 37*C and 7% CO^ in air. Then the embryos 
were removed and washed in three changes of 0.5 ml Whltten and Blggers 
medium. All Incubations with mitomycin C and all washes were performed 
in 35 X 10 mm Falcon plastic tissue culture dishes (Becton, Dickinson 
and Co., Oxnard, California). After the third wash, the embryos were 
transferred to a 96-well microtlter plate. One embryo was placed per 
3 
well containing 25 pi of Whltten and Blggers medium and H-thymidine 
(sp. act. 20 Cl/mmole) at a concentration of 4 pCi/ml. A seven-hour 
Incubation period at 37°C and 7% CO^ in air was performed prior to cell 
harvesting and processing of filter papers. 
b. DNase I treatment of embryos DNase I activity was 
determined by the spectrophotometric method of Kunltz (1950). Several 
8 ml glass test tubes, each containing 3 ml of substrate solution, were 
placed in a water bath at 25*C for 10 minutes. One ml of HgO was added 
to one of these tubes and served as the blank. A sample of 1 ml 
deoxyribonuclease solution (5 or 10 pg/ml) was added to each of the 
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other test tubes. The test tubes were gently vortexed (Clay Adams, 
Chicago, Illinois) and a stop watch was started. A sample from each 
tube was transferred to a cuvette (Fisher, Chicago, Illinois). Readings 
were taken at intervals of 0.5 to 1 minute for 5 minutes, using a 
Gilford 250 spectrophotometer (Oberlln, Ohio) set at 260 nm. All assays 
were performed in duplicate. The activity of the enzyme solution was 
expressed in terms of the mean slope of a plot of the optical density 
versus time (in minutes). The specific activity was then determined 
by dividing the mean slope by the concentration of the enzyme in milli­
grams of proteins per milliliter of the final digestion mixture. 
In order to examine the effect of the Whltten and Biggers medium, 
pH, and Triton X-100 on DNase I activity, Kunitz's procedure was re­
peated with the following modifications. The substrate solution was 
diluted with 2X Whltten and Biggers medium and the pH was adjusted to 
5.0 with 1 M HCl. Kunitz's procedure was also repeated with 0.1% 
Triton X-100 per test tube. The DNase I solution was used at a final 
concentration of 2.5 Mg/ml on CFl embryos. 
Either 1 CFl blastocyst or 5 CFl blastocysts were added to 25 pi 
of Whltten and Biggers medium in a well of a 96-well mlcrotlter plate. 
After a two-hour incubation of 37*C and 7% CO^ in air, 25 fil of Whltten 
and Biggers media containing 8 p Cl/ml ^-thymidine were added to all 
wells and the embryos were Incubated for two hours. Fifty fil of either 
Whltten and Biggers medium or 1% Triton X-100, diluted with Whltten 
and Biggers medium were added to designated wells and the embryos were 
incubated for 30 minutes. Then 100 fil of either Whltten and Biggers 
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medium or DNase I (5 pg/ml In Whltten and Blggers medium) adjusted 
to pH - 5.0 by adding 0.8 pi IM HCl for every 100 pi of medium was 
added to designated wells and the embryos were relncubated for one hour. 
The mlcrotlter plate was then placed on Ice and treated am described 
previously. 
3. Effect of compounds on embryos 
The MIA synthesis assay for embryos was used to Investigate the 
effects of PBS, saline, a-amanltln, aphldlcolln, mitomycin C, cyclo-
hexlmlde, puromycln, hCG, and theophylline on CFl blastocysts. For 
these experiments, 3-5 blastocysts were Incubated In 50 pi of a desig­
nated concentration of compound diluted with Whltten and Blggers medium. 
All concentrations of compounds were tested In duplicate. Controls con­
sisted of blastocysts Incubated In Whltten and Blggers medium only. 
For the aphldlcolln studies, the control consisted of Whltten and Blg­
gers medium containing the appropriate concentrations of EMSO. After 
a seven-hour Incubation at 37*C and 7% CO^ In air, 50 pi of 8 pCl/ml 
3 
of H-thymldlne were added to all wells. The embryos were relncubated 
for an additional three hours, then the embryonic DNA was collected with 
a cell harvester and the filters were processed. 
The effect of a-amanltln was further examined on CFl 8-cell and 
blastocysts embryos. Five blastocysts or ten 8-cell embryos were cul­
tured In 50 pi of Whltten and Blggers medium either with or without a 
given concentration of a-amanltln. After a two-hour Incubation at 37*C 
in a humid atmosphere of 7% CO^ in air, 50 pi of an 8 pCl/ml solution 
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of H-thymldlne in culture medium were added to all wells and the 
embryos were reincubated for three to seven hours. The mlcrotiter plate 
was then processed with a cell harvester and the filters were counted. 
The effect of aphidicolin was further examined 6n CFl 8-cell 
embryos according to the blastocyst protocol except 10 embryos were in­
cubated per 50 ^ 1 of designated aphidicolin concentrations. 
The experimental data were expressed as: 
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% Inhibition of H-thymidine Incorporation • 
E. Sera 
1. Rabbit anti-mouse serum 
g 
Rabbit anti-mouse serum was prepared by injecting 1x 10 C57BL/10Sn 
spleen cells into the marginal ear vein of an eight-pound female New 
Zealand rabbit. Three injections were given on days 1, 10 and 20 with 
a test bleeding performed on day 30. Three more booster injections 
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of 1 X 10 spleen cells were given about six weeks apart with a cardiac 
puncture performed two weeks after the final booster. The blood was 
allowed to clot at room temperature, then refrigerated overnight. The 
clot was removed and discarded. The remaining serum was centrifuged 
(Beckman Model TJ-6, Irvine, California) at 125 g and room temperature 
for about 15 minutes to sediment any cells. The supernatant was col­
lected via a pasteur pipette and was transferred to a clean test tube. 
The serum was heat inactivated in a 56"C water bath for 30 minutes and 
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was then tested In a trypan blue cytotoxicity assay against CFl spleen 
lymphocytes and also against CS7BL/10Sn spleen lymphocytes. The anti­
serum from the final bleeding gave the highest percent killing of 
lymphocytes (>80% at 1:64) and was, therefore, used for all experiments. 
Normal rabbit serum (GIBCO, Grand Island, New York) was heat-inactivated 
and used as the serum control. The antiserum was stored in 50 ^ 1 
aliquots at -70*C until used. The normal serum was stored in 100 pi 
aliquots at -70*C until used. 
2. Congenic antisera 
Anti-H-2 sera were prepared using spleen cells from C57BL/10Sn 
mice and the BIO congenic strains BIO.BR, BIO.A and B10.D2 by a modi­
fication of the method of Batchelor (1973). The spleen cell suspension 
was prepared by injecting one spleen with a 1 ml disposable TB syringe 
(Becton-Dickinson, Rutherford, New Jersey) filled with RPMI 1640 (GIBCO, 
Grand Island, New York). The swollen spleen was then pressed through 
a 40-gauge stainless steel screen. The cells on the underside of the 
screen were gently washed into the resulting cell suspension. One 
mouse spleen per 1 ml of RPMI 1640 yielded a cell suspension containing 
about 10^ cells per a 0.2 ml injection. Usually, two spleens were used 
to immunize eight mice. Prior to immunization, the mice were bled from 
the orbital venus sinus for normal control sera which was heat inacti­
vated and stored at -70*C before being used. Each mouse received one 
injection per week for seven weeks. A test bleeding was made in which 
serum from each set of injected mice was pooled and heat-inactivated 
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at 56*C for 30 minutes. The antlsera were then tested against the 
lymphocytes from the Immunizing strain and also against the lymphocytes 
from the other strains. Injections were resumed the week after the 
test bleeding. Three more weekly Injections of 10^ cells followed. 
Another test bleeding was performed a week after the tenth Injection. 
The mice were boosted once a month, then bled one week later. Five 
bleedings were taken with the fifth bleeding yielding the best cytotox­
icity titers (>90% killing at 1:4). 
Table 3 lists the K, D and la alloantlgens of the mouse strains 
used In this study. A list of the antlsera, and their possible K and 
D specificities are shown In Table 4. Since the mice were Immunized 
with lymphocytes, only K, I and D antigens should be recognized with 
K and D antigens showing Immunodomlnance to I region antigens. This 
Is the basis for listing only K and D antigenic specificities in Table 
4. 
3. NIH antlsera 
The antlsera listed in Table 5 were obtained from the Transplantation 
and Immunology Division, NIH, Bethesda, Maryland. Single vials con­
taining the lyophillzed antiserum were reconstituted with 1.0 ml de-
ionized distilled water and stored in aliquots of either 50 pi or 100 
m at -70*C. 
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Table 3. K, D and la alloantlgens of Inbred stralns*'^'^ 
Strain H-2 Haplotype K, D and la Alloantlgens 
C57BL/10Sn b 5, 28, 33, 35, 36, 39, 53, 54 
2, 6, 27, 28, 29, 56 
la 3, 8, 9, 15, 20 
BIO.A a 1, 3, 5, 8, 11, 23, 24, 25, 45, 
49?, 52 
3, 4, 6, 13, 27, 28, 29, 
35, 36, 41, 42, 43, 44, 49 
la 1, 2, 3, 6, 7, 15, 17, 18, 19, 
22 
310.BR k 1, 3, 5, 8, 11, 23, 24, 25, 45, 
49?, 52 
1, 5, 32 
la 1, 2, 3, 7, 15, 17, 18, 19, 22 
B10.D2 d K*' 3, 8, 28, 29, 31, 34 
3, 4, 6, 13, 27, 28, 29, 35, 
36, 41, 42, 43, 44, 49 
la 6, 7, 8, 11, 15, 16, 23 
^Thls information was compiled from Dèmant's haplotype specificity 
tables (1979). 
^Private specificities are underlined. 
^Any superscripts within text of table refer to specific 
alloantlgens; these are not footnote notations. 
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Table 4. Specificities of congenlc alloantlsera**^'^ 
Antiserum Recipient-Donor Possible K and D Specificities 
X-BIO BIO. ,BR antl-BlO Kb 28, 33, 35, 36, 39, 53, 54 
2, 6, 27, 28, 29, 56 
X-BIO. A BIO antl-BlO.A 1, 3, 8, 11, 23, 24, 25, 
45, 49?, 52 
3, 4, 6, 13, 35, 36, 41, 
42, 43, 44, 49 
X-BIO. BR BIO anti-BlO.BR K^ 1, 3, 8, 11, 23, 24, 25, 
45, 49?, 52 
1, 3, 5, 32 
X-BIO. D2 BIO anti-B10.D2 K^ 3, 8, 29, 31, 34 
3, 4, 13, 35, 36, 41, 42, 
43, 44, 49 
*Thls Information was Compiled from Démant's haplotype specificity 
tables (1979), 
^Private specificities are underlined. 
^Any superscripts within the text of the table refer to specific 
alloantlgens; these are not footnote notations. 
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Table 5. Specificities of NIH alloantlsera* 
Antiserum Recipient-Donor (Strains Detected Specificities^'^ 
and Genotype) 
D-2 [B10.A(5R) X LP.RIII] anti-BlO D 2 ,  56 
(K^D^ X K'D*") anti-Kbob 
D-23b (B10.D2 X SJL) anti-BlO.A 
(Kdod X RSD®) antl-Kkod 
K"- 11, 2 3 ,  25, 52 
D-32 [B10.A(2R) X C3H.5W1 anti-C3H D*' 32 
(K^D^x K^D^) anti-K*D* 
D-31 (BIO X A) anti-B10.D2 
(K^Db X K^Dd) anti-K^Dd 
K" 31, 34 
la 1,2,3,7 A.TH anti-A.TL 
(RSlSDd) anti K^I^Dd 
la 1, 2, 3, 7 (15, 22?) 
Private specificities are underlined. 
^This information was obtained from the NIH catalog of Mouse 
Alloantlsera CSnell. 1975; Ray, 1977). 
^Any superscripts within the text of the table refer to specific 
alloantigens; these are not footnote notations. 
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4. Guinea pig complement 
Complement was obtained from reconstituted lyophlllzed guinea pig 
serum prepared In our laboratory. Guinea pigs were bled via the jug­
ular vein Into a 250 ml beaker. The blood was allowed to clot at room 
temperature for about one hour, then was refrigerated overnight. The 
clot was removed and the remaining supernatant was centrlfuged at 100 g 
and room temperature for 15-20 minutes to sediment any suspended cells. 
The 150 ml of supernatant was collected with a pasteur pipette and 
placed In a 250 ml round bottom flask. The contents of the flask were 
frozen with dry Ice and acetone. The flask was attached to a lyophlllzer 
(Vlrtls Research Equipment, Gardner, New York) and a vacuum was induced. 
About 24 hours later, the resulting precipitate was weighed and ali-
quotted into 12 ml glass storage vials. The vials were stored at -70*C. 
The complement was reconstituted with 10 ml of distilled water and was 
then divided into 200 (il aliquots and stored at -70*C. The complement 
was tested for cytotoxic activity in a lymphocyte cytotoxicity assay 
with an antiserum exhibiting cytotoxicity of greater than 90% killing. 
5. Rabbit complement 
Rabbit serum was obtained by cardiac puncture of a New Zealand 
white rabbit. The blood was allowed to clot then set on ice for two 
hours to allow the clot to contract. The serum was collected after 
centrifugatlon at 100 g and room temperature for 20 minutes, then was 
stored at 4''C until absorbed within the next 24 hours. 
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Rabbit serum was absorbed according to the method of Boyse et al. 
(1970). Spleens, thymuses, spermatocytes and testes, obtained from 
C57BL/10Sn male mice were minced In 10 ml of a 0.1% deoxyrlbonuclease 
(Worthington, Freehold, New Jersey) solution. The tissue suspension 
was vortexed for two to three minutes at low speed in a Vlrtls Homogen-
izer (Gardner, 'Jew York). The suspension was then centrifuged (Beck-
man Model TJ-6, Irvine, California) at 125 g and room temperature for 
about five minutes. The supernatant was decanted and the cells were 
washed three times with Earle's medium lacking calcium and magnesium. 
One volume of 0.1 M EDTA was added to nine volumes of rabbit serum about 
0.5 hour prior to addition of cells. Seven volumes of BDTA-treated 
serum were absorbed with one volume of packed cells. Absorption was 
performed on ice and in a cold room (4*C) for 45 minutes with frequent 
agitation of the cell-serum suspension. The serum was recovered after 
centrlfugation (Beckman Model TJ-6, Irvine, California) at 125 g and 
4°C for 15 minutes. Free divalent cations were restored by the addition 
of one volume of 0.1 M CaCl^. Absorbed serum was tested in a lympho­
cyte assay where the rabbit serum replaced the guinea pig serum as the 
source of complement. 
6. Attempted production of H-Y antlsera 
Three different Injection protocols for H-Y antlsera production 
were followed. The first protocol was the same as that used for the 
production of congenlc H-2 antlsera, except male spleen cells of a 
strain were Injected into female mice of the same strain. The second 
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protocol involved weekly inoculations of 25 x 10^ C57BL/6 male spleen 
cells into C57BL/6 female mice as described by Krco and Goldberg (1976). 
Serum was obtained on day 10 after the seventh inoculation and was then 
aliquotted and frozen at -70°C. The third protocol was adapted from 
Shalev et al. (1978). Fifteen i.p. injections of 1-3 x 10^ C57BL/6 
male spleen cells in a 0.1 ml volume were injected into C57BL/6 female 
mice. Mice were bled on days 17, 24, 32, and 40 from the Initial injec­
tion. Serum was tested within a couple of hours of collection. 
7. Tests for H-Y antisera activity 
H-Y antisera were tested by using at least one of the following 
methods. 
a. Spermatocyte cytotoxicity assay The spermatocyte 
cytotoxicity assay of Goldberg et al. (1971) was followed. Sperm were 
obtained by mincing the epididymus in a concave culture slide contain­
ing a few drops of PBS with 0.5% fructose and 5% fetal calf serum. 
The sperm suspension was washed two times with PBS, then diluted to 
4 X 10^ cells/ml. The assay was performed by adding 50 /il of anti-
H-Y sera of designated dilutions or normal mouse serum, 50 /il of sperm 
cell suspension, and 50 /il of absorbed rabbit complement diluted 1:4 
with PBS to 12 X 75 mm disposable culture tubes (Fisher, Pittsburgh, 
Pennsylvania) then incubating at 37"C. After 45 minutes, 0.1 ml of a 
1% trypan blue dye solution (GIBCO, Grand Island, New York) diluted 
1:5 with a 0.73 M NaCl solution was added. The spermatocytes were 
examined for dye uptake after 10-15 minutes. Formalin fixed 
54 
spermatocytes served as dye Inclusion controls. In a few experiments, 
eosin dye (0.4%) was substituted for trypan blue dye to enhance dye 
uptake. 
Spermatocytes were fixed with formalin to provide a positive 
control which took up trypan blue dye. The procedure of Drake et al. 
(1972) was used. Mouse spermatocytes were collected in 0.15 M saline 
and washed once,then were resuspended at 10^ cells/ml. An equal volume 
of methanol was added and the cell suspension was vortexed (Cyclomixer, 
Clay-Adams, Chicago, Illinois) at low speed for one minute, then cen-
trifuged at 125 g and room temperature for five minutes. The super­
natant was removed with a pasteur pipette. The spermatocytes were then 
fixed in 10% buffered formalin in 25 times the cell volume. The cells 
were suspended in solution and were fixed overnight at room temperature. 
Cells were stored in the 10% buffered formaline at 4*C. 
b. Staph aureus "rosetting" procedure The Staph aureus 
"rosetting" procedure of Tokuda et al. (1977) was followed. Staphlo-
coccus aureus (Cowan I, strain) was obtained from Dr. P. Patee (Bacteri­
ology Department, ISU) and was cultured in a shaker in Todd-Hewitt 
Broth (Difro, Detroit, Michigan) at 37'C for 18 hours. A sample of the 
cell suspension was counted and gram stained to confirm a cell concen-
tration of 1 x 10 cells/ml and the presence of gram positive cocci. 
The suspension was divided into several 250 ml polypropylene centrifuge 
bottles (Fisher, Chicago, Illinois) and centrifuged at 1000 g and A'C 
for 30 minutes in a Sorvall RC-29 centrifuge (Sorvall, Norwalk, Connect­
icut). The broth was decanted and autoclaved before discarding. The 
cell sediments were pooled and washed three times with PBS. After the 
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last wash, the sediment was suspended In 200 ml of PBS containing 0.5% 
formaldehyde (37%) and Incubated at 37*C for three hours. The suspen­
sion was centrlfuged at 1000 g and 4*C for 30 minutes then washed In 
PBS four times. The cells were resuspended In PBS to a 10% (v/v) cell 
concentration and were placed In a boiling water bath for three minutes. 
The suspension was stored at A'C In the presence of 0.1% NaN^. Cells 
were washed and resuspended In PBS before each use. 
Spleen lymphocytes from male and female (negative control) mice 
were obtained via a Flcoll-Hypaque separation (described later) and 
were used as the target cells In the assay. 
The assay was performed by adding 50 f i l  o f  antiserum to 250 /il 
of lymphocytes (2 x 10^ cells/ml) In 12 x 75 mm disposable culture 
tubes and incubating for 30 minutes at 4*C. Controls consisted of 
female lymphocyte targets or normal mouse serum. The culture tubes 
were centrlfuged (International Centrifuge, Boston, Massachusetts) at 
125 g and 4°C for 10 minutes, then were washed twice with RPMI 1640. 
Cell pellets were resuspended In 50 ^ 1 of the Staph aureus cell suspen­
sion and were incubated at 4'*C for 15 minutes. The cells were washed 
three times with RPMI 1640. After the final wash, the cells were resus­
pended in 250 fil RPMI 1640. Smears were prepared on microscope slides. 
After air drying and fixing in methanol, the slides were stained in 
Giemsa (GIBCO, Grand Island, New York) for 20 minutes. Lymphocytes 
exhibiting five or more Staph aureus cells were considered positive. 
c. Haemagglutination test The haemagglutination test was 
performed according to the procedure of Shalev et al. (1978) in V-shaped 
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wells of microtlter plates (Llnbro, Flow Labs, McLean, Virginia). 
Sera were diluted with a 0.5% dextran buffer solution (DB) and 0.1 ml 
was added to designated wells of the microtiter plate. Red blood cells 
were collected by bleeding mice from the supraorbital venous sinus and 
collecting the blood in a 40 times volume of PBS. The cell suspensions 
were kept on ice, then washed twice in the same volume of PBS. Centrlf-
ugations were performed at 4°C. Cell concentrations were adjusted to 
10^/ml In DB, then 25 pi were added to designated wells of the micro­
tlter plate. Plates were read when the red blood cells in the negative 
controls (no serum wells) had completely settled—usually after a two-
hour room temperature incubation. The positive control consisted of 
serial dilutions of rabbit antl C57BL/10Sn sera incubated with C57BL/10Sn 
red blood cells. 
F. Ascites Antibody Production 
1. Cell culture and maintenance 
One ampule of Ehrllch's-Lettre ascites mouse carcinoma. Strain E, 
was obtained from the American Type Culture Collection (Rockville, Mary­
land). The cells were cultured according to the method of Boone et 
al. (1965). Briefly, 10^ cells were cultured in 50 ml Falcon flasks 
(Fisher, Chicago, Illinois) in 10-12 ml of NCTC 135 medium (GIBCO, 
Grand Island, New York), containing 10% GG-free newborn calf serum and 
antibiotics. Cells were incubated at 37*C and 7° COg. Media changes 
were made every four to five days. When cultures became confluent, 
portions of the cells were scraped free with a rubber policeman and 
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discarded with media changes. Cells were subcultured as needed. Cells 
were scraped free and about 10^ cells were inoculated into each freshly 
prepared flask. 
2. Cell passages 
Cells were passaged from cell culture to the mouse by dislodging 
confluent cells with 0.2% trypsin. The cell suspension was washed once 
with medium, the the cells were counted in a hemacytometer. Between 
1.4 and 2.0 x 10^ cells in 0.2 ml of culture medium were inoculated, 
i.p., per mouse. Nontrypsinized cells failed to develop tumors in mice. 
The ascites were tapped aseptically with a 10 cc syringe and specially 
prepared 18 gauge needle 14 to 21 days after inoculation. The 18 gauge 
needle contained six holes perforated along its barrel within 2 cm of 
Q 
the beveled end of the needle. Two-tenths of a ml of ascites (10 
cells/ml) was injected into each of a second set of mice. The ascites 
were collected and injected into a third set of mice as described for 
the second set. Passaged cells were grown ^  vitro by Inoculating 10^ 
cells into a Falcon flask containing 10-12 ml of culture medium. 
3. Hyperimmune ascites production 
and testing 
Hyperimmune ascites were produced based on the methods of Fathman 
et al. (1975) and Sachs and Cone (1973). Ascites cells (25 x 10^), 
prepassaged in host strains, were injected concomitantly with 1 x 10^ 
donor spleen cells in a 0.2 ml volume into host mice, previously 
Immunized against the donor spleen cell population. The injection of 
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tumor and spleen cells resulted in the production of large volumes (up 
to 10 ml) of ascites fluid containing antibodies to the donor spleen 
cell population. The hyperimmune ascites was compared to antiserum 
from the same mouse for reactivity against donor lymphocytes in a 
lymphocyte cytotoxicity assay. Ascites fluid collected from the third 
cell passage was used as the negative ascites control and normal host 
mouse serum served as the negative serum control. The hyperimmune 
ascites was aliquotted and stored at -70"C. 
4. Confirmation of cell lines after 
in vivo explantation 
Chromosomal studies were performed on explanted cells to confirm 
the cell lines according to Boone et al. (1965). Cultured explanted 
ascites cells were treated with 1 pg/ml colcemid (GIBCO, Grand Island, 
New York) during a five-hour incubation period. Cells were detached 
from the monolayer by treatment with 0.2% trypsin. The cell suspension 
was centrlfuged (Beckman Model TJ-6, Irvine, California) at 125 g and 
room temperature for 10 minutes. The supernatant was decanted and the 
cells were resuspended in 5 ml of 0.9% sodium citrate, then placed in 
a water bath at 37®C for 20 minutes. Cold acetic-alcohol (5 ml) was 
then slowly added to the cell suspension with gentle agitation. The 
suspension was set at room temperature for 15 minutes, then centrlfuged 
at 125 g and room temperature for 10 minutes. The supernatant was dis­
carded and the cell pellet was resuspended in 5 ml of cold acetic-
alcohol and centrlfuged again. The supernatant was decanted and the 
cell pellet was resuspended in 10 to 20 times its own volume of 
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acetic-alcohol. Five to ten drops of cell suspension were placed on 
a glass slide wetted with 50% alcohol. The slide was held horizontally 
while the fluid was ignited and was then allowed to bum itself out. 
The slide was gently heated until thoroughly dry. Cells were stained 
in Giemsa (GIBCO, Grand Island, New York) for about 30 minutes then 
rinsed in distilled water and dried over a low flame. The slide was 
placed in xylene for two minutes, then air-dried and examined under oil 
Immersion with a Zeiss microscope (West Germany). 
5. Storage of cells 
Passaged and nonpassaged cells were periodically frozen and stored 
in liquid nitrogen. Ascites or cultured cells were counted then cen-
trifuged (Beckman Model TJ-6, Irvine, California) at 125 g and room 
temperature for 10 minutes. The cells were washed once with culture 
medium and were then suspended in culture medium containing 10% DMSO 
to give a final concentration of 1-5 x 10^ cells/ml. The cell suspension 
was dispensed as 1 ml aliquots into Nunc Interned storage vials (Den­
mark). The vials were labeled and were attached to a BF-5 necktube 
cone adjusted to ring B and the entire freezer apparatus (Union Carbide, 
Indianapolis, Indiana) was inserted into the neck of a liquid nitrogen 
storage tank (American Breeders Service, Madison, Wisconsin) for one 
hour. The vials were then removed from the freezing apparatus and 
placed in a storage container which was then submerged in liquid 
nitrogen. 
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6. Thawing of cells 
Cells were thawed rapidly by submerging the storage vial in a 37®C 
water bath for about one minute. The vial was then submerged in 70% 
alcohol and transferred to a sterile hood where the cell suspension 
was aseptlcally transferred to a 50 ml Falcon flask (Fisher, Chicago, 
Illinois) containing 10 to 15 ml of culture medium. A 0.1 ml aliquot 
was removed for a viability count in 0.4% trypan blue dye. Twenty-four 
hours later, the cells were centrifuged (Beckman Model TJ-6, Irvine, 
California) at 125 g and room temperature for 10 minutes. The cells 
were resuspended in 10-15 ml of fresh culture medium and were maintained 
as described previously. 
G. Cytotoxicity Assays 
1. Lymphocyte cytotoxicity assay 
The rabbit, congenlc and NIH antisera and hyperimmune ascites 
were tested for cytotoxicity against lymphocytes by the trypan blue dye 
exclusion method (Gorer and 0'Gorman, 1956). White blood cells were 
collected by the Ficoll-Hypaque density gradient centrlfugation method 
(Btiyum, 1968). Spleen suspensions were prepared as described for the 
production of congenlc antisera. About 200 pi of the spleen suspension 
was layered over 200 fil of Ficoll-Hypaque, prepared as shown in Table 
2, in 400 pi mlcrofuge tubes (Beckman, Irvine, California). The tubes 
were then centrifuged in a Beckman 152 Mlcrofuge (Beckman, Irvine, 
California) for 2.5 to 3 minutes. The white blood cell layer was re­
moved with a pasteur pipette to clean 400 pi mlcrofuge tubes. The tubes 
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were filled with RPMI 1640 and the cells were resuspended in the medium 
with a pasteur pipette to wash the cells. The tube was then centri-
fuged in the microfuge (Beckman Model 152, Irvine, California) for 
5 to 10 seconds. The supernatant was removed via a pasteur pipette 
and the cells were resuspended in additional RPMI 1640. After the 
second wash, the cell pellets were collected into a test tube (12 x 75 
mm glass; Fisher, Fair Lawn, New Jersey) and brought to 1 ml with RPMI 
1640. A 1:50 dilution was made of the cell suspension which was then 
counted on a hemacytometer (Brightlight; Fisher, Fair Lawn, New Jersey). 
The cell suspension was adjusted to 6 x 10^ cells/ml with RPMI 1640. 
The cytotoxicity assay was performed in 250 pi microfuge tubes 
(Beckman, Irvine, California) by adding 10 fil of 6.0 x 10^ cells/ml, 
10 fil of antiserum serially diluted with RPMI 1640, and 10 Ml of guinea 
pig complement diluted 1:2 with RPMI 1640. The tubes were capped and 
mixed, then incubated at 37*C. After one hour, 10 pi of a 0.4% trypan 
blue solution (GIBCO, Grand Island, New York) were added to each tube 
and the tubes mixed. After five minutes, the tubes were placed on ice, 
then counted in a hemocytometer. At least 200 total cells were scored 
for each tube tested. The live cells were those which had excluded 
the dye. All serum samples were tested in duplicate with either lympho­
cytes from the host strain or normal serum serving as the negative 
control. 
The data were reported as: % Killing - T^Pn^L^Cells * l^O. 
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2. Embryo cytotoxicity assay 
The rabbit, congenlc and NIH antlsera were tested for cytotoxicity 
3 
against embryos by measuring the Inhibition of H-thymidlne incorpora­
tion Into DNA. Figure 2 outlines the procedure. One to five blasto­
cysts or five to ten 8-cells were placed in 25 ^1 of Whitten and Biggers 
medium in the well of a 96-well flat bottom microtiter plate, then 
gassed for 10 to 15 minutes with 7% COg in air. Twenty-five microliters 
of normal serum or antiserum, diluted with Whitten and Biggers medium, 
were added to designated wells. The congenlc and NIH antlsera were 
added to the microtiter wells at a 1:4 dilution, which seemed to give 
optimal inhibition of DNA synthesis. After a 0.5 to 5 hour incubation 
at 37°C and 7% CO^ in air, 25 ^1 of guinea pig complement diluted 1:2 
with Whitten and Biggers medium were added to all wells and the micro­
titer plate incubated for an additional hour. Then 75 ^ 1 of 8 pCi/ml 
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of H-thymldlne ([methyl- H]-thymldlne, 20 Ci/nroole, aqueous solution, 
New England Nuclear, Boston, Massachussetts) were added to all wells, 
giving a final concentration of 4 p Cl/ml (0.02 mole thymidine). After 
a five-hour incubation for blastocysts or a 24-hour incubation for 8-
cells at 37°C and 7% CO^ in air, the microtiter plate was cell harvested 
and the filters processed. 
Due to day-to-day biological variability inherent to DNA synthesis 
by embryos, similar to that observed with RNA synthesis in embryos 
(Warner and Tollefson, 1978), each experiment was performed in conjunc­
tion with a control. The control was always done in duplicate, and the 
average cpm in the control was determined after the subtraction of the 
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Total Volume/Well Step 1; 
25 ni 
Step 2; 
50 til 
Step 3; 
75 Hi 
Step A; 
150 Ml 
Step 5; 
150 Hi 
Step 6; 
150 pi 
Short Preincubation of Embryos 
(10 to 15 minutes at 37 C and 
7% COg in air) 
25 pi culture medium 
Embryos 
Incubation with Antiserum 
(1 hour Incubation at 37*C and 
7X COg In air) 
25 Ml from Step 1 
25 pi normal mouse serum or. 
25 pi antiserum 
Incubation with Complement 
(1 hour Incubation at 37 C and 
7% COg In air) 
50 pi from Step 2 
25 pi guinea pig complement (1:2) 
3 
Incubation with H-thymldlne 
(5 hour or 24 hour incubation at 
37'C and 7% CO^ In air) 
75 pi from Step 3 
75 pi thymidine (8 pCi/ml) 
Termination of Assay 
(Place plate on ice for 5-10 
minutes, then cell harvest and 
process filter papers) 
Counting of Samples 
(Place filter papers in fluor and 
count in scintillation counter) 
Figure 2. The embryo cytotoxicity assay 
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background cpm to give "Av. Control cpm." The experimental data (minus 
background cpm) were then expressed as the ratio: 
Experimental cpm 
Av. Control cpm 
A value of 1.0 reflects no effect, whereas a value of 0.0 reflects 
3 
complete blocking of H-thymldlne Incorporation. The ratios were then 
averaged for a particular set of experiments and the significance of the 
difference of the mean from a value of 1.0 was determined by Student's 
t test (Steel and Torrie, 1960). The final results were then reported as: 
3 
% Inhibition of H-thymidlne incorporation • 
1-0 - A'^Co^êrol cpm " 
H. T Cell Growth Factor 
1. T cell growth factor production 
T cell growth factor (TCGF) was prepared according to the method 
of Rosenberg et al. (1978a). Spleens from DBA/2 mice were removed 
aseptically and teased apart In Hank's Balanced Salt Solution (HBSS), 
then pressed through a AO-gauge wire screen into a 30 ml disposable 
conical centrifuge tube (Fisher, Chicago, Illinois). The resulting 
suspension was centrlfuged at 500 g and room temperature for five min­
utes. The supernatant was decanted and the cell pellet was suspended 
in 10 ml of buffered ammonium chloride solution at room temperature for 
two to five minutes to lyse the red blood cells. The cell suspension 
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was diluted to 50 ml with HBSS and was then centrlfuged at 500 g and 
room temperature for five minutes. The supernatant was decanted and 
the cells were washed two more times. After the final wash, the cell 
pellet was suspended in supplemented RPMI 1640. A 0.1 ml aliquot was 
collected,diluted 1:50, and counted in 0.1% trypan blue. The cell 
suspension was diluted with supplemented RPMI 1640 to give 1 x 10^ 
viable cells/ml then 2 ml of the cell suspension were dispensed per 
well of a 24-well tissue culture plate (Costar, Cambridge, Massachusetts). 
Twenty microliters of concanavalln A (Miles-Yeda, Israel) were added 
to each well to give a final concentration of 10 pg/ml. The tissue 
culture plate was then incubated at 37*C and 7% CO^ in air for 48 hours. 
The supernatant was removed from each well with a pasteur pipette and 
collected in a 50 ml conical centrifuge tube which was then centrl­
fuged at 900 g and room temperature for 10 minutes. The supernatant 
was then passed through a 0.45 ^ m filter (Mllllpore Corp., Bedford, 
Massachusetts), aliquotted and stored at -70°C until used. TCGF which 
was to be purified from concanavalln A and serum proteins was not fil­
tered, aliquotted, nor frozen, but was stored at 4°C. 
2. Partial purification of T cell 
growth factor 
T cell growth factor was partially purified from concanavalln A 
and serum proteins according to the method of Rosenberg et al. (1980). 
Ammonium sulfate precipitation of TCGF supernatants was performed accord­
ing to the method of Heide and Schwlch (1978). Saturated ammonium 
sulfate was added dropwise to the TCGF supernatant with constant 
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stirring until 50% ammonium sulfate saturation was reached. The 
preparation was allowed to stand at room temperature for two hours and 
was then centrlfuged (Becknan Model TJ-6, Irvine, California) at 500 g 
and room temperature for 30 minutes. The precipitate was resuspended 
In saline. The supernatant was decanted Into the starting beaker and 
a second ammonium sulfate fractionation was performed by adding suffi­
cient saturated ammonium sulfate to form a 70% saturated solution. 
The preparation was allowed to stand at room temperature for two hours 
and was then centrlfuged at 500 g and room temperature for 30 minutes. 
The supernatant was discarded and the precipitate was resuspended In 
saline and pooled with the precipitate from the 50% saturated ammonium 
sulfate precipitation. The 10-15 ml of resuspended precipitate was 
then dlalyzed at A'C against BBSS for one to two days with five to six 
0.5 to 1 liter changes of dlalysate a day. The TCGF solution was then 
concentrated (Amlcon, Danvers, Massachusetts) at A'C with a 
>10,000 MM retenslon membrane and positive Ng pressure to a 10 ml 
volume. 
A 2 X 80 cm Sephadex G-lOO gel filtration column was prepared and 
was equilibrated with 0.9% saline. A 10 ml solution containing three 
standard proteins—bovine serum albumin (MW 69,000), human chorionic 
gonadotrophin (MW 36,700) and rlbonuclease A (MW 13,000) was loaded on 
the column and eluted in 6 ml fractions with 0.9% saline. A semi-
logarithmic plot of elution fraction versus molecular weight yielded 
a straight line from which the fractions containing TCGF (MW 45,000 and 
20,000-30,000 daltons) could be determined. The column was washed with 
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one to two bed volumes of saline, then the 10 ml TCGF sample was loaded 
onto the column and eluted In 6 ml fractions with 0.9% saline. 
3. Assays for T cell growth 
factor activity 
T cell growth factor activity was assayed by a procedure developed 
from the methods of Rosenberg et al. (1980) and Glllis et al. (1978) 
for TCGF activity analysis. B10*CBA^ cytotoxic T cells were harvested 
from a day 4 mixed lymphocyte reaction (details given later) culture 
plate, washed in HBSS, and suspended in supplemented RPKL 1640 at a 
concentration of 5 x 10^ cells/ml. One hundred microliters (5 x 10^) 
cytotoxic T cells were added to each well of a 96-well microtiter plate. 
Serial dilutions of unpurified TCGF were made and 1:4 dilutions of 
each Sephadex G-lOO column fraction from the 15,000 to 60,000 molecular 
weight range were made. One hundred microliters of a TCGF dilution 
were added to the designated wells of the microtiter plate. Cytotoxic 
cells only and cytotoxic cells plus concanavalin A (10 /ig/ml) served 
as negative and positive controls, respectively. The microtiter plate 
was incubated at 37°C and 7% COg in air for 24 hours. The 2 ^Ci of 
3 3 
H-thymidine ([methyl- H]-thymidine, 6.7 Ci/mmole, aqueous solution. 
New England Nuclear, Boston, Massachusetts) in 50 Jil of medium were 
added to each well of the microtiter plate which was then reincubated 
at 37*C and 7% CO^ in air for 18 hours. The microtiter plate was processed 
with a cell harvester and the filters were counted in toluene fLusr in a 
scintillation counter. 
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4. Protein concentration determination 
Protein concentrations in each Sephadex G-lOO column fraction were 
determined by measuring absorbance at 280 nm with a Gilford spectro­
photometer (Oberlin, Ohio) and by performing a Lowry test (Lowry et al., 
1951). Samples, standards, and blanks were prepared to give a final 
volume of 1.2 ml of solution, then 3 ml of one part 2.68% Na tartrate 
plus one part 1% CuSO^ SHgO plus 100 parts of 2% NagCO^ In 0.1 N NaOH 
were added to samples, standards, and blanks. The test tubes were vor-
texed, then were allowed to stand for 10 minutes. Folln reagent (0.3 
ml of IN) was added to all tubes, which were then mixed and were 
allowed to stand for 30 minutes before absorbance was read at 750 nm. 
Protein concentrations of samples were then extrapolated from a BSA 
standard curve. 
I. Cell Interaction Assays 
1. Mixed lymphocyte reaction (MLR) 
a. Generation of cytotoxic T cells to H^-Y Cytotoxic T cells 
were produced, based on the methods of Gordon et al. (1975) and Simpson 
et al. (1975). C57BL/6 female mice were each Injected with 1 x 10^ 
C57BL/6 male spleen cells. Fourteen days later, the female mice were 
sacrificed and their spleens were aseptlcally removed and teased apart 
into HBSS. The spleen suspension was then passed through a 40-gauge 
stainless steel screen. The suspension was centrlfuged (Becknan Model 
TJ-6, Irvine, California) at 100 g and room temperature for five minutes. 
The supernatant was decanted and 10 ml of buffered ammonium chloride was 
60 
added. The cell suspension was set at room temperature for two to 
five minutes, then diluted to 50 ml with HBSS and centrlfuged. The 
cells were washed with HBSS two more times, then suspended In 10 ml of 
supplemented RPMI 1640. An aliquot was collected for a cell count in 
0.1% trypan blue. The cell concentration was adjusted to 5 x 10^ 
cells/ml. 
C57BL/6 male spleen lymphocytes were collected and Isolated In the 
same way as the female spleen lymphocytes. Stimulator cells were pre­
pared as follows. Half of the male cells and half of the female cells 
were each treated with mitomycin C at a concentration of 25 ;^g/ml for 
30 minutes at 37*C and 7% CO^ In air, according to the procedure of 
Bach and Voynow (1966). After two HBSS washes, the cells were suspended 
in supplemented RPMI 1640 medium and an aliquot was counted in 0.1% 
trypan blue. The cell suspensions were adjusted to 5 x 10^ cells/ml. 
A MLR monitoring 96-well mlcrotiter plate was set up with 0.1 ml 
of responder cells and 0.1 ml of stimulator cells in designated wells. 
Responder cells only and stimulator cells only wells were set up as 
controls. The remaining cell suspensions were added as 1 ml of respon­
der cells and 1 ml of stimulator cells to each well of a 24-well tissue 
culture plate. Both plates were incubated at 37*C and 7% CO^ in air. 
On day 1 of the MLR, 20 fil of a 0.01% PHA-P (Dlfco, Detroit, Michigan) 
solution or 20 pi of Concanavalin A (Miles-Yeda, Israel) (1000 ^ g/ml) 
were added to designated control wells of the MLR monitoring plate. 
On day 4 of the MLR, 2 fid of ^H-thymldlne ([methyl-^H]-thymidine, 
6.7 Ci/mmole, New England Nuclear, Boston, Massachussetts) in 50 pi of 
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media were added to all wells of the MLR monitoring plate. Eighteen 
to twenty-four hours later, the monitoring plate was cell harvested 
and the filters were processed. The cytotoxic cells generated in the 
24-well tissue culture plate were then collected and tested for activity 
in a cell mediated lympholysis reaction. 
b. Generation of cytotoxic T cells to H-2 Cytotoxic T Cells 
to H-2 were generated according to the method of Rosenberg et al. (1978b). 
Spleen lymphocyte suspensions were prepared as described for the gener­
ation of cytotoxic T cells to H-Y. Stimulator cells were treated with 
mitomycin C and washed twice. Responder cells were used at 7 x 10* 
cells/ml and stimulator cells were used at 3 x 10* cells/ml. A MLR 
monitoring plate was set up with 0.1 ml of stimulator cells (3 x 10^) 
and 0.1 ml of responder cells (7 x 10^) in each well. The remaining 
cell suspensions were added to a 24-well tissue culture plate as 1 ml 
of responder cells to 1 ml of stimulator cells. The plates were incu­
bated at 37*C and 7% CO^ in air for four days. The monitoring plate 
was treated as described previously and harvested on day 5. 
A secondary stimulation of cytotoxic cells was performed by 
collecting the responder cells and adjusting the cell concentration to 
4 X 10* responder cells/ml, then adding one ml of 1 x 10* cells/ml of 
freshly treated mitomycin C stimulator cells and one ml of responder 
cells to give a final volume of two ml per well. A tertiary stimulation 
was performed as described for the secondary stimulation. 
Cells were grown in the presence of T cell growth factor (TCGF) 
four days after each stimulation and for six to nine days before the 
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next stimulation was performed. After the tertiary stimulation, cells 
were grown in the presence of TCGF and counted every four to five days. 
Cells were diluted with fresh medium containing TCGF and were plated 
at 2 X 10^ cells per well. The responder cells were tested periodically 
against lymphocytes in a micro-cell-mediated lympholysls assay or 
against embryos in a mixed embryo-lymphocyte Interaction assay as 
described in the next sections. 
2. Cell-mediated lympholysls (CML) 
a. Assaying for cytotoxic effector cells The detection of 
H-Y cytotoxic effector cells was performed according to the procedures 
of Gordon et al. (1975) and Simpson et al. (1975). Sensitized cells 
were collected from 24-well tissue culture plates and centrlfuged at 
125 g and room temperature for 10 minutes. The supernatant was decanted 
and the cells were washed with HBSS, then resuspended in a small volume 
of culture medium. The cells were counted in a hemacytometer and the 
concentration was adjusted to 2 x 10^ cells/ml. Several serial dilutions 
were made. Control cell suspensions of unsensltlzed cells at the same 
concentration as the sensitized cells were prepared from fresh spleen 
suspensions treated with the ammonium chloride buffer, then washed three 
times in HBSS. Medium controls of target cells incubated with medium 
alone were included in each experiment. 
Target cells consisted of mitogen-induced blasts which were 
prepared by incubating 10 ml of C57BL/6 spleen cells at a concentration 
of 4 X 10^ cells/ml in 30 ml Falcon flasks (Fisher, Chicago, Illinois). 
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Concanavalln A was added to each flask of cells to yield a final 
concentration of 10 pg/ml. The cells were incubated at 37*C and 7% 
CO2 in air for 48 to 72 hours. The cells were then collected and washed 
once with HBSS. The cells were resuspended in culture medium at a concen­
tration of 3 X 10^ cells/ml. The cells were labeled with 250 fiCi of ^^Cr 
sodium chromate Na[^^CrJ (New England Nuclear, 200-500 Cl/g, Boston 
Massachusetts) per ml of cell suspension. Labeling was performed at 
f 
37°C and 7% CO^ in air for 45 minutes with frequent agitation of the 
cell suspension. The cell suspension was centrifuged at 125 g and room 
temperature for 10 minutes. The supernatant was decanted and the cells 
were washed two times with HBSS. The cells were suspended in culture 
medium at a concentration of 2 x 10^ cells/ml. 
The assay was performed in 96-well round bottom tissue culture 
plates (Linbro: Flow Labs, McLean, Virginia) with three to four repli­
cates. Fifty fil of target cells (1 x 10^ cells) were placed in desig­
nated wells, then 200 ^ 1 of the effector cell suspensions were placed 
in the appropriate wells. The plate was centrifuged at 40 g and 4®C 
for five minutes in an International portable refrigerated centrifuge 
Model PR-2 (Boston, Massachusetts), then was incubated for four hours 
at 37®C and 7% CO^ in air. After the incubation period, the plate was 
centrifuged (International Model PR-2, Boston, Massachussetts) for 20 
minutes at 200 g and 4*C. One hundred fil of supernatant was removed 
from each well and was dispensed in 12 x 75 mm disposable culture tubes 
containing 200 pi of medium. The tubes were then counted In a Tracor 
Analytic Automatic V-counter Model 1197 (Elk Grove Village, Illinois). 
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Maximum lysis was obtained by adding 200 ^ 1 of 0.1 N IICl to wells 
containing 50 #il of ^^Cr-labeled target cells. 
Results were expressed as: 
% Corrected lysis « 
j^QQ Counts released by experiment - counts released by control 
Maximum released counts - medium background counts 
b. Assaying for cytotoxic effector cells H-2 cytotoxic 
cells were detected by the micromethod of Traill et al. (1981). Sen­
sitized effector cells were pooled, washed once with HBSS, then resus-
pended in culture medium at a concentration of 8 x 10^ cells/ml. A 
microtest Terasaki plate (Fisher, Chicago, Illinois) was prepared for 
the assay by using a hot needle to perforate the periphery of the lid 
with eight holes to allow for maximum gas exchange. The outer wells 
of the plate were filled with 25 fil of PBS or culture medium. Various 
concentrations of sensitized effector cells were dispensed in 20 fxl 
volumes into designated wells of the Terasaki plate. Target cells were 
4 
prepared as described for the H-Y CML assay, then 1 x 10 cells were 
dispensed in a 5 pi volume into designated wells. The Terasaki plate 
was covered, inverted, and placed on a damp paper towel and then was 
Incubated at 37®C and 7% CO^ in air. After four hours, the contents 
of each well were transferred to 185 fil of medium in a well of a round-
bottom microtiter plate (Linbro: Flow Labs, McLean, Virginia). Each 
Terasaki well was washed with 50 fil of medium and then was dispensed 
into the appropriate well of the round-bottom microtiter plate. The 
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plate was centrlfuged at 125 g and 4"C for 30 minutes, then 100 ^ 1 of 
supernatant was removed and was dispensed into 12 x 75 mm disposable 
culture tubes, containing 200 ^ 1 of culture medium. Chromium release 
measurements were made in a manual Nuclear Chicago y-counter (Des 
Plaines, Illinois). Maximum release was determined by adding 20 f^l of 
O.lNHCl to 5 fil of target cells. Results were expressed as 
% Specific release * 
cpm of experimental release - cpm of spontaneous release 
cpm of maximum release - cpm of spontaneous release 
3. Mixed embryo lymphocyte 
interaction assay (MELIA) 
The mixed embryo lymphocyte assay was developed utilizing the 
micro-cell mediated lympholysis procedure of Traill et al. (1981). 
Embryos of the blastocyst stage of development were collected from super-
ovulated mice and washed three times in Whitten and Biggers medium. 
The embryos were pronased, then washed three times and incubated at 37"C 
and 7% CO^ in air in about 0.5 ml of Whitten and Biggers medium for 
two to three hours. Cytotoxic T cells were collected from day 5 mixed 
lymphocyte reaction plates or from long-term T cell growth factor main­
tained cytotoxic T cells. The cell concentrations were determined with 
the aid of a hemacytometer. Cell suspensions were centrifuged at 125 g 
and room temperature for 5-10 minutes. The supernatant was decanted 
and the cells were washed with HBSS, then brought up to the desired 
concentration with supplemented RFMI 1640. Various cell concentrations 
of cytotoxic T cells in 20 fil volumes were dispensed into designated 
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wells of microtest Terasakl plates (Falcon Plastics, Oxnard, California). 
One embryo was dispensed Into each designated well of the Terasakl plate. 
All wells were brought to a final volume of 25 pi by adding 5 pi of 
culture medium. The lid of the Terasakl plate was perforated with a hot 
needle to form several holes around the periphery to allow for gas ex­
change. The Terasakl plate was then covered, inverted, and placed on a 
damp paper towel on a small tray. The tray was placed In a 37*C and 
7% COg in air Incubator for four hours. The plate was then examined 
under a dissecting microscope and the embryos were removed with a mlcro-
plpette and washed three times In Whltten and Blggers medium. Individual 
embryos were then assayed for viability in the embryo DNÂ synthesis 
assay. Briefly, one embryo was placed in 75 pi of Whltten and Blggers 
medium in the well of a 96-well flat-bottom mlcrotlter plate (Llnbro: 
Flow Labs, McLean, Virginia). After a 5-10 minute CO^ gassing period, 
3 
75 pi of H-thymldine (8 pCl/ml) were added to all wells and at least 
two background wells containing no embryos. The plate was Incubated 
for five hours. The embryonic DNA was collected with a cell harvester. 
The filters were processed and counted in a liquid scintillation counter. 
7.') 
III. RESULTS 
A. DNA Synthesis Assay for Embryos 
1. Development of the DNA 
synthesis assay 
Initial experiments were designed to optimize the parameters of the 
DNA synthesis assay. Outbred CFl embryos were used for these experiments. 
3 
Figure 3 shows that the optimal concentration of H-thymldlne Is 2-8 
^Cl/ml for blastocysts and 4-125 fiCl/ml for 8-cell embryos when the 
embryos are Incubated for seven hours. The low Incorporation of label 
at high specific activities by blastocysts may be caused by radiation 
effects (Snow, 1973). Based on these experiments, 4 /iCl/ml was chosen 
3 
as the concentration of H-thymldine to use in the next experiments. 
Figures 4a and 4b show time course studies of the Incorporation of 
3 
H-thymldlne into blastocyst (Figure 4a) and 8-cell (Figure 4b) embryos. 
In both cases, incorporation is linear up to seven hours and then slows 
3 down. Therefore, a three-to-five hour H-thymldlne labeling time was 
used for most experiments. 
The effect of preincubation at 37*C and 7% CO^ in air was tested 
3 
on the subsequent incorporation of H-thymldine. Figure 5 shows that 
there is little effect of preincubation on 8-cell embryos prior to label-
3 ing with H-thymldine. However, blastocysts show a marked increase and 
then a decrease of the incorporated counts. The decrease may be due to 
the lack of cell division by late blastocysts in Whitten and Biggers 
medium. The reason for the initial lag in incorporation is unknown. 
77 
140 
120 
100 
I 
0.1 10 10 100 
[^ThymkNn#] (pCI/ml) 
Figure 3. Cpm incorporated into DNA by blastocyst (•) and 8-cell (•) 
mouse embryos as a function of the concentration of 
^H-thymidine. A seven-hour labeling period was used for 
each experiment 
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Figure 4a. Cpm incorporated into DNA by blastocyst mouse embryos as a function of time 
in 4 fiCi/ml ^H-thymidine 
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Figure 4b. Cpm incorporated into DNA by 8—cell mouse embryos as a function of time 
in 4 ^ Ci/ml thymidine 
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Figure 5. The effect of preincubation on the incorporation of %-thymidine into UNA by blastocyst 
(•) and 8-cell (o) mouse embryos. Embryos were incubated with 4 pCi/ml of thymidine 
for three hours after the designated preincubation period 
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Perhaps the multicellular blastocyst embryo requires 3 to 4 hours to 
acclimate to ^  vitro conditions. 
To examine whether thymidine pools were saturated in each embryo 
with 4 ^ Cl/ml (sp. act. 20 Ci/mmole) of ^H-thymindfne, the relationship 
between label incorporation and the number of embryos present in 50 pi 
3 
of H-thymldine labeled Whltten and Biggers medium was examined. For 
both blastocyst (Figure 6a) and 8-cell (Figure 6b) embryos Incorporation 
was linear up to 64 embryos in 50 fxl of labeled medium. It should be 
noted that at the blastocyst stage, individual embryos are easily assayed 
using this technique. Each CFl blastocyst incorporates about 200 cpm 
per embryo per hour with a background of only 20-30 cpm in each well, 
containing medium and radioactivity, but no embryos. 
The presence or absence of the zona pellucida appears to slightly 
3 
affect H-thymidlne incorporation by blastocyst embryos. The optimal 
3 
concentration of H-thymidlne is about the same for blastocyst embryos 
with and without the zona pellucida (compare Figure 3 and Figure 7a). 
For 8-cell mouse embryos (Figure 7b) the absence of the zona pellucida 
3 
appears to shift the H-thymidlne concentration for optimal Incorporation 
to the right (see Figure 3). The reason for the shift is not known. 
The effect of thymidine incorporation involving two different 
3 
specific activities of H-thymidlne was examined on blastocyst embryos. 
a 
In Figure 7a, H-thymldine of specific activity 20 Ci/mmole was used, 
while in Figure 8, H-thymldine of specific activity 52 Cl/mmole was 
3 
used. Increasing the specific activity of the H-thymidlne increased 
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Figure 6a. Cpm incorporated into IMA by varying numbers of blastocyst 
(•) mouse embryos preincubated for three hours without 
label and then for three hours in 4 nCl/tal 3H-thymidine. 
The equation for the least squares linear regression line 
through the points is y » S36x + 100; the correlation coef­
ficient, r " 0.99 
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Figure 6b. Cpm Incorporated into DNA by varying numbers of 8-cell (e) 
mouse embryos prelncubated for three hours without label 
and then three hours In 4 pCi/ml ^-thymidine. The equation 
for the least squares linear regression line through the 
points is y - 65x + 94; the correlation coefficient, r • 0.99 
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Figure 7a. Cpm Incorporated Into DNA by blastocyst mouse embryos, 
which have had their zona pelluclda removed by pronase 
digestion, as a function of concentration of ^-thymidine. 
A seven-hour labeling period was used. thymidine was 
of specific activity 20 Cl/mmole 
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Figure 7b. Cpm Incorporated Into DNA by 8-cell mouse embryos, which 
have had their zona pelluclda removed by pronase digestion, 
as a function of concentration of ^-thymidine. A seven-
hour labeling period was used 
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Figure 8. Cpm into DNA by blastocyst embryos, which have had their 
zona pellucida removed by pronase digestion, as a function 
of concentration of %-thymidine. A seven-hour labeling 
period was used. The thymidine was of specific activity 
52 Ci/mmole 
87 
the total cpm's Incorporated per embryo per hour as expected. The 
Incorporation curves follow essentially the same pattern, regardless of 
specific activity. 
In summary, conditions for the DNA synthesis assay were optimized 
3 
as follows: (1) 4 ^ Ci/ml H-thymidine (sp. act. 20 Ci/nmole); (2) a 
labeling period from two to seven hours; (3) a three-hour preincubation 
period for blastocyst embryos and from zero to seven hours preincubation 
for 8-cell embryos; (4) 1-64 embryos per assay well; (5) absence of the 
zona pellucida does not significantly affect incorporation of H-thymidine 
for blastocyst embryos or 8-cell embryos and, therefore, the zona pel­
lucida was not removed for most experiments; and (6) increasing the 
3 
specific activity of H-thymidine can be used to increase the total num­
ber of cpm's incorporated per blastocyst embryo per hour. However, 
because of increased background counts with the higher specific activity 
3 
H-TdR, at least five blastocysts had to be assayed in the same well. 
2. Verification of ^H-thymidine 
Incorporation into the embryonic 
DNA 
3 
Two experiments were performed to prove that H-thymidine was 
incorporated into the embryonic DNA. First, the effect of mitomycin C, 
a known inhibitor of DNA synthesis, was examined on CFl blastocyst em­
bryos. The results, as shown in Table 6, demonstrate almost 100% inhi-
3 bition of H-thymidine incorporation by a 300 /ig/ml mitomycin C treatment 
3 
of blastocyst embryos prior to the H-thymidine labeling period. 
In the second experiment, the effect of DNase I on embryonic DNA 
was examined. Figure 9 demonstrates the activity of DNase I in 
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Table 6. Effect of mitomycin C on CFl blastocyst embryos. Blastocysts 
were Incubated with mitomycin C for one hour then were 
incubated with 4 pCi/ml of thymidine for seven hours 
Mitomycin C Number of Mean cpm Percent Inhibition 
( f i g / m l )  Embryos per embryo ^H-thymldine Incorporation 
Tested + SEM 
0 4 898 0 
100 A 196 78+6 
200 4 74 92+3 
300 4 26 97+1 
2.15 
.90 - 205 
1.95 
1.85 
M  
Tim# (minut##) 
Figure 9. Spectrophotonetrlc measurement of DNase I activity in an acetate buffered 
substrate solution (•) and in acidified Whltten and Biggers medium (o) 
containing an equivalent amount of deoxyribonuclease 
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acidified Whltten and Blggers medium and also in an acetate buffered 
substrate solution. It was necessary to acidify Whitten and Blggers 
medium to pH " 5 in order to optimize the activity of DNase I on blast­
ocyst embryos. The specific activity of DNase I in acidified Whltten 
and Blggers medium was reduced to 4 units/mg as opposed to 12 units/mg 
for the acetate buffered substrate solution, ffllase I was then tested 
on blastocyst embryos in acidified Whltten and Blggers medium. The re­
sults are shown in Table 7. It can be seen that DNase I and Triton X-100, 
together, greatly decrease incorporated counts. Apparently, Triton X-100 
breaks open cell membranes and exposes the embryonic DNA to DNase I 
which then degrades the labeled DNA into pieces which are too small to 
be trapped on the glass filter mat during the cell harvesting procedure. 
3 
3. H-thymldlne incorporation by 
47, 53, 56, 65, and 89 hour post-
hCG embryos 
The ability of preImplantation stages of CFl embryos to incorporate 
3 4 pCl/ml of H-thymldlne was examined. Table 8 lists the stages of CFl 
prelmplantatlon mouse development that were examined. The results are 
3 
shown in Figure 10. Incorporation of H-thymidine per cell per hour 
appears to Increase for the later stages of development (I.e., blasto­
cysts) . The most probable explanation is that more cells in any given 
embryo are labeled at later stages of development. The reason for this 
is that the cell cycle decreases from 24 to 12 hours during development 
(McLaren, 1972), but the length of the S phase remains the same (six to 
seven hours). Thus, during a three-seven hour labeling period, the 
3 
Table 7. Verification of H-thymidine incorporation into the DNA of blastocyst embryos treated 
with DNase I and/or Triton X-100 
Experiment DNase I Triton X-100 Number of Mean Percent of 
(10 pg/ml) (1%) Embryos cpm per Control 
Tested Embryo + SEM 
No. 1 (Control) - - 15 434 100 
No. 2 - + 15 324 75+10 
No. 3 + - 15 284 66+12 
No. 4 + + 15 26 6+2 
Table 8. Stage of preimplantation mouse development relative to hours post-hCG injection for 
CFl embryos 
Hours Post-hCG Stage of 
Development 
Number of Cells 
per Embryo + SEM* 
cpm per Embryo 
+ SEN 
cpm per cell per 
hour + SEM^ 
47 2 cells 2.0+0.0 3+1 0.5+0.1 
53 3-4 cells 3.6+p.l 2840 2.6+p.l 
56 4 cells 4.0+0.1 25+3 2.1+0.3 
65 6-8 cells 6.8+1.0 60+3 2.9+0.2 
89 blastocyst 44.4+2.2 1159+56 8.7+0.5 
^Verbanac and Goldbard, unpublished results. 
The result of the embryos' ability to Incorporate 4 pCi/ml of H-thymidine in a DNA 
synthesis assay. 
93 
100 
Hours post hCG 
Figure 10. Cpm Incorporated Into DNA per cell per hour of CFl embryos 
at 47, 53, 56, 65, and 89 hours post-hCG injection. Embryos 
from each stage of development were prelncubated three hours 
prior to a three-hour labeling period with 4 ^ Ci/ml of 
%-thymidine. The equation for the least squares linear 
regression line through the points is y - 0.2x - 8.0; the 
correlation coefficient, r « 0.97 
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shorter the cell cycle, the more likely that the cells will pass through 
the S phase during the labeling period. Fifty to sixty embryos from the 
47, 53 and 56 hours post-hCG stages of development were used per assay in 
3 
order to obtain H-thymidine incorporation that was above background 
counts. 
3 4. H-thymidine incorporation by 
the inner cell mass 
The ability of blastocyst inner cell masses (ICM) to incorporate 
3 
H-thymidine was examined. Immunosurgery was performed on CFl blastocyst 
embryos according to the method of Solter and Knowles (1975). The re­
sults of a 7-hour labeling period and a 24-hour labeling period with 
3 
H-thymidine are shown in Table 9. It can be seen that ICMs incorporate 
less than 10% of the total counts incorporated by the intact blastocyst. 
These results were unexpected in light of studies by Barlow et al. (1972) 
who demonstrated a higher H-thymidine labeling index for "inside" cells 
as opposed to "outside" cells of preimplantation mouse embryos based on 
grain counts. They concluded that the "inside" cells were dividing 
faster than the "outside" cells. The blastocyst embryo exhibits "inside" 
cells (i.e., ICM) and "outside" cells (i.e., trophectoderm). It could 
be that separation of the ICM from the trophectoderm impairs synthesis 
in the ICM. 
3 5. H-thymidine incorporation as a 
measure of number of cells per embryo 
An experiment was performed to test whether the DNA synthesis assay 
for embryos could be used as a measure of the number of cells (i.e.. 
3 
Table 9. H-thymidine incorporation by CFl Inner Cell Mass (ICM) 
Embryo Embryo/Well cpm/Embryo Mean cpm/Embryo 
+ S EM 
ICM 
ICM + Trophectoderm' •X 100 
A. Seven hour incubation with H-thymidine 
ICM + 
trophectoderm 1 1780 
1 2551 
2166+273 
ICM 81 
120 101+ 14 
5% 
B. Twenty-four hour incubation with H-thymidine 
ICM + 
trophectoderm 
ICM 
1460 
1774 
1388 
805 
150 
165 
30 
0 
42 
11 
163 
1 
245 
418 
92 
59 
52 
1357+175 
110+ 32 
8% 
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nuclei) per embryo. Our laboratory has observed that different inbred 
mouse strains have different number of cells per embryo at a given time 
post-hCG injection. Table 10 shows the data collected for CFl and five 
Inbred strains of mice (Cozad et al., 1981). One set of embryos was 
treated by the Tarkowski procedure to determine the number of cells per 
embryo. The other set of embryos was subjected to the DNÂ synthesis 
assay procedure. The correlation of the two sets of data is shown in 
Figure 11. The DNA synthesis assay can be used as an accurate indicator 
of number of cells per embryo. 
B. The Effect of Compounds on WA Synthesis 
in Preimplantation Mouse Embryos 
1. The effect of salts 
Osmolarity plays an important role in maintaining embryo viability 
in vitro. Development of one-cell ova to blastocysts occurs best between 
0.250 and 0.280 osmol (Whittingham, 1971). The effects of various con­
centrations of saline and PBS on CFl blastocyst embryos were examined. 
The results are shown In Figure 12. Normal saline (0.15 M), when added 
to an equal amount of double strength Whitten and Biggers medium, in-
3 hlblted H-thymldine incorporation by 40% in blastocyst embryos. The 
longer preincubation time with NaCl as opposed to PBS probably led to 
the Increased inhibitory effect of MaCl. 
2. The effect of various compounds 
The effect of mitomycin C on CFl blastocyst embryos was examined. 
Mitomycin C inhibits DNA synthesis by covalently cross-linking 
Table 10. Determination of the number of cells per mouse embryo 
Hours Counting Nuclei* DNA Synthesis Assay^ 
Strain 
Post-
hCG 
No. 
Expts. 
No. 
Embryos 
Mean 
Cell No./Embryo(SE) 
No. 
Expts. 
No. 
Embryos cpm/Embryo/hour(SE) 
CFl 89 5 51 44.4 (2.2) 3 263 178 (26) 
CFl 65 4 50 6.8 (1.0) 5 91 16 (1) 
C57BL/10Sn 89 8 48 33.1 (2.1) 3 55 112 (31) 
CBA 89 7 45 18.9 (1.0) 2 84 91 (7) 
SJL 89 5 48 31.9 (2.0) 2 74 107 (26) 
BALB/c 89 4 49 22.0 (1.4) 2 59 99 (11) 
MA/l 89 8 47 30.2 (1.5) 2 39 115 (5) 
Nuclei were counted using Tarkowski (1966) procedure. 
^DNA synthesis was measured as described in the text. The assay Included a three-hour 
preincubation, followed by a three-hour labeling period in 4 /iCi/ml ^-thymidine. 
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Figure 11. Cpm Incorporated Into DNA of blastocyst (•) and 8-cell (•) 
mouse embryos as a function of the number of cells per 
embryo. The embryos were prelncubated for three hours with­
out label and for three hours In 4 fiCl/ml %-thymidine. 
The equation for the least squares linear regression line 
through the points Is y - 3.8x + 1.6; the correlation 
coefficient, r - 0.96 
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Figure 12. The effect of NaCl (A) and PBS (A) on ^-thymidine Incorporation by CFl blastocyst 
embryos. Embryos were prelncubated with NaCl In Whltten and Blggers medium for 
seven hours prior to a three-hour labeling period with 4 /iCl/ml of thymidine. 
Embryos were prelncubated with PBS in Whltten and Blggers medium for five hours 
prior to a three-hour labeling period with 4 fiCl/ml of ^-thymidine 
ion 
complementary DNA strands. The effect of mitomycin C on CFl blastocyst 
embryos with the zona pellucida present and absent are shown in Figure 
13a and 13b, respectively. Similar results were obtained for both graphs, 
but the effect of mitomycin C is enhanced at lower concentrations (i.e., 
50/ig/ml) when the zona pellucida is absent. In both graphs, a treatment 
of about 300 pg/ml of mitomycin C for at least one hour is necessary 
3 
to give 100% inhibition of H-thymidine incorporation. 
Of-Amanitin, a known inhibitor of RNA synthesis through binding to 
Form II and Form III RNA polymerases has been shown to block the cleavage 
of early mouse embryos (Golbus et al., 1973; Warner and Versteegh, 1974; 
Levey et al., 1977). It has been suggested that a-amanltin inhibits 
IX4A synthesis in preImplantation mouse embryos. Warner and Hearn (1977) 
3 
showed that embryos labeled with H-thymidine incorporated about 10% 
of the label into DNA (presumably by conversion of uridine to deoxycyti-
dine). The incorporation of the label into DNA was inhibited by 
3 
a-amanitin. The effects of 0(-amanltln on H-thymidine incorporation by 
CFl 8-cell and blastocyst embryo is shown in Table 11. Both stages of 
development are Inhibited by a-amanitin, but blastocysts appear to be 
more susceptible to Ot-amanitin than 8-cell embryos—especially at the 
50 ^ g/ml concentration of Ot-amanitin. 
The effect of aphidicolin on CFl 8-cell and blastocyst embryos is 
shown in Figure 14. Blastocyst and 8-cell embryos are sensitive to 
aphidicolin at concentrations of 20-50 ^ g/ml. Aphidicolin is believed 
to interact with the catalytic sub unit of DNA polymerase OL or with an 
3 
accessory subunit (Huberman, 1981). The inhibition of H-thymidine 
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Figure 13a. The % Inhibition of H-thymidine incorporation by CFl 
blastocyst embryos as a function of mitomycin C treatments 
for 0.5 (•), 1.0 (o), and 2.0 (*) hours followed by a 
seven-hour labeling period with ^-thymidine 
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Figure 13b. The % Inhibition of H-thymidine incorporation by CFl 
blastocyst embryos without their zona pellucidae as a 
function of mitomycin C treatments for 0.5 (•), 1.0 (•), 
and 2.0 (A) hours followed by a seven-hour labeling 
period with %-thymidine 
3 
Table 11. The effect of a-amanltin on H-thymidine incorporation by CFl 8-cell and blastocyst 
embryos. Embryos were incubated with Of-amanltin for two hours prior to a three, five or 
seven hour labeling period with ^-thymidine 
a-Amanitin 
Qwg/ml) 
Number of 
Assays 
Number Embryos 
per Assay 
% Inhibition of H-thymldine 
Incorporation + SEM 
Time of 3H-thymldine labeling(hrs.) 
3 5 7 
8-cell 
0 2 9 0 0 0 
50 2 9 6+4 15+ 5 0+ 0 
100 2 9 8+5 17+12 ^ 2 
200 2 9 16+6 37+ 0 25+11 
Blastocyst 
0 2 5 0 0 0 
50 2 5 25+1 34+ 6 10+ 1 
100 2 5 41+2 24+ 2 23+ 4 
200 2 5 4246 28+ 5 22+ 0 
100 
40-m 
001 100 0.1 10 
ApMdicolin (jig/ml) 
Figure 14. The effect of aphldlcolln on CFl 8-cell (e) and blastocyst (•) embryos. Embryos 
were Incubated with aphldlcolln for seven hours prior to a three-hour labeling 
period of ^-thymidine 
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Incorporation by aphldlcolln suggests that DNA polymerase a or a 
subunlt is active In early embryonic development. 
The effects of cyclohexlmide, puromycin, and theophylline on 
3 
H-thymidlne Incorporation by CFl blastocyst embryos are shown in Figure 
15. Theophylline has a negligible effect on blastocyst embryos, where-
-4 
as cycloheximide and puromycin are Inhibitory at 10 M. Puromycin 
blocks protein synthesis by interfering with the elongation cycle of trans­
lation, while aycloheximide binds to the ribosomes and causes premature 
termination of peptide synthesis. Therefore, proteins essential for 
3 
DNA synthesis are probably not produced and subsequently, H-thymidlne 
incorporation is inhibited. 
3. The effect of hCG 
One of the early indicators of pregnancy in mammals is the 
production of chorionic gonadotrophins. To examine whether hCG affects 
embryos, CFl blastocyst embryos were incubated with hCG or the /3-subunit 
of hCG, The results are shown in Table 12. It can be concluded that 
hCG and its 0-subunit at 1.7 mg/ml and 2.3 mg/ml concentrations, respec-
3 tively, have no effect on H-thymidine incorporation by blastocyst embryos. 
Wiley (1974) used antiserum to hCG in an indirect immunofluoresence 
assay on mouse embryos. She examined mouse embryos from the unfertilized 
egg stage to blastocyst outgrowths. Maximal hCG or "hCG-like" concen­
trations were found at the morula stage with blastocyst exhibiting 
slight fluorescence. The negative results obtained with 1.7 mg/ml of 
exogenous hCG could be due to a lack of receptors for hCG on blastocyst 
100-1 
mo­
rn 
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Flgure 15. The effects of cyclohexlmlde (A), puromycin (•), and theophylline (•) on CFl 
blastocyst embryos. Embryos were Incubated with a designated compound for 
seven hours prior to a three-hour labeling period with %-thymidine 
3 
Table 12. The effect of hCG and its /3-subunlt on the Incorporation of H-thymldlne by CFl blasto­
cyst embryos. Embryos were Incubated five hours with the designated compound prior 
to a three-hour labeling period with %-thymldlne 
Controls Experiments Ratios % Inhibition of 
Experiment Average Number Average Number of cpm/ Experiment com thymidine In-
Number Embryos cpm/embryo Embryos Embryo Average control cpm corporation+SEM 
A. hCG (1.7 mg/ml) Treatment 
1 5 898 5 
5 
1587 
1546 
1.77 
1.72 
0-K) 
B. g-Subunlt (2.3 mg/ml) Treatment 
1 5 1404 
2 5 1737 
1380 
1777 
1690 
1219 
0.98 
1.27 
0.97 
0.70 
1+1 
17+10 
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embryos or the receptors could be filled with endogenous hCG and not be 
affected by exogenous hCG. 
C. Development of the Embryo 
Cytotoxicity Assay 
1. Cytotoxic activity of rabbit 
anti-mouse serum 
Rabbit anti-C57BL/10Sn serum was tested against C57BL/10Sn spleen 
lymphocytes and also against CFl spleen lymphocytes in a lymphocyte 
cytotoxicity assay. The results, expressed as % Killing of Lymphocytes, 
are shown in Table 13. As can be seen, the antiserum gave a titer of 
1:128 against both targets. (The titer is the last dilution at which 
>50% of targets are killed.) The antiserum was then tested against CFl 
blastocyst embryos in a cytotoxicity assay. Antiserum was added for one 
hour, then guinea pig complement for one hour, followed by a five-hour 
3 labeling period with H-thymidine. Theoretically, antibody molecules, 
present in the antiserum, should bind to antigenic determinants on the 
embryos. The addition of complement would result in complement binding 
Co antibody molecules on the embryonic cells and the initiation of the 
complement cascade with cell lysis resulting. Bound antibody molecules 
plus complement have been shown to produce holes as large as 150 A in 
diameter (i.e., ribosome size) in the outer cell membrane (Goldberg and 
Green, 1960). Therefore, enzymes and substrates necessary for DNA repli­
cation could easily escape from such cells, thereby diminishing the 
3 
incorporation of H-thymidine into DNA. Embryos treated with normal 
serum, lacking antibodies, would not be lysed and would therefore Incor-
3 porate H-thymidine. 
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Table 13. Rabbit antl-C57BL/10Sn serum (2®) activity against C57BL/10Sn 
and CFl lymphocytes In a lymphocyte cytotoxicity assay 
% Killing of Lymphocytes + SEM 
C57BL/10Sn Target CFl Target 
1:2 93+4 94+3 
1:4 98+1 95+0 
1:8 954^ 96+1 
1:16 93+2 94+1 
1:32 87+2 87+5 
1:64 85+1 83+3 
1:128 59+p 73+p 
1:256 30+5 43+8 
1:512 9+1 8+2 
1:1024 8+2 4jK) 
1:2048 6+0 3+0 
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The results for antiserum treatment of CFl blastocyst embryos 
and also CFl lymphocytes are shown In Figure 16. The antiserum effec-
3 
tively (50% killing) inhibits H-thymidine incorporation by embryos to 
a titer of 1:1024, while the lymphocyte cytotoxicity assay is effective 
to a titer of 1:256. The embryo cytotoxicity assay is sensitive enough 
to perform on individual blastocyst embryos. 
3 
It is seen that there is a lower inhibition of H-thymidine 
incorporation at 1:2, 1:4 and 1:8 dilutions of antiserum. The probable 
explanation is a prozone effect in which the number of antibody molecules 
binding to antigenic determinants is so great that only one of the two 
binding sites of the IgG molecule attaches to the embryos. Therefore, 
neither aggregation nor a conformational change would occur in the IgG 
molecule, so that the complement cascade with subsequent lysis could 
not be initiated. 
Figure 17 exhibits the morphological changes which can be observed 
when blastocyst embryos were treated with normal serum or with anti­
serum, followed by treatment with guinea pig complement. Note that the 
complement-treated embryos have collapsed blastocoels and the lysed 
trophectoderm cells have retracted from the zona pellucida and surround 
the centrally condensed inner cell mass. 
The rabbit anti-C57BL/10Sn serum was titered against CFl 8-cell 
embryos. The results are shown in Figure 18 and later in Figure 21. 
As in the case with the blastocyst embryos, the antiserum was cytotoxic 
to the embryos. The 8-cell embryos appear to be as sensitive to anti­
serum as the blastocyst embryos. There is 50% inhibition of 
Ill 
Serum Dilution* 
Figure 16. The titer of rabbit anti-mouse serum in cytotoxicity assays 
of CFl blastocyst embryos (•) and CFl lymphocytes (o). 
The cytotoxicity on blastocyst embryos was measured by the 
incorporation of %-thymidine (% Inhibition of thymidine 
incorporation). The cytotoxicity on lymphocytes was measured 
by trypan blue dye exclusion (% Killing of lymphocytes) 
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Figure 17. The effect of a one-hour normal rabbit serum (1:32) or 
rabbit anti-C57BL/10Sn serum (1:32) treatment of CFl 
blastocyst embryos, followed by a one-hour treatment 
with guinea pig complement. No. 1 designates the group 
of blastocysts treated with normal serum, while No. 2 
designates the group of blastocysts treated with anti­
serum. Magnification > 80x 
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Figure 18. The titer of rabbit anti-mouse serum against CFl 8-cell 
embryos 
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H-thymldlne incorporation at 1:1024 for blastocysts and also at 1:1024 
for 8-cell embryos. 
2. Necessity of complement in 
the embryo cytotoxicity assay 
To confirm the necessity of complement in the assay system, CFl 
blastocyst embryos were treated with rabbit anti-C57BL/10Sn serum then 
active or heat-inactivated guinea pig complement was added. The results 
are shown in Figure 19. Active guinea pig complement is necessary for 
3 
optimal inhibition of H-thymidine incorporation. 
3. Optimization of antibody 
binding to embryos 
The length of time that the antiserum needed to be in contact with 
the embryos before complement addition, was examined concomitantly with 
the effect of the zona pellucida on antibody diffusion. Sellens and 
Jenkinson (1975) demonstrated that the zona pellucida impairs the attach­
ment of antibodies to the preimplantation mouse embryo when the anti­
serum was incubated with embryos for 30 minutes. This limitation was 
circumvented by allowing a longer incubation time with antiserum. Pro-
nase digestion of the zona pellucida has one major drawback in that 
there is the potential for altering proteins (and, therefore, antigenic 
determinants) on the trophectoderm. Figure 20 shows that the absence 
of the zona pellucida allows optimal binding (and optimal inhibition of 
3 
H-thymidine Incorporation) after 30 minutes, whereas one hour with 
antiserum prior to the addition of complement was needed to achieve optimal 
3 inhibition of H-thymidine incorporation when the zona pellucida was 
present. 
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Figure 19. The effect of active (•) and heat-Inactivated (•) guinea pig complement on CFl 
blastocysts treated with rabbit anti-C57BL/10Sn serum for one hour. After a 
one-hour treatment with complement, the embryos were labeled for five hours 
with thymidine 
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Figure 20. The % Inhibition of ^-thymidine incorporation by CFl blastocyst embryos was 
examined in relationship to the incubation time with rabbit anti-C57BL/10Sn serum 
(1:4) prior to complement addition and prior to a five-hour labeling period with 
^-thymidine. Blastocyst embryos with (•) and without (•) their zona pellucldae 
were examined 
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An antiserum time course study was performed on CFl 8-cell 
embryos and the data are shown in Table 14. Optimal percent Inhibition 
of ^H-thymldlne incorporation occurred after a 30-mlnute incubation 
with antiserum, followed by addition of guinea pig complement. When 
the zona pelluclda was removed from 8-cell embryos, both normal serum-
treated embryos and antlserum-treated embryos failed to incorporate 
3 
H-thymidine. Evidently, the serum or the complement contained a "serum 
factor" that was deleterious to 8-cell embryos lacking the zona pelluclda. 
Tlie reason for this observation is unclear since 8-cell embryos treated 
with pronase will undergo further cell division in Whltten and Diggers 
medium. 
3 4. Long-term H-thymldine 
incorporation by 8-cell 
embryos 
The cytotoxicity assay on blastocyst embryos gave reproducible 
results for one to five embryos per assay well. The assay, when per­
formed on 8-cell embryos gave repeatable results for nine to ten embryos 
per assay well. Repeatable results for at least five 8-cell embryos 
3 
per assay were obtained by utilizing a 24-hour H-thymldine labeling 
period. The results are shown in Figure 21. It can be seen that the 
results obtained with a five-hour labeling period of ten 8-cell embryos 
are essentially identical to those results obtained with a 24-hour label­
ing period of five 8-cell embryos. 
In summary, the embryo cytotoxicity assay can be performed on both 
CFl blastocyst embryos and CFl 8-cell embryos. At least a one-hour 
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Table 14. Rabbit antl-C57BL/10Sn serum (1:8) time course on CFl 
8-cell embryos. The embryos were Incubated with antiserum 
for designated time periods prior to a one-hour Incubation 
with guinea pig complement and a five-hour ^H-thymldlne 
labeling period 
3 
Antiserum Incubation % Inhibition of H-thymldlne 
(hours) Incorporation + SEM 
0.5 lOOjHO 
1.0 lop+p 
2.0 100+0 
M 
32 512 128 4 256 16 8 64 
Antiserum Dilution'^ 
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Figure 21. The effects of labeling ten 8-cell embryos with H-thymidine for five hours (•) and 
of labeling five 8-cell embryos with %-thymidine for twenty-four hours (•). Rabbit 
anti-C57BL/10Sn serum was titered against the embryos. Embryos were Incubated with 
antiserum for one hour then with guinea pig complement for one hour, prior to the 
^H-thymidine labeling 
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Incubation with antiserum Is needed for blastocyst embryos and at least 
a half-hour incubation with antiserum Is needed for 8-cell embryos prior 
to a one-hour Incubation period with guinea pig complement. A flve-
3 hour H-thymldlne labeling period Is sufficient for one to five blastocyst 
embryos or nine to ten 8-cell embryos. Five 8-cell embryos can be 
assayed when labeled for 24 hours. 
D. Application of the Embryo Cytotoxicity 
Assay to the Detection of the Major 
Histocompatibility Antigens 
1. Production and testing of 
^-2 antlsera 
Congenlc antlsera were prepared according to a modification of the 
method of Batchelor (1973). Five bleedings were made and each bleeding 
was tested against C57BL/10Sn, BIO.A, BIO.BR, and B10.D2 lymphocytes in 
a lymphocyte cytotoxicity assay. Antiserum from each bleeding was tested 
at titers of 1:2, 1:4 and 1:8. The results for the five bleedings of 
anti-C57BL/10Sn, antl-BlO.A, anti-BlO.BR, and antl-B10.D2 sera are shown 
in Tables 15, 16, 17, and 18, respectively. In most cases, the cytotox­
icity of the antiserum from the 5° bleeding at a 1:4 titer exhibited 
the highest cytotoxicity against its specific target lymphocyte. 
H-2 specific antlsera were obtained from the National Institutes of 
Health (Bethesda, Maryland). The NIH antlsera are specific to a private 
specificity and some public specificities at either the K or the D end 
of the H-2 complex (see Table 5). The cytotoxicity of the NIH antlsera 
against specific target lymphocyts is shown in Table 19. Most of the 
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Table 15. Summary of C57BL/10Sn antlsera (1®, 2', 3®, 4°, 5® bleedings) 
made In BIO.BR mice. Cytotoxicity against CS7BL/10Sn, BIO.A, 
BIO.BR, and B10.D2 target lymphocytes was measured In 
lymphocyte cytotoxicity assays 
Titer % Killing 
C57BL/10Sn BIO.A BIO.BR B10.D2 
1° bleeding 1:2 91 72 20 86 
1:4 95 40 11 86 
1:8 90 23 11 41 
2° bleeding 1:2 86 50 19 63 
1:4 79 27 9 47 
1:8 44 5 5 28 
3° bleeding 1:2 92 23 3 68 
1:4 97 1 2 67 
1:8 90 1 2 20 
4® bleeding 1:2 89 15 4 67 
1:4 85 18 3 42 
1:8 92 6 3 12 
5® bleeding 1:2 95 65 2 77 
1:4 93 24 4 67 
1:8 85 19 3 44 
1 2 2  
Table 16. Summary of BIO.A antisera (1®, 2®, 3®, 4®, 5® bleedings) 
made In C57BL/10Sn mice. Cytotoxicity against BIO.A, BIO.BR, 
B10.D2, and C57BL/10Sn target lymphocytes was measured In 
lymphocyte cytotoxicity assays 
Titer % Killing 
BIO.A BIO.BR B10.D2 C57BL/10Sn 
1® bleeding 1:2 70 73 62 2 
1:4 60 45 58 3 
1:8 30 36 34 3 
2® bleeding 1:2 70 51 37 5 
1:4 52 45 46 3 
1:8 38 32 29 6 
3® bleeding 1:2 81 71 61 7 
1:4 83 67 59 7 
1:8 76 71 55 8 
4® bleeding 1:2 88 77 74 2 
1:4 80 67 72 2 
1:8 42 59 35 5 
5® bleeding 1:2 89 79 81 5 
1:4 87 81 80 7 
1:8 83 84 65 12 
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Table 17. Summary of B10.D2 antlsera (1°, 2°, 3°, 4®, 5° bleedings) 
made In C57BL/10Sn mice. Cytotoxicity against B10.D2 
C57BL/10Sn, BIO.A, and BIO.BR target lymphocytes was measured 
In lymphocyte cytotoxicity assays 
Titer % Killing 
B10.D2 C57BL/10Sn BIO.A BIO.BR 
1° bleeding 1:2 90 4 87 58 
1:4 82 2 79 42 
1:8 75 4 75 51 
2" bleeding 1:2 90 4 86 57 
1:4 79 7 88 58 
1:8 75 7 54 53 
3" bleeding 1:2 93 5 91 90 
1:4 95 9 91 75 
1:8 91 6 84 70 
4" bleeding 1:2 95 3 97 75 
1:4 94 2 95 61 
1:8 93 2 74 56 
5° bleeding 1:2 99 4 97 85 
1:4 96 8 97 95 
1:8 96 9 98 87 
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Table 18. Summary of BIO.BR antisera (1°, 2®, 3®, 4®, 5® bleedings) 
made In CS7BL/10Sn mice. Cytotoxicity against BIO.BR, 
B10.D2, C57BL/10Sn, and BlO.A target lymphocytes was 
measured In lymphocyte cytotoxicity assays 
Titer % Killing 
BlO.BR B10.D2 C57BL/10Sn BlO.A 
1® bleeding 1:2 72 50 5 53 
1:4 78 57 8 68 
1:8 57 44 7 55 
2® bleeding 1:2 86 53 7 75 
1:4 76 46 4 72 
1:8 64 30 6 70 
3® bleeding 1:2 94 64 5 87 
1:4 90 76 1 77 
1:8 89 60 2 81 
4® bleeding 1:2 95 62 3 89 
1:4 95 57 3 91 
1:8 93 50 1 88 
5® bleeding 1:2 89 61 6 92 
1:4 96 64 8 90 
1:8 84 64 6 90 
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Table 19. Summary of lymphocyte cytotoxicity assays for NIH-23b, 
NIH-D2. NIH-D31, and MIH-D32 antlsera against BIO.A, 
C57BL/IOSn, B10.D2, and BIO.BR lymphocytes 
Titer Z Killing ± SEM 
NIH-D2 NIH-23b NIH-D32 NIH-D31 
(Anti-C57BL/10Sn) (Anti-BIO.A) (Anti-BIO.BR) (Anti-BALB/c)^ 
1:2 86+ 6 76+0 73+7 60+4 
1:4 78+ 1 80+0 86+1 73+3 
1:8 68+12 69+2 79+5 62+6 
1:16 57+ 3 59+2 84+p 62+1 
1:32 64+10 53+p 78+1 52+2 
1:64 41+ 6 10+1 69+2 25+1 
^ B A L B / c  mice are haplotype d, as are B10.D2. 
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NIH antlsera exhibit maximum cytotoxic activity at a 1:4 titer and 
was, therefore, used at a 1:4 dilution when testing embryos. 
la specific antiserum was obtained from the National Institutes 
of Health (Bethesda, Maryland). The antiserum is specific to la 1,2,3, 
and 7 specificities. The cytotoxic activity of the antiserum to 
C57BL/10Sn, BIO.A, BIO.BR, and B10.D2 lymphocytes is shown in Table 
20. The antiserum was used at a 1:4 dilution against C57BL/10Sn, BIO.A, 
BIO.BR, and B10.D2 blastocyst embryos. 
Anti-B10.D2 ascites and antisera from four C57BL/10Sn mice were 
tested against B10.D2 lymphocytes in a lymphocyte cytotoxicity assay. 
The results are shown in Table 21. The cytotoxicity of the ascites 
parallels the cytotoxicity of the serum. The production of ascites 
is an excellent way to produce large quantities (i.e., 10-15 ml) of 
antibody solution that closely parallels the serum's cytotoxicity to an 
antigen. 
Table 22 shows the cytotoxicity of antl-C57BL/10Sn ascites from 
a B10.D2 mouse. The immune response of this mouse to C57BL/10Sn 
lymphocyte targets was relatively low. 
H-Y antisera were produced and tested by several protocols, as 
described In the Experiment Procedures. No clearly repeatable results 
were obtained by using any of the test systems—heamagglutination, 
sperm cytotoxicity or staph A assays. Only a few labs have successfully 
and reproducibly produced H-Y antiserum. Many labs have attempted to 
reproduce these earlier findings with great difficulty. Since H-Y 
antisera were not successfully produced, an attempt was made to generate 
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Table 20. Summary of lymphocyte cytotoxicity assays for NIH la 1, 2, 
3, 7 antiserum against C57BL/10Sn, BIO.A, B10.D2, and BIO.BR 
lymphocytes 
Titer % Killing ± SEM 
C57BL/10Sn BIO.A BIO.BR B10.D2 
1:2 604^ 48+ 0 60+ 4 69+11 
1:4 354^ 64+ 2 68+11 46+ 3 
1:8 38+2 64+ 5 81+ 5 55+2 
1:16 28+3 33+ 9 66+ 2 39+1 
1:32 15+2 64+7 40+4 37+5 
1:64 12+2 46+15 35+ 1 38+0 
Table 21. Summary of lymphocyte cytotoxicity assays for anti-B10.D2 ascites and serum from four 
C57BL/10Sn mice against 310.D2 lymphocytes 
Titer 
Mouse No. 1 
Ascites Serum 
Mouse No. 2 
Ascites Serum 
% Killing ± SEM 
Mouse No. 3 
Ascites Serum 
Mouse No. 4 
Ascites Serum 
4 
8 
16 
32 
74+4 
83+2 
76+2 
79+6 
79+2 
87+ 2 
85+ 2 
65+11 
75+ 2 
77+ 0 
86+4 
88+2 
87+0 
92+0 
86+1 
89+1 
83+3 
90+0 
90+3 
87+2 
85+2 
86+5 
75+7 
72+1 
45+3 
86+2 
80+1 
85+3 
71+6 
65+8 
92+ 0 
90+ 3 
80+ 4 
48+11 
15+ 2 
84+1 
81+6 
85+4 
79+2 
61+1 
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Table 2 2 .  Summary of lymphocyte cytotoxicity assay for anti-C57BL/10Sn 
ascites from a B10.D2 mouse against C57BL/10Sn lymphocytes 
Titer % Killing + SEM 
1 2 46+4 
1 4 44 
1 8 12+p 
1 16 5+4 
1 32 2+1 
1 64 4+3 
1 128 3+2 
1 256 1+1 
1 512 4+3 
1 1024 3+1 
1 2048 1+1 
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cytotoxic T cells to H-Y. The results of a cell-mediated lympholysls 
reaction are shown in Table 23. Cytotoxic T cells were successfully 
generated to H-Y on C57BL/10Sn ^  target lymphocytes. 
2. Determination of optimal antisera 
dilutions for the embryo cytotoxicity 
assay 
BIO.A congenic antiserum was titered at 1:2, 1:4 and 1:8 
against BIO.A blastocyst embryos in the embryo cytotoxicity assay. The 
results are shown in Figure 22. The antiserum gave the greatest inhibi­
tion when used at a 1:4 dilution. 
NIH-23b antiserum (X-BIO.A) was titered at 1:2, 1:4, 1:8, 
and 1:16 against BIO.A blastocyst embryos. The results are shown in 
3 
Figure 23. A 1:4 dilution gave the highest inhibition of H-thymidine 
incorporation. It should be noted that the NIH-23b antiserum is against 
11, 23, 25, and 52 (see Table 5), while the BIO.A congenic antiserum 
k k 
Is against all public and private specificities in both K and D ends 
of the H-2 complex. Therefore, the narrower specificity of the NIH 
antisera could result in less activity with blastocyst embryos and, 
3 
therefore, less inhibition of H-thymidine incorporation. Based on 
Figures 22 and 23, all congenic and NIH antisera were used at a 1:4 
dilution on inbred mouse embryos in the embryo cytotoxicity assay. 
3. Effects of NIH and congenic 
antisera on inbred blastocyst 
embryos 
Tables 24a, 24b, 25, 26, and 27 list the results obtained when 
NIH and congenic antisera to C57BL/10Sn, BIO.A, BIO.BR, and B10.D2 
Table 23. The effect of C57BL/10Sn ? cytotoxic T cells to H-Y against 
C57BL/10Sn target lymphocytes In a cell-mediated lympholysls 
assay. The control consisted of the effect of nonprimed 
C57BL/10Sn % cells on C57BL/10Sn d* target lymphocytes 
Nonprimed C57BL/10Sn Ç Primed C57BL/10Sn ? 
Cells Cells 
E:T Î cpm ± SEM 7 cpn + SEM % Corrected® 
Lysis 
20:1 1083+39 2986+ 24 14 
10:1 1150+41 2794+ 96 12 
5:1 1113+23 2754+ 58 12 
2.5:1 1220+44 3025+112 13 
1.3:1 1090+23 3180+207 15 
0.6:1 1573+78 3228+263 19 
^7, Corrected Lysis * 
counts released by experiment-counts released by control ^ 
maximum released counts-medium background counts 
100 r-
Antiserum Dilution - 1  
8 16 
Figure 22. The effect of BIO.A congenic antiserum on BIO.A blastocyst embryos in the embryo 
cytotoxicity assay 
4 8 
Antiserum Dilution'^ 
Figure 23. The effect of NlH-23b antiserum (X-BIO.A) on BIO.A blastocyst embryos in the embryo 
cytotoxicity assay 
Table 24a. Effect of NIH and congenic antisera on C57BL/10Sn blastocyst embryos 
Controls 
Average Average 
Experiment Antiserum Number cpm/ 
Number Embryos Embryo 
Experiments Ratios 
Number cpm/ Experiment cpm 
Embryos Embryo Average Control cpm 
A. NIH Antiserum Treatment 
1 D-2 4 475 4 313 0.659 
4 167 0.352 
4 413 0.870 
2 D-2 3 2 256 1.44 
2 287 1.61 
B. Congenic Antiserum Treatment 
1 X-BIO 1 210 1 74 0.352 
1 0 0.000 
1 55 0.262 
2 X-BIO 4 475 4 79 0.166 
4 44 0.0926 
3 X-BIO.A 3 783 3 898 1.15 
3 945 1.21 
4 X-BIO.BR 3 783 3 18 0.0230 
2 403 0.515 
5 X-BIO.BR 3 316 3 23 0.0728 
3 100 0.316 
1 59 0.187 
6 X-B10.D2 2 217 2 22 0.101 
2 163 0.751 
2 253 1.17 
7 X-B10.D2 1 305 1 118 0.387 
1 198 0.649 
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Table 24b. Method for the statistical evaluation of data in Table 24a-A 
(NIH antiserum treatment on C57BL/10Sn blastocyst embryos) 
Rat ios (Experiment cpm \ Average control cpm J 
Experiment No. 1 0.659 
0.352 
0.870 
Experiment No. 2 1.44 
1.61 
Mean of control ratio (by definition) (X ) • 1.000 
Mean of experimental ratios 05^,) • 0.987 
Standard deviation (S.D.) • 0.474 
Variance (SD^) * 0.225 
Number of experimental observations (n^) • 5 
Degrees of freedom (d.f.) "5-1 
t Test: 
^c • ^E 1.000 - 0.987 
/ 
0.06132 
0.225 
Compare t value to a "Values of t" table according 
to degrees of freedoms. Read probably from the top 
of the column. 
. p >0.5 
Table 25. Effect of NIH and congenic antisera on BIO.A blastocyst embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Antiserum Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
A. NIH Antiserum Treatment 
1 D-23b 1 268 1 151 0.563 
1 30 0.112 
2 D-23b 3 214 3 85 0.397 
3 255 1.19 
B. Congenic Antiserum Treatment 
1 X-BIO.A 4 118 4 73 0.619 
4 30 0.254 
2 X-BIO.A 1 414 1 57 0.138 
1 106 0.256 
1 348 0.841 
1 386 0.932 
1 151 0.365 
3 X-BIO.BR 2 462 2 405 0.877 
2 252 0.545 
4 X-B10.D2 4 118 4 139 0.180 
4 195 1.65 
5 X-B10.D2 2 462 2 516 1.12 
2 397 0.859 
6 X-BIO 2 462 2 110 0.238 
2 65 0.141 
Table 26. Effect of NIH and congenic antlsera on BIO.BR blastocyst embryos 
Experiment 
Number 
Antiserum 
Controls 
Average Average 
Number cpm/ 
Embryos Embryo 
Experiments 
Number 
Embryos 
cpm/ 
Embryo 
Ratios 
Experiment cpm 
Average Control cpm 
k. NIH Antiserum Treatment 
1 D-32 5 559 5 557 0.996 
5 548 0.980 
2 D-32 3 1653 3 89 0.0538 
3 532 0.322 
3 D-32 3 592 3 208 0.351 
3 326 0.551 
4 D-32 3 324 3 213 0.657 
3 256 0.790 
3 264 0.815 
B, Congenic Antiserum Treatment 
1 X-BIO.BR 5 559 5 344 0.615 
5 199 0.356 
2 X-B10.D2 3 592 3 882 1.49 
3 64 0.108 
3 269 0.454 
3 X-B10.D2 3 186 3 77 0.414 
3 56 0.301 
4 X-B10.D2 1 187 1 167 0.893 
1 199 1.06 
5 X-BIO 1 695 1 
1 
6 X-BIO 3 186 3 
3 
7 X-BIO.A 3 592 3 
3 
3 
203 
51 
61 
107 
468 
438 
287 
0.292 
0.0734 
0.326 
0.572 
0.791 
0.740 
0.485 
Table 27. Effect of NIH and congenic antlsera on B10.D2 blastocyst embryos 
Controls Experiments Ratios 
Average Average Numbercpm/ Experiment cpm 
Experiment Antiserum Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
A. NIH Antiserum Treatment 
1 D-31 3 816 3 364 0.446 
3 281 0.344 
3 272 0.333 
B. Congenic Antiserum Treatment 
1 X-B10.D2 3 816 3 162 0.199 
3 185 0.227 
2 X-B10.D2 3 672 3 160 0.238 
3 167 0.249 
3 X-BIO 1 349 1 145 0.416 
1 325 0.931 
4 X-BIO 3 672 3 92 0.137 
3 178 0.265 
5 X-BIO 2 665 2 455 0.684 
2 197 0.296 
6 X-BIO.A 3 672 3 394 0.586 
3 147 0.219 
7 X-BIO.BR 3 672 3 69 0.103 
3 168 0.250 
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blastocyst embryos, respectively, were tested in an embryo cytotoxicity 
assay. A sample of the method for statistical evaluation of the data is 
shown in Table 24b. The congenic antlsera data on lymphocytes and blast­
ocyst embryos are summarized in Table 28. In all cases, a statistically 
3 
significant inhibition of H-thymidine incorporation was observed and 
indicates that the H-2 specific congenic antisera are detecting H-2 
specifIrifies on the blastocyst embryos. 
A summary of the NIH antisera data on lymphocytes and blastocyst 
embryos is shown in Table 29. A statistically significant inhibition 
3 
of H-thymidine incorporation was seen in BIO.BR and B10.D2 blastocyst 
d k 
embryos. The data show (consult Table 5) that both K (K ) and D (D ) 
k 
molecules are expressed on blastocyst embryos. Since the anti-D serum 
k (D-32) detects only the private specificity D (Table 5), it seems likely 
that this private specificity is expressed on H-2 blastocyst embryos. 
The two statistically insignificant results (D^ and K^) could either 
reflect a weakness in the antisera (unlikely, since the antisera do kill 
lymphocytes), or else the absence or low concentration of and 
m o l e c u l e s  o n  b l a s t o c y s t  e m b r y o s .  
A summary of the cross-reactions of the congenic antisera on 
blastocyst embryos of different haplotypes is shown in Table 30. The 
first line in each experimental group represents reactions with the 
homologous target. It is seen that H-2 antigens are detected on both 
lymphocytes and blastocyst embryos. The second line in each experiment 
group is the negative control; the targets are of the same strain in 
which the antisera were made. As expected, the lymphocyte controls gave 
negative results. However, in three cases, the blastocyst embryo controls 
1 4 1  
Table 28. Effect of congenic antisera on lymphocytes and blastocyst 
embryos 
Congenic Target % Killing of % Inhibition of 
Antiserum Strain Lymphocytes + %-Thymidine Incorporation 
S EM® + SEM*) 
X-C57BL/10Sn C57BL/10Sn 93+2 83+ 6 
(P < 0.001)*c 
X-BIO.A BIO.A 87+1 57+13 
(P < 0.05)* 
X-BIO.BR BIO.BR 96+1 51+ 9 
(P <• 0.02)* 
X-B10.D2 B10.D2 9640 77+ 1 
(P 0.001)* 
^Cytotoxicity of the antisera on lymphocytes was tested by trypan 
blue dye exclusion, as described in the Experimental Procedures. 
^Cytotoxicity of the antisera on blastocyst embryos was tested by 
the inhibition of the incorporation of ^H-thymidine into DNA, as described 
in the Experimental Procedures. 
^P values obtained upon testing of embryo cytotoxicity data by 
Student's t test. The values reflect the probability that the % 
Inhibition of %J-thymidine incorporation is significantly greater than 
0%. Statistically significant P values are indicated by an asterisk (*). 
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Table 29. Effect of NIH antlsera on lymphocytes and blastocyst embryos 
NIH Target 
Antiserum Strain 
% Killing of 
Lymphocytes + 
SEM® 
% Inhibition of 
^-Thymidine Incorporation 
+ SEMb 
D-2 C57BL/10Sn 98+1 1+21 
(P > 0.5) 
D-23b BIO.A 8 0 f l  43+20 
(P > 0.1) 
D-32 BIO.BR 86+2 39+10 
(P <. 0.01)* 
D-31 B10.D2 73+5 63+ 3 
(P < 0.01)* 
^Cytotoxicity of the antlsera on lymphocytes was tested by trypan 
blue dye exclusion, as described in the Experimental Procedures. 
^Cytotoxicity of the antlsera on blastocyst embryos was tested by 
the inhibition of the incorporation of %-thymldine into DNA, as described 
in the Experimental Procedures. 
^P values obtained upon testing of embryo cytotoxicity assay data 
by Student's t test. The values reflect the probability that the % 
Inhibition of ^H-thymldlne Incorporation is significantly greater than 0%. 
Statistically significant P values are indicated by an asterisk (*). 
1 4 )  
gave positive results. These numbers are in boxes in Table 30. The 
third and fourth lines in each experimental group represent targets 
which should show cross-reactivity based on Table 4. This is generally 
true for both the lymphocytes and the blastocyst embryos. The most 
notable exception is the lack of cross-reactivity of BIO.A blastocyst 
embryos treated with anti-B10.D2 serum in experimental group D. Since 
â le d 
H-2 is a recombinant haplotype between H-2 and H-2 (see Table 1), 
d â 
this result may suggest the absence of D antigens on H-2 blastocyst 
embryos. 
To further investigate the ability of the antisera to recognize 
H-2 specificities on blastocyst embryos, but not on lymphocytes of the 
same strain as the embryos, the effect of NIH-D31 was examined on BIO.BR 
lymphocytes and blastocyst embryos. The results are shown in Table 31. 
N1H-D31 is specific to private specificity 31 and public specificity 
34 (see Table 5). BIO.BR mice do not express these specificities on 
adult lymphocytes (see Table 3). Therefore, the data in Table 31 strongly 
support the hypothesis that H-2 antigens exist in a modified form on 
blastocyst embryos as compared to adult lymphocytes of the same haplotype. 
4. Effects of NIH and congenic 
antisera on inbred 8-cell embryos 
The effects of NIH and congenic antisera on 8-cell embryos is 
shown in Tables 32, 33, 34, and 35 for C57BL/10Sn, BIO.A, BIO.BR, and 
B10.D2 8-cell embryos, respectively. The summary of the effect of NIH 
and congenic antisera on lymphocytes and 8-cell embryos is shown in 
Table 36. The data show that a statistically significant Inhibition of 
Table 30. Cross-reactions of congenic antisera with blastocyst embryos 
of different haplotypes 
Experimental Group Congenic Antiserum Target Strain 
A X-C57BL/10Sn C57BL/10Sn 
BIO.BR 
BIO.A 
B10.D2 
B X-BIO.A BIO.A 
C57BL/10Sn 
BIO.BR 
B10.D2 
C X-BIO.BR BIO.BR 
C57BL/10Sn 
BIO. A 
B10.D2 
D X-B10.D2 B10.D2 
C57BL/10Sn 
BIO. A 
BIO.BR 
^Cytotoxicity of the antisera on lymphocytes was tested by trypan 
blue dye exclusion, as described in the Experimental Procedures. 
^Cytotoxicity of the antisera on blastocyst embryos was tested by 
the inhibition of the incorporation of ^H-thymidine into DNA, as 
described in the Experimental Procedures. 
^The boxes reflect unexpected cross-reactions. 
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% Killing of Lymphocytes + SEM^ % Inhibition of ^ H-thymidine Incorporation'' 
93+2 
4+2 
24+8 
67+4 
87+1 
7+2 
81+3 
80+7 
96+1 
8+5 
90+p 
64+2 
96+0 
8+4 
97+2 
95+3 
83± 6 
I 68+ 9 |C 
'81T 3 ' 
55+11 
57+13 
0+ 2 
33+ 8 
60+13 
51+ 9 
CMD 
29+12 
82+ 5 
, 77* 1, 
QUE 
0+14 
33+17 
Table 31. Effect of NIH-D31 antisera on BIO.BR lymphocytes and BIO.BR blastocyst embryos 
A. Effect of NIH-D31 titered against BIO.BR lymphocytes 
Titer "x % Killing ± SEM 
1:2 1+p 
1:4 2+0 
1:8 2+p 
1:16 5+2 
B. Effect of NIH-D31 antisera (1:4) on BIO.BR blastocyst embryos^ 
Experiment 
Number 
Controls 
Average 
Number 
Embryos 
Average 
cpm/ 
Embryo 
331 
Experiments 
Number 
Embryos 
2 
2 
2 
2 
com/ 
Embryo 
177 
111 
294 
194 
Ratios 
Experiment cpm 
Average Control cpm 
0.5347 
0.3353 
0.8882 
0.5861 
252 140 0.5556 
3 c 
% Inhibition of H-thymidine incorporation + SEM = 42+ 8 (?•<. 0.01)* 
^Cytotoxicity of the antisera on lymphocytes was tested by trypan blue dye exclusion, as 
described in the Experimental Procedures. 
Cytotoxicity of the antisera on blastocyst embryos was tested by the inhibition of the 
incorporation of ^-thymidine into DNA, as described in the Experimental Procedures. 
^P value obtained upon testing of embryo cytotoxicity data by Student's t test. The values 
reflect the probability that the % inhibition of %-thymldine Incorporation is significantly 
greater than 0%. The asterisk indicates a statistically significant P value. 
Table 32. Effect of congenic anti-C57BL/10Sn serum on C57BL/10Sn 8-cell embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
1 5 121 5 97 0.8017 
5 116 0.9587 
5 183 1.512 
2 5 137 2 48 0.3504 
3 4 66 4 72 1.090 
4 38 0.5758 
4 4 0.06061 
4 4 119 4 60 0.5063 
5 5 127 5 87 0.6819 
5 94 0.7402 
5 85 0.6724 
5 75 0.5906 
5 109 0.8551 
5 106 0.8362 
5 75 0.5890 
Table 33. Effect of congenic anti-BlO.A serum on BIO.A 8-cell embryos 
Cont rols Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
1 5 279 5 255 0.9140 
5 204 0.7312 
2 4 111 4 119 1.072 
4 60 0.5383 
4 235 2.117 
3 4 126 4 109 0.8671 
4 110 0.8690 
4 166 1.319 
4 161 1.280 
4 118 0.9365 
Table 34. Effect of NIH and congenic antisera on BIO.BR 8-cell embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
A. NIH-D32 Antiserum Treatment 
1 4 68 4 66 0.9706 
4 123 1.809 
2 4 123 4 46 0.3740 
B. BIO.BR Congenic Antiserum Treatment 
1 5 115 5 92 0.8000 
4 64 0.5565 
2 5 173 5 107 0.6185 
5 159 0.9191 
5 120 0.6936 
3 4 123 4 89 0.7256 
4 140 1.140 
Table 35. Effect of NIH and congenic antisera on B10.D2 8-cell embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Contol cpm 
Number Embryos Embryo 
A. NIH-D31 Antiserum Treatment 
1 4 152 4 233 1.533 
4 167 1.099 
2 4 167 4 204 1.222 
4 0 0.000 
B. B10.D2 Congenic Antiserum Treatment 
1 4 180 4 109 0.6028 
4 130 0.7222 
4 72 0.4014 
2 5 116 5 90 0.7724 
5 0 0.0000 
4 87 0.7478 
3 4 153 4 157 1.349 
4 77 0.6659 
4 91 0.7845 
4 5 118 3 33 0.2797 
5 4 140 4 105 0.7518 
4 195 1.393 
6 4 123 4 108 0.8780 
Table 36. Effects of NIH and congenlc antlsera on lymphocytes and 8-cell embryos 
Antiserum Target 
Strain 
% Killing of 
Lymphocytes 
+ S EM 
Total Number Embryos Tested 
Control Experiment 
- % Inhibition of 
H-thymidine Incor­
poration + S EM 
Effect of NIH Antlsera 
D32 
D31 
BIO.BR 
B10.D2 
86+2 
73+5 
12 
16 
B. Effect of Congenlc Antlsera 
X-C57BL/10Sn C57BL/10Sn 93+2 64 
X-BIO.A 
X-BIO.BR 
X-B10.D2 
BIO.A 
BIO.BR 
B10.D2 
87+1 
96+1 
9640 
26 
33 
57 
12 
16 
68 
42 
32 
53 
7+ 7 
(P > 0.5)C 
0+ 9 
(P> 0.4) 
2^ 8 
(P < 0.01)* 
0+13 
(P > 0.5) 
22+ 7 
(P 0.02)* 
2^ 10 
(P< 0.02)* 
Cytotoxicity of the antlsera on lymphocytes was tested by trypan blue dye exclusion, as 
described in the Experimental Procedures. 
^Cytotoxicity of the antlsera on 8-cell embryos was tested by the inhibition of the incorporation 
of thymidine into DMA, as described in the Experimental Procedures. 
^P values obtained upon testing of embryo cytotoxicity data by Student's t test. The values 
reflect the probability that the % inhibition of ^H-thymidine incorporation is significantly greater 
than 0%. The asterisk indicates a statistically significant P value. 
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3 
H-thyraidine Incorporation was obtained from C57BL/10Sn, BIO.BR and 
B10.D2, but not BIO.A 8-cell embryos, when treated with the congenic 
antisera. The NIH antisera failed to detect H-2 specificities on BIO.BR 
and B10.D2 8-cell embryos. 
3 
The low percent inhibition of H-thymidine Incorporation for 
statistically significant C57BL/10Sn, BIO.BR and B10.D2 8-cell embryos 
may suggest that the H-2 specificities that are detected may be concen­
trated on only some of the cells of the embryos at this stage of develop-
3 
ment. Therefore, H-thymidine incorporation is not greatly inhibited. 
The congenic antiserum failed to detect H-2 antigens on BIO.A 8-cell 
embryos. The NIH antiserum had failed to recognize H-2 specificities on 
BIO.A blastocyst embryos, while the congenic antisera had recognized H-2 
specificities (see Tables 28 and 29). Evidently, the recombinant event 
that produced the BIO.A haplotype affects either the quantity or the 
type of H-2 specificities expressed on the BIO.A embryo. 
5. Effect of NIH la 1. 2, 3, and 7 
antiserum on inbred blastocyst 
embryos 
The data for the effect of NIH la 1, 2, 3, and 7 antiserum on 
inbred blastocyst embryos are shown in Tables 37, 38, 39, and 40 for 
C57BL/10Sn, BIO.A, BIO.BR, and B10.D2 blastocyst embryos, respectively. 
The results are summarized in Table 41. The antiserum does not slgnifi-
3 
cantly affect the H-thymldlne incorporation by blastocyst embryos. 
Therefore, the antiserum does not detect la specificities 1, 2, 3, or 
7 on C57BL/10Sn, BIO.A, BIO.BR, or B10.D2 blastocyst embryos. 
Table 37. Effect of NIH antiserum on C57BL/10Sn blastocyst embryos 
Controls Experiments Ratios 
Average Average Number cpm/ 
Experiment Number cpm/ Embryos Embryo -—xper men—cgm 
Number Embryos Embryo Control cpm 
NIH la 1. 2. 3. 7 Antiserum Treatment 
1 1 299 1 591 1.976 
2 1 350 1 379 1.083 
1 344 0.9829 
3 2 237 2 516 2.177 
2 216 0.9114 
4 2 262 2 329 1.255 
1 382 1.458 
Table 38. Effect of NIH antiserum on BIO.A blastocyst embryos 
Controls Experiments Ratios 
Experiment 
Number 
Average 
Number 
Embryos 
Average 
cpm/ 
Embryo 
Number cpm/ 
Embryos Embryo 
Experiment cpm 
Average Control cpm 
NIH la 1, 2. 3, 7 Antiserum Treatment 
1 1 237 1 263 1.109 
1 0 0.000 
1 346 1.459 
1 460 1.940 
2 2 195 2 534 2.738 
2 406 2.082 
3 4 26 4 73 2.807 
4 2 329 2 124 0.3769 
1 232 0.7052 
Table 39. Effect of NIH antiserum on BIO.BR blastocyst embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
NIH la 1. 2. 3, 7 Antiserum Treatment 
1 1 220 1 451 2.050 
1 248 1.127 
2 2 124 2 245 1.975 
2 0 0.000 
3 1 140 1 245 1.750 
1 421 3.007 
4 4 149 4 0 0.000 
4 288 1.932 
4 0 0.0000 
5 4 164 4 208 1.268 
3 147 0.8963 
6 2 346 2 283 0.8179 
Table 40. Effect of NIH antiserum on B10.D2 blastocyst embryos 
Controls Experiments Ratios 
Average Average Number cpm/ Experiment cpm 
Experiment Number cpm/ Embryos Embryo Average Control cpm 
Number Embryos Embryo 
NIH la 1, 2, 3, 7 Antiserum Treatment 
1 1 312 1 450 1.442 
1 436 1.397 
1 160 0.5128 
1 337 1.080 
1 177 0.5673 
1 0 0.0000 
2 1 189 1 61 0.3228 
3 1 185 1 395 2.135 
4 1 249 1 341 1.369 
1 391 1.570 
Table 41. The effect of NIH la 1, 2, 3, and 7 antiserum on lymphocytes and blastocyst embryos 
Target 
Strain 
% Killing of* 
Lymphocytes 
+ SEM 
Total Number of 
Control 
Embryos Tested 
Experimental 
% Inhibition of 
^-Thymidine Incorporation^ 
+ SEM 
C57BL/10Sn 35+2 12 10 0+17 
(P > 0.1) 
BIO.A 64+2 18 15 0+ 2 
(P > 0.2) 
BIO.BR 55+4 26 29 0+26 
(P > 0.5) 
B10.D2 46+2 8 10 0+20 
(P > 0.3) 
^Cytotoxicity of the antlsera on lymphocytes was tested by trypan blue dye exclusion, as 
described In the Experimental Procedures. 
^Cytotoxicity of the antlsera on blastocyst embryos was tested by the inhibition of the 
incorporation of ^ -thymidine into DNA, as described in the Experimental Procedures. 
values obtained upon testing of embryo cytotoxicity data by Student's t test. The values 
reflect the probability that the % inhibition of %-thymidlne incorporation is significantly greater 
than 0%. The asterisk indicates a statistically significant P value. 
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6. Effect of rabbit anti-mouse 
-microglobulin on CFl and 
Inbred blastocyst embryos 
/^-microglobulin comprises the 12,000 W subunlt that is noncovalently 
linked to the 45,000 MW subunlt of the H-2 molecule. The xenogenlc anti­
serum to f^-microglobulln was tested on CFl blastocyst embryos and 
lymphocytes. The results are shown in Table 42. It can be seen that 
the antiserum is cytotoxic to lymphocytes at 1:2 and 1:4 dilutions, but 
rapidly loses its cytotoxic effect at higher dilutions. Unexpected re­
sults were obtained when the antiserum was incubated with CFl blastocyst 
embryos In an embryo cytotoxicity assay. The percent inhibition values 
Indicate that ^^-microglobulin is not detectable on CFl blastocyst em­
bryos. Perhaps, a conformational arrangement of the molecule in 
relation to the H-2 molecule, prevents the antiserum from detecting Its 
presence. Or else, perhaps the low titer of the antiserum accounts for 
the negative results. 
The embryo cytotoxicity assay was performed with rabbit anti-mouse 
^^-microglobulin on C57BL/10Sn, BIO.A, BIO.BR, and B10.D2 lymphocytes 
and blastocyst embryos. The results are shown in Table 43. It can be 
seen that the lymphocytes are positive for #2"™icroglobulin, while the 
embryos are negative for /^-microglobulin. 
Table 42. Summary of lymphocyte cytotoxicity assays of rabbit anti-mouse ^2~™icroglobulin against 
CFl lymphocytes in a lymphocyte cytotoxicity assay and against CFl blastocyst embryos 
in an embryo cytotoxicity assay 
Antiserum Lymphocyte Target Blastocyst Target 
Titer % Killing + SEM Total Number of % Inhibition of ^H-thymidine 
Embryos Tested Incorporation + SEM 
Control Experiment 
1:2 73 10 10 4+ 2 
1:4 804^ 10 10 0± 0 
1:8 29+7 10 10 0+ 0 
1:16 19+6 10 10 10+ 7 
1:32 13+1 10 10 0 
1:64 13+5 10 10 0+ 0 
1:128 2+1 10 10 27+19 
1:256 5+1 10 10 0+ 0 
1:512 8+1 10 10 0+ 0 
Table 43. The effect of rabbit anti-mouse f^-microglobulln (1:4) on inbred lymphocytes in a 
lymphocyte cytotoxicity assay and on inbred blastocyst embryos in an embryo 
cytotoxicity assay 
Target Lymphocytes 
% Killing + SEM Total Number of 
Embryos Tested 
Control Experiment 
Blastocyst Embryos 
% Inhibition of %-thymidine 
Incorporation + SEN 
C57BL/10Sn 
BIO.A 
BIO.BR 
B10.D2 
73+5 
83+5 
88+3 
4(H5 
8 
4 
6 
4 
4 
4 
6 
4 
7+ 5 
16+ 0 
29+18 
0+ 0 
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E. Development of the Mixed Embryo-Lymphocyte 
Interaction Assay 
1. Blastocyst embryo viability 
In lymphocyte media 
3 
The ability of blastocyst embryos to Incorporate H-thymldine was 
used as a viability measurement of blastocyst embryos in lymphocyte 
media. Blastocyst embryos were Incubated for 4, 7 and 24 hours in dif­
ferent lymphocyte media and in Whltten and Biggers medium. The results 
are shown in Figure 24. It can be seen that blastocyst embryos in 
Whltten and Biggers medium alone gradually lose their ability to Incor-
3 
porate H-thymldine. Blastocyst embryos in supplemented RPMI 1640 medium, 
3 
containing serum, maintain a steady ability to incorporate H-thymidine 
over time. RPMI 1640 medium, alone, was deleterious to blastocyst 
3 
embryos, as shown by the decrease in H-thymldine incorporation over time. 
Supplemented RPMI 1640 medium, containing 10% newborn calf serum was 
used for experiments in which blastocyst embryos were to be cultured 
with lymphocytes. 
2. Partial purification of 
T-cell growth factor 
T-cell growth factor (TCGF) was purified from concanavalin A 
according to the methods of Rosenberg et al. (1980) and Helde and Schwich 
(1978). The (NH^)2S0^ precipitate was dissolved in saline and layered 
on a Sephadex G-IOO column. The column was eluted with 0.9% saline. 
Each fraction was examined for protein content by spectrophotometrlc 
absorbance at 280 nm and by the Lowry protein test. TCGF exhibits a 
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re 24. The ability of CFl blastocyst embryos to Incorporate %-thymidine when Incubated for 
4, 7 and 24 hours in Whitten and Biggers medium (•), RPMI 1640 (c), supplemented 
RPMI 1640 with 5% human serum (A), and supplemented RPMI 1640 with 10% newborn calf 
serum (A) 
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mitogenic activity when incubated with cytotoxic T cells. Fractions 
in the appropriate molecular weight ranges were examined for mitogenic 
activity in a DNA synthesis assay involving cytotoxic cells generated 
in a mixed lymphocyte reaction. 
Figure 25 exhibits the 280 nm absorbance profile for the fractions 
eluted from the Sephadex G-lOO and the mitogenic effect of the fractions 
3 
on H-thymidlne incorporation by cytotoxic T-cells. The TCGF activity 
is clearly separate from the serum albumin (MW 69,000) and the concanava-
lin A (MW 90,000) peaks. The mitogenic activity occurred in those 
molecular weight fractions (MW 50,000-45,000 and MW 30,000-20,000) which 
characterize TCGF. The fractions containing the three mitogenic activity 
peaks were pooled and used to maintain long-term cytotoxic T cells. 
3. Production and maintenance of 
cytotoxic T cells in vitro 
T-cell growth factor was added to supplemented RPMI 1640, containing 
10% NBCS. The medium was then used to culture cytotoxic T cells 
(B10*CBA^). Figure 26 demonstrates the growth curve of cytotoxic T 
cells in TCGF supplemented medium. Sensitizations against CBA^ spleen 
lymphocytes are indicated as 2°, 3° and 4°. Cytotoxic assays were per­
formed on days marked by T^. For each data point, the cytotoxic T cells 
were counted, then centrifuged at 500 g and room temperature. The 
supernatant was decanted and replaced by fresh medium containing TCGF. 
For 2°, 3° and 4° sensitizations, CBA^ spleen lymphocytes were present 
in the TCGF supplemented medium. It can be seen that cytotoxic T cells 
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Figure 25. Fraction profile of T-cell growth factor (TCFG) run over a 
Sephadex G-lOO column. The fractions were examined for 
protein content by spectrophotometric readings at A.-- (•). 
TCGF raitogenlc activity was measured in a DNA synthesis 
assay with cytotoxic T cells (•). Protein standard markers 
were bovine serum albumin (69,000 MW), human chorionic 
gonadotrophln (26,700 MW) and rlbonuclease A (13,000 MW) 
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Figure 26. The cell growth of BIO'CBA^ cytotoxic T cells in supplemented RFMl 1640 medium, 
containing 10% newborn calf serum and TCGF (1:10). The initial mixed lymphocyte 
reaction was set up on day 0 with 3.6 x 10^ cells total. 2°, 3®, 4' refer to 
secondary, tertiary and quaternary sensitizations with CBA^ spleen lymphocytes in 
medium containing TCGF. T^ refers to the days on which cell-mediated lympholysis 
and/or mixed embryo-lymphocyte Interaction assays were performed 
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were successfully cultured in the presence of TCGF. Cytotoxic cells 
were unable to be detected after 60 days of culture. 
4. Mixed embryo-lymphocyte 
interaction assay (MELIA) 
Table 44 gives the cytotoxic response of T^ cells to ^^Cr-labeled 
lymphocytes and to BIO.BR blastocyst embryos. It can be seen that 
cytotoxic T cells are capable of affecting the ability of pronased BIO.BR 
3 51 blastocyst embryos to incorporate H-thymldlne. The Cr release by 
BIO cytotoxic lymphocytes to CBA target lymphyocytes confirms the cyto­
toxicity of the BIO lymphocytes. Since the cytotoxic response of 
cytotoxic T cells is dependent on and ^  antigen recognition, MELIA 
functionally demonstrates the presence of H-2 K and D antigens on BIO.BR 
blastocyst embryos. 
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Table 44. The effect of BIO-CBA^ cytotoxic T cells against CBA 
lymphocytes in a release microassay and against 
BIO.BR blastocyst embryos in the mixed embryo-lymphocyte 
interaction assay. Cytotoxic T cells were Incubated with 
lymphocytes or embryos for four hours 
Cytotoxic T cell CBA Lymphocytes BIO.BR Embryos . 
Concentration cpm + SEM % Specific" 
Release 
cpm + SEM % of Control 
0 0+ 0 0 414j^5 100 
1 X 10^ cells 313+23 15 14+ 5 3 
4 X 10^ cells 288+22 4 117+93 28 
Specific Release = 
cpm of experimental release-cpm of spontaneous release ^ 
cpm of maximum release - cpm of spontaneous release 
of Control = Average Experimental cpm ^ 
Average Control cpm 
168 
IV. DISCUSSION 
The first goal of these studies was to develop a cytotoxicity test 
3 based on li-thymidine incorporation into the DNA of preimplantation 
3 
mouse embryos. Parameters for the incorporation of H-thymidine into 
DNA were optimized and the following is a summary of the final conditions 
3 3 
chosen: (1) 4 ^ Ci/ml Il-thymidine (sp. act. 20 Ci/mmole); (2) a H-
thymidine labeling period of two to seven hours; (3) a three-hour pre­
incubation period for blastocyst embryos and from zero to seven hours 
preincubation period for 8-cell embryos; (4) from 1-64 embryos per assay; 
and (5) presence or absence of the zona pellucida. 
3 
The ability of embryos to incorporate H-thymidine was then used 
as a measurement of embryo viability after treatment with various com­
pounds or antisera and complement. The main advantage of this assay is 
that it can be performed in a microtiter plate and, therefore, can be 
processed automatically using a Titertek cell harvester. An assay can 
be performed and results can be obtained in less than 24 hours, whereas, 
another assay system (i.e., autoradiography) would require weeks or even 
months to obtain the final result. Another advantage of this assay is 
the inherent objectivity in obtaining the final results. The cytotoxicity 
assay with rabbit anti-mouse sera could be visually scored as to the 
effect of antisera and complement, since the effect is rather pronounced 
(see Figure 17), but for antisera with lower cytotoxicity titers (i.e.. 
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Table 28 and 29) the effect is not as pronounced and is more open to 
3 
subjective evaluation. Incorporated H-thymidine from experimental 
tests can be statistically compared to control tests to determine the 
effectiveness of the antisera and, consequently, the presence of the 
target antigen. 
A few negative aspects of this assay should also be mentioned. For 
instance, this assay would not be feasible to use for cell cycle studies 
of the , S and G2 phases where autoradiography and cytophotometry have 
played a predominant role in determining which cells within the embryo 
were entering the different phases of the cell cycle (reviewed by 
Sherman, 1979). Also, this assay is not practical to use if embryonic 
DNA is to be collected and used for another test purpose. The DNA is 
bound to the OF/C filter papers during the cell harvesting procedure and 
is not easily eluted from the papers. 
As a viability measure, this assay Is particularly good because it 
is (1) sensitive—an individual blastocyst embryo can be successfully 
assayed; (2) reproducible—as long as control embryos and test embryos 
are assayed at the same time, so that ratios from experiment to experi­
ment can be compared; and (3) automated—the number of assays that can 
be performed is limited only by the availability of embryos or test 
compounds. 
The DNA synthesis assay, as described in this disseration has four 
potential applications: (1) study of the mechanisms and control of DNA 
synthesis in preimplantation mouse embryos; (2) evaluation of the number 
of cells per embryo; (3) study of the effects of various compounds which 
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might affect cell division, and, therefore, DNA synthesis, in 
preimplantation mouse embryos; and (4) use of the assay as a measure of 
embryo viability after treatment with antisera and complement. The 
first application is not discussed in this dissertation. The second 
application is shown to be feasible in a given population of embryos, 
as demonstrated in Figure 11. This is Important when measuring enzyme 
activities in embryos, because the data may then be expressed on a per 
cell as well as per embryo basis. 
The third application was used to study the effects of salt, 
ûf-amanitin, aphidicolin, theophylline, cycloheximide, puromycin, and hCG 
on cell division by pre implantation mouse embryos. Increased salt con­
centrations impair the ability of blastocyst embryos to Incorporate 
3 
H-thymidine (Figure 12) and corroborates early reports where increased 
salt concentrations prevented cleavage division (Whittlngham, 1971). 
3 Of-Amanitin, an RNA inhibitor, was shown to affect H-thymidlne 
Incorporation in 8-cell and blastocyst embryos (Table 11). It was inter­
esting to note that 8-cell embryos were more refractory to inhibition 
than were blastocyst embryos. This result was opposite to that for RNA 
synthesis studies, in which blastocyst embryos were more refractory to 
Of-amanitin than 8-cell embryos (Warner and Hearn, 1977). This may re­
flect that 8-cell embryos were more actively synthesizing RNA as compared 
to DNA and blastocyst embryos were more actively synthesizing DNA as 
compared to RNA. During cleavage, DNA must be synthesized de novo from 
each new cell, but pre-existing RNA could be divided among cells because 
the size of the cells is constantly decreasing during cleavage division 
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during preimplantation mouse development, though the total size of the 
embryo is remaining constant. Barlow et al. (1972) demonstrated a higher 
3 
H-thymidine labeling Index for "inside" cells as opposed to "outside" 
cells of preimplantation mouse embryos. They concluded that the "inside" 
cells were dividing faster than the "outside" cells. The 8-cell embryo 
does not exhibit this cellular differentiation into "inside" versus 
"outside" cells, but the blastocyst embryo exhibits inner cell mass con­
stituents as opposed to outer, trophectodermal cells. The rapidly 
dividing inner cell mass of the blastocyst could be the main target of 
CK-amanltin action. This idea remains to be tested experimentally. 
Welnmann and Roeder (1974) have shown that Form II RNA polymerase 
is inhibited by 0.03 /4g/ml a-amanltin. Form III enzyme by 200 ^g/ml and 
Form I enzyme is refractory to inhibition by CK-amanitin. Cleavage divi­
sion and RNA synthesis are blocked by 0(-amanitin at concentrations as 
low as 1 ^ g/ml (Warner and Versteegh, 1974; Levey et al., 1977; Levey 
and Brinster, 1978). It was concluded that inhibition of Form II enzyme 
and, consequently, mRNA synthesis is blocked at 1 ^g/ml. The high con­
centration of Of-amanitin needed to elicit significant inhibition of DNA 
synthesis in mouse embryos may suggest that Form III enzyme is directly 
affected by the inhibitor. 
The mechanism of inhibition of DNA synthesis by CK-amanitin is unknown. 
It is possible that the synthesis of an RNA primer, required for the ini­
tiation of DNA synthesis, is blocked. It is also possible that crucial 
mRIM production, such as that for DNA polymerase or thymidine kinase is 
blocked. 
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3 
Aphldicolin was shown to affect H-thymidine incorporation in 
8-cell and blastocyst embryos (Figure 14). This appears to be the first 
report of aphidlcolln's effect on preimplantation mouse embryos. The 
effect of aphidicolin on sea urchins (Oguro et al., 1978), rat liver 
cells (Ohashl et al., 1978) and human embryonic lung cells (Bucknall et 
al., 1973) have been examined. Aphidicolin doses in the range of 5-15 
^g/ml completely blocked DNA synthesis (i.e., cell cleavage) in these 
systems. In this study 20 pg/ml of aphidicolin completely blocked DNA 
3 
synthesis (i.e., H-thymidine incorporation) in 8-cell and blastocyst 
embryos. Since aphidicolin is a specific inhibitor of animal IXJA poly-
polymerase-Of, but not /3 or V forms (Oguro et al., 1978), it can be con­
cluded that mouse embryos of the 8-cell and blastocyst stages of develop­
ment express functional DNA polymerase-ùt. This finding is interesting 
in light of %iessling and Weitlauf's (1981) recent report where they 
detected a DNA polymerase-V-like enzyme which increased in activity when 
the morula differentiates into the inner cell mass and the trophectoderm 
of the blastocyst. They have suggested that DNA polymerase-"/ may have 
a specialized, differentiation function in development. It would be 
interesting to incubate morula embryos with aphidicolin to see if the 
differentiation process to the ICM and trophectoderm would still occur. 
If no inhibition was observed,this would support the hypothesis that a 
DNA polymerase-Y-like enzyme was responsible for the differentiation 
process. 
3 
Theophylline was seen to have a negligible effect on H-thymidine 
incorporation by blastocyst embryos (Figure 15). Theophylline inhibits 
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phosphodiesterase which changes cyclic AMP to AMP. It is possible that 
phosphodiesterase and cyclic AMP do not play a major role in the bio­
chemistry of the blastocyst embryo. By examining in vitro medium require­
ments, it was shown that embryos were able to use only certain carbon 
sources during their development. Growth of 1-cell embryos was supported 
only by oxaloacetate or pyruvate. Growth of 2-cell embryos was supported 
by lactate, oxaloacetate, pyruvate, or phosphoenolpyruvate. After the 
8-cell stage, embryos could also utilize glucose, malate, and Of-
ketoglutarate as energy sources (Whittingham, 1971). Therefore, it is 
quite reasonable to conclude that the embryonic genome is slowly acti­
vated during development and that adult enzymes may not be present in 
early stages of development. 
-5 3 
Cycloheximide and puromycin at 10 M inhibited H-thymidine 
incorporation by blastocyst embryos (Figure 15) and suggests that blasto­
cyst embryos are producing proteins which are probably essential for 
DNA replication. 
Since embryos are constantly exposed to hormones present in the 
uterine fluid during early pregnancy, it would seem possible for hormones 
to affect the molecular machinery of the embryo. Steroid hormones have 
been shoim to have no effect on RNA synthesis in preimplantation mouse 
embryos (Warner and Tollefson, 1978). Wiley (1980) demonstrated that 
an hCG-like molecule was present on the surface of inner cell mass cells, 
but not on the surface of trophectodermal cells. Instead, the hCG-like 
molecule was detectable in the cytoplasm of trophectodermal cells. The 
hCG-like molecule was detectable by antiserum to the a-subunit of hCG. 
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Based on Wiley's findings, and the negative results reported in this 
thesis for hCG and the 0-subunit of hCG (Table 12), it would be inter­
esting to examine the effect that hCG and the 01- subunit would have on 
late 8-cell embryos as they divide in culture to form morulae. Perhaps, 
the hCG serves the function of Indirectly affecting differentiation into 
not only the ICM and trophectodermal cells following the morula stage 
of development, but also affects the differentiation of the ICM and 
tropectodermal cells into giant cells and phagocytic-like cells at the 
time of implantation. 
Finally, experiments in which the DNA synthesis assay was used to 
measure embryo viability, after treatment with antisera and complement, 
will be discussed. The Cytotoxicity assay for 8-cell and blastocyst 
embryos consists of incubation with antiserum or normal serum for one 
hour, then with guinea pig complement for one hour, followed by a five 
3 
hour incubation period with H-thymidine. 
The data (Table 28) demonstrate that mouse blastocyst embryos of 
the H-2 b, a, k, and d haplotypes express H-2 antigens as demonstrated 
by the embryo cytotoxicity assay performed with a congenlc antiserum 
directed to cell surface proteins of the H-2 complex. It is possible 
to obtain complete elimination of DNA synthesis in mouse blastocyst 
embryos by using a multlspeclfic antiserum directed to mouse cell sur­
face proteins (Figure 16). This implies that both cells of the trophec-
toderm and of the inner cell mass killed by the antisera treatment. 
However, the use of more restricted antisera (Tables 4 and 5), did not 
give complete killing of the embryos (Tables 28 and 29). 
175  
This may be due to the expression of different cell surface antigens on 
the inner cell mass as opposed to the trophectoderm. Therefore, an anti­
serum which would bind to one cell type would not necessarily bind to 
the other cell type. Also, the quantitative expression of H-2 antigens 
may vary from haplotype to haplotype of mouse embryos. O'Neill and 
McKenzie (1980) demonstrated that H-2K and H-2D antigen expression on 
spleen lymphocytes varied quantitatively among the different haplotypes 
tested. 
It is clear from the data that different conclusions about the 
expression of H-2 antigens on blastocyst embryos are generated by examin­
ing different haplotypes. Only when a complete array of antisera are 
available to detect K and D molecules of each of the haplotypes will 
definite conclusions be able to be drawn about the presence or absence 
of these molecules on blastocyst and 8-cell embryos. From the present 
d Ic 
study, it appears that K and D molecules are expressed on blastocyst 
embryos, but D^, and molecules are not expressed. The development 
of monoclonal antibodies of defined H-2 specificities should facilitate 
further studies in this area. 
Of special interest in this study are the unpredicted cross-
k b 
reactivities seen with H-2 and H-2 blastocyst embryos (Table 30). 
Ostrand-Rosenberg et al. (1977) found similar aberrant cross-reactions 
when studying blastocyst outgrowths of the H-2^ and 11-2^ haplotypes. 
They also noted that blastocyst outgrowths showed different specificities 
from lymphocytes of the same haplotype. The data shown in Table 30, 
using the congenic antisera, and the data shown in Table 31, using NIH 
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d le le 
antlsera specific to K on BIO.BR blastocyst embryos (H-2 K D ) and 
lymphocytes, suggest that this same conclusion is appropriate when com­
paring blastocyst embryos and lymphocytes in our system. 
There are several possible explanations for the observed aberrant 
cross-reactivities. One is that the unexpected antigens on embryos may 
be due to derepression of pre-existing genetic information for H-2 
specificities of different liaplotypes. Garrido et al. (1976) have shown 
that foreign H-2 liaplotypes could be expressed by certain cell lines 
after viral infection. Perhaps, embryos, too, possess the genetic informa­
tion for more than one 11-2 haplotype, then upon differentiation, embryos 
could process their DNA to allow the expression of only one adult H-2 
haplotype. Another possibility is that embryos express a general multi-
specific antigen, which later gives rise to the haplotype specific H-2 
antigens found in adult tissues. This hypothesis is especially appeal­
ing because it could explain how embryos escape maternal immune surveil­
lance. The multisperific 11-2 antigen would present paternal antigens 
in a form unrecognizable by the maternal system and would, therefore, not 
elicit an immune response. 
la antigens do not appear to be present on blastocyst embryos 
(Table 41) and, therefore, earlier reports (Delovitch et al., 1978; 
Jenkinson and Searle, 1979) are confirmed. 
H-2 antigens were detected on 8-cell embryos of the b, k and d 
haplotypes in embryo cytotoxicity assays involving congenic antigens 
(Table 36). The more restricted NIH antlsera (D32 and D31) were unable 
to detect H-2 antigens on 8-cell embryos of the k and d haplotypes. 
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These results suggest that H-2 antigens are expressed in lower 
concentrations on 8-cell embryos than on blastocyst embryos, since the 
restricted HIH antisera (D32 and D31) were able to detect 11-2 antigens 
on blastocyst embryos of the k and d haplotypes (Table 29). Krco and 
Goldberg (1977) reported the presence of 11-2 antigens on 8-cell embryos 
by visual observation of lysis of one to eight cells of the 8-cell 
embryo by antiserum and complement. If H-2 antigens are expressed on 
only some cells of the 8-cell embryo, as suggested by Krco and Goldberg's 
data, then the sensitivity of the embryo cytotoxicity assay described 
in this dissertation would have to be enhanced to get more meaningful 
results. One method of enhancement would be to utilize the "sandwich" 
technique in which embryos would first be treated with anti-H-2 serum, 
then incubated with rabbit anti-mouse immunoglobulin, and then finally 
incubated with guinea pig complement. The rabbit anti-mouse immunoglobu-
line would bind to two antigenic mouse immunoglobulin molecules which 
may each be bound to only one H-2 molecule, rather than two. Therefore, 
complement would bind to the rabbit anti-mouse Immunoglobulin molecule 
and initiate the complement cascade. 
The inability to detect ^^-microglobulin (/S^m) on mouse embryos 
(Tables 42 and 43) was somewhat puzzling in light of a brief communica­
tion by Hâkansson and Peterson (1976) in which they used indirect 
Immunofluorescence to detect on delayed implanting blastocyst embryos 
and on estradiol-actlvated blastocyst embryos. There are .ree possible 
explanations for this discrepancy. First, there was a dif rence in 
antiserum in their study and ours. Hâkansson and Peterson used affinity 
178  
column purified antibody to human ^m, whereas rabbit anti-mouse 
serum was used in this study. Antibodies raised to human have been 
shown to cross-react extensively with mouse (Rask et al., 1974; 
Ostberg et al., 1975), therefore, this difference may not be critical. 
Second, the cytotoxic titer, of the rabbit anti-mouse used in this 
study was quite low. It decreased greatly at a 1:16 dilution against 
lymphocyte targets. The low cytotoxicity titer suggests that the 
antibody concentration probably was not large enough to be able to detect 
on the embryos. Third, this study used early blastocyst embryos 
(89 hours post-hCf.) which had not been induced to enter into a state of 
delayed implantation nor had been estradiol-activated. It may be that 
^^-microglobulin is not expressed on early mouse blastocysts or that a 
non-^m light chain may be expressed instead. There is some precedence 
for this in the literature, as discussed below. 
F9 antigens are common to primitive teratocarcinoma cells, to 
preimplantation embryos and to spermatozoa (Artzt et al., 1973). The 
F9 molecule is composed of two heavy chains (44,000 MW each) crosslinked 
by a disulfide bridge and two light chains (12,000 MW each) (Vitteta et 
al., 1975). The light chains were believed to be ^^-microglobulin chains, 
but serological studies in conjunction with immunofluorescence have 
demonstrated that the light chains are not detected by rabbit anti-mouse 
^^-microglobulin (Dubois et al., 1976). Due to the fact that F9 anti­
gens are a product of the T/t locus on chromosome 17 and due to their 
structural homology with H-2 antigens, it has been postulated that the 
expression of H-2 and T/t (i.e., F9) antigens may be reciprocal, with 
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the F9 antigen appearing during early development prior to the appearance 
of H-2 antigens (Artzt and Bennett, 1975). Therefore, it would seem 
possible that a transitory form of f^-microglohulin may exist, attached 
to H-2 antigens in early preimplantatIon development. This transitory 
"j^,-mlcroglobulin like" molecule may also provide a conformational form 
of the 11-2 antigen that alters the antigenic determinants so that they 
differ from those determinants expressed in the adult tissue when 
microglobulin is complexed to the H-2 subunit. 
The ability of ^g'^icroglobulin to affect conformational change and, 
subsequently, antigenicity of the H-2 molecule is not clear. Sege et al. 
(1979) demonstrated that presence or absence of ^-microglobulin did not 
affect the ability of anti-H-2 sera to bind to H-2 antigens. In contrast, 
in man it has been reported that absence of ^^-microglobulin from HLA 
seriously Impaired antlsera reactivity to the intact HLA molecule (Lancet 
et al., 1979). 
It has been reported that H-2 antigens on mouse lymphocytes are 
not all expressed with intact g^m (Sege et al., 1979). If the adult tis­
sue lacks it may be that the embryonic H-2 lacks /J^m. An examina­
tion of the ability of exogenous ^^m to bind to embryonic H-2 antigens 
may further elucidate this problem. Schmidt et al. (1981) demonstrated 
that exogenous j3^m was capable of binding to H-2 on mouse lymphocytes 
and tumor cells. 
One other point of interest (see Table 43) is that the cytotoxicity 
of rabbit anti-mouse ^^-microglobulin on lymphocytes is noticeably lower 
for B10.D2 (H-2^) lymphocytes than for the other strains tested. Schmidt 
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et al. (1981) reported a similar low reactivity of anti-ZS^m serum for the 
d haplotype. It seems that the binding affinity of to H-2^ molecules 
is lower than that of the other haplotypes. 
The last part of this dissertation deals with some preliminary 
attempts to detect H-2 antigens on mouse embryos by using specific cyto­
toxic T cells, rather than serum antibody. Ostrand-Rosenberg (1980) 
demonstrated the feasibility of using cell-mediated Immune responses to 
detect embryonic antigens. She employed two test systems—one, the mixed 
cell culture system, in which syngeneic lymphocytes were added to syn­
geneic blastocyst outgrowth cells and blastogenesis by the lymphocytes 
3 
was measured by H-thymldlne uptake. • The second system Involved the 
growth Inhibition assay in which lymphocytes from a five-day mixed cell 
culture reaction were Incubated with target embryonic cell lines for 48 
3 hours, then pulsed with H-thymidlne for 24 hours. Inhibition of cell 
growth was recorded as a reduction in cell counts. 
The cell-mediated lympholysls reaction involves four stages: 
(1) cell-cell interaction, (2) programming for lysis, (3) a lethal hit, 
2+ 
and (4) the rupture of the target cell's membrane (Henney, 1980). Mg 
2+ is needed for the binding of the effector cell to its target. Ca and 
cAMP appear to have roles in the events following cell-cell interaction, 
though the exact mechanism of programming for lysis is unclear. The 
lethal hit has been postulated to Involve soluble factors, a membrane 
associated phospholipase, or even effector cell surface enzymes with 
trypsln-like activity. The target cells appear to be destroyed by osmotic 
forces, resulting from the influx of water Into the cell (Henney, 1980). 
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The cell-mediated lympholysLs reaction is dependent on H-2K and H-2D 
antigen recognition by effector cells (cytotoxic T cells). 
Cytotoxic T cells were generated and their ability to kill mouse 
embryos was tested. The preliminary data presented in Table 44 indicate 
k that cytotoxic T lymphocytes, sensitized to H-2 lymphocytes, are cyto-
toxic to H-2 embryos. These results provide functional proof that H-2 
antigens are expressed on preimplantation mouse embryos. 
The cytotoxic T cell response is very specific. Cytotoxic T cells, 
sensitized to H-2 antigens, do not kill murine teratoma cells bearing 
F9, but lacking H-2 antigens, in spite of the structural similarities 
between H-2 and F9 (Forman and Vitetta, 1975). 
The specificity of the H-2 antigens recognized on mouse blastocyst 
embryos by cytotoxic T cells is uncertain. Vazquez et al. (1980) report 
that public H-2 specificities are the target determinants for alloreac-
tive cytotoxic T lymphocytes. Therefore, the cytotoxic T cells may be 
recognizing public H-2 specificities on blastocyst embryos. 
The embryo-lymphocyte assay was performed by using cytotoxic T 
cells, sensitized to adult lymphocytes. It would be interesting to ex­
amine the specificity of cytotoxic T cells generated to embryonic cells, 
especially since the embryo appears to be expressing H-2 antigens which 
differ from the H-2 antigen of adult tissues. Schirrmacher et al. (1980) 
demonstrated that cytotoxic T lymphocytes sensitized to an H-2^ derived 
sarcoma were capable of lysing not only the sarcoma cells, but also H-2 
bearing target cells. The 11-2^ sarcoma cells were believed to express 
public specificities common to the H-2 haplotype. 
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Ce 11-mediated cytolysis reactions need to be handled carefully In 
order to obtain meaningful data. Goldstein et al. (1978) found that 
target cells and sensitizing cells exhibited adsorbed xenogeneic serum 
constituents on their cell surfaces. Cytotoxic T cells were sensitized 
to these xenogeneic determinants and, therefore, lysed target cells which 
had been cultured in the presence of the xenogeneic serum, though the 
target cells had been washed several times. It therefore appears that the 
detection of H-2 antigens on prelmplantation embryos by using cytotoxic 
T cells will be possible, but care must be taken in experimental design. 
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V. CONCLUSIONS 
Preimplantation mouse embryos were found capable of incorporating 
3 
U-thymidine into their DNA. This ability was utilized in three differ­
ent ways. First, this ability was correlated to the number of cytolog-
ically determined cells present in the embryos from different strains 
of mice. A 0.96 correlation coefficient was obtained, suggesting the 
feasibility of using DNA synthesis by embryos to determine the average 
number of cells per embryo In a given population of embryos. 
3 
Second, the ability to incorporate H-thymldlne was utilized to 
examine the effect of various compounds on DNA synthesis in preimplanta-
3 
tion mouse embryos. Ability to Incorporate H-thymldlne demonstrated 
that blastocyst embryos were refractory to theophylline and hCG, while 
salt, CK-amanitln, aphidicolln, cycloheximlde, and puromycin impaired 
3 
11-thymidine incorporation by blastocyst embryos. Ot-Amanltln is able to 
directly affect DNA synthesis in blastocyst embryos and to a lesser 
extent, in 8-cell embryos. Aphidicolln has been used in other animal 
systems, but not previously on 8-cell and blastocyst embryos. 
3 
Third, the ability to incorporate H-thymldlne was utilized in two 
types of cytotoxicity assays as an embryo viability indicator. In the 
embryo cytotoxicity assay, embryos were incubated with antiserum and com-
3 
plement and cell death was measured by inhibition of H-thymidlne 
incorporation into DNA. The use of congenic and NIH antl-H-2 sera on 
the embryos, demonstrated that H-2 antigens were detectable on 8-cell 
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d le 
and blastocyst embryos. K and D molecures were detectable on blasto­
cyst embryos, but and molecules were not detectable. An 
interesting aspect of this study was the finding that H-2 antigens on 
blastocyst embryos exhibit specificities which differ from those speci­
ficities present on adult lymphocytes. This general, multlspeclfIc H-2 
antigen on the embryo was postulated to serve the function of allowing 
the embryo to escape immune surveillance by the mother during early 
mammalian embryogenesis. Eight-cell embryos were found to express H-2 
antigens, but in lower concentrations than on blastocyst embryos. la 
antigens were not detectable on blastocyst embryos and this finding con­
firms earlier negative reports, ^^-microglobulin was not detected on 
mouse blastocyst embryos which expressed H-2 antigens. The meaning of 
this result is not clear, A cell-mediated lympholysls reaction, In which 
cytotoxic T cells were used against blastocyst embryo targets, showed 
the functional presence of H-2 antigens on blastocyst embryos. 
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